Processing 00000000.tx.1: Formation of 2'-deoxyoxanosine from 2'-deoxyguanosine and nitrous acid: mechanism and intermediates Toshinori Suzuki, Hiroshi Ide1, Masaki Yamada, Nobuyuki Endo, Kenji Kanaori2, Kunihiko Tajima2, Takashi Morii and Keisuke Makino* Institute of Advanced Energy, Kyoto University, Gokasho, Uji 611-0011, Japan, 1Department of Mathematical and Life Sciences, Graduate School of Science, Hiroshima University, Kagamiyama, Higashi-Hiroshima 739-8526, Japan and 2Department of Polymer Science and Engineering, Kyoto Institute of Technology, Matsugasaki, Sakyo-ku, Kyoto 606-8585, Japan Received August 31, 1999; 

Phrase: "Formation of 2'-deoxyoxanosine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "from 2'-deoxyguanosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "nitrous acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028214:Nitrous Acid [Inorganic Chemical]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: ":"

Phrase: "mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "and"

Phrase: "intermediates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205103:Intermediate [Spatial Concept]
  1000   C1550465:intermediate [Idea or Concept]
  1000   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "Toshinori Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0998924:suzuki [Fish]

Phrase: "Hiroshi Ide1,"

Phrase: "Masaki Yamada,"

Phrase: "Nobuyuki Endo, Kenji Kanaori2,"

Phrase: "Kunihiko Tajima2,"

Phrase: "Takashi Morii"

Phrase: "and"

Phrase: "Keisuke Makino"

Phrase: "* Institute of Advanced Energy,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021622:institute [Organization]
   770   C1272753:Institute [Idea or Concept]

Phrase: "Kyoto University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Gokasho,"

Phrase: "Uji 611-0011,"

Phrase: "Japan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: "1Department of Mathematical"

Phrase: "and"

Phrase: "Life Sciences,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005526:Life Sciences [Occupation or Discipline]
   861   C0036397:Sciences [Occupation or Discipline]

Phrase: "Graduate School of Science,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0870614:graduate school [Manufactured Object,Organization]
   770   C0036375:School [Manufactured Object,Organization]
   770   C0588053:Graduate [Population Group]
   770   C1547183:Graduate [Idea or Concept]

Phrase: "Hiroshima University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Kagamiyama,"

Phrase: "Higashi-Hiroshima 739-8526,"

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: "and"

Phrase: "2Department of Polymer Science"

Phrase: "and"

Phrase: "Engineering,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014279:Engineering [Occupation or Discipline]

Phrase: "Kyoto Institute of Technology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021622:institute [Organization]
   770   C1272753:Institute [Idea or Concept]

Phrase: "Matsugasaki,"

Phrase: "Sakyo-ku,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1532717:ku [Quantitative Concept]
   861   C1881335:kU [Quantitative Concept]

Phrase: "Kyoto 606-8585,"

Phrase: "Japan Received August 31,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0022341:Japan [Geographic Area]
   812   C0450355:31 [Intellectual Product]
   812   C1514756:Received [Qualitative Concept]

Phrase: "1999"

Phrase: ";"
Processing 00000000.tx.2: Revised and Accepted November 21, 1999.  

Phrase: "Revised"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1527075:Revised [Therapeutic or Preventive Procedure]
   966 E C3244319:revise [Functional Concept]

Phrase: "and"

Phrase: "Accepted November 21,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "1999."
Processing 00000000.tx.3: ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS AND DISCUSSION REFERENCES  The reaction mechanism for the formation of 2'-deoxyoxanosine from 2'-deoxyguanosine by nitrous acid was explored using methyl derivatives of guanosine and an isolated intermediate of the reaction. 

Phrase: "ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "AND"

Phrase: "DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The reaction mechanism for the formation of 2'-deoxyoxanosine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0441712:Mechanism [Functional Concept]
   742   C1706376:Mechanism [Manufactured Object]

Phrase: "from 2'-deoxyguanosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "by nitrous acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028214:Nitrous Acid [Inorganic Chemical]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "was"

Phrase: "explored"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "methyl derivatives of guanosine"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0243072:derivatives [Chemical Viewed Structurally]
   737 E C1527240:Derivative [Functional Concept]

Phrase: "and"

Phrase: "an isolated intermediate of the reaction."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205103:Intermediate [Spatial Concept]
   753   C1550465:intermediate [Idea or Concept]
   753   C2827755:INTERMEDIATE [Laboratory or Test Result]
Processing 00000000.tx.4: When 1-methylguanosine was incubated with NaNO2 under acidic conditions, N5-methyloxanosine and 1-methylxanthosine were generated, whereas the same treatment of N2,N2-dimethylguanosine generated no product. 

Phrase: "When"

Phrase: "1-methylguanosine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0044469:1-methylguanosine [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0762000:methylguanosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "incubated with NaNO2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "under acidic conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "N5-methyloxanosine"

Phrase: "and"

Phrase: "1-methylxanthosine"

Phrase: "were"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: ","

Phrase: "whereas"

Phrase: "the same treatment of N2,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "N2-dimethylguanosine"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "no product."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514468:product [Entity]
  1000   C1704444:Product [Quantitative Concept]
Processing 00000000.tx.5: In a similar experiment without NO2, participation of a Dimroth rearrangement was ruled out. 

Phrase: "In a similar experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0681814:Experiment [Research Activity]
   861   C1706386:Experiment [Conceptual Entity]
   789 E C1517586:Experimental [Qualitative Concept]

Phrase: "without NO2,"

Phrase: "participation of a Dimroth rearrangement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0679823:Participation [Functional Concept]

Phrase: "was"

Phrase: "ruled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1446409:ruled [Qualitative Concept]
   966 E C0805874:Rule [Idea or Concept]
   966 E C0870077:Rule [Intellectual Product]

Phrase: "out."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]
Processing 00000000.tx.6: In the guanosineHNO2 reaction system, an intermediate with a half-life of 5.6 min (pH 7.0, 20C) was isolated and tentatively identified as a diazoate derivative of guanosine. 

Phrase: "In the guanosineHNO2 reaction system,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "an intermediate with a half-life"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205103:Intermediate [Spatial Concept]
   753   C1550465:intermediate [Idea or Concept]
   753   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "of 5.6 min (pH 7.0,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   827   C0442749:5 6 [Finding]
   827   C1882074:pH 7 [Qualitative Concept]
   799   C0020283:[pH] [Quantitative Concept]
   799   C0439084:>5 [Quantitative Concept]
   799   C0450407:ph+ [Finding]
   799   C0450408:ph++ [Finding]
   799   C0450409:ph+++ [Finding]
   799   C0702093:/min [Temporal Concept]
   799   C0728893:+5 [Quantitative Concept]

Phrase: "20C"

Phrase: ")"

Phrase: "was"

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "tentatively"

Phrase: "identified as a diazoate derivative of guanosine."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   748   C0205396:Identified [Qualitative Concept]
   748   C1527240:Derivative [Functional Concept]
   748   C1550043:Identified [Finding]
   748   C1551388:Identified [Functional Concept]
Processing 00000000.tx.7: The diazoate intermediate was converted into oxanosine and xanthosine at a molar ratio (oxanosine:xanthosine) of 0.26 at pH 7.0 and 20C. 

Phrase: "The diazoate"

Phrase: "intermediate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205103:Intermediate [Spatial Concept]
  1000   C1550465:intermediate [Idea or Concept]
  1000   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "was"

Phrase: "converted into oxanosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0069733:oxanosine [Antibiotic]

Phrase: "and"

Phrase: "xanthosine at a molar ratio"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0078606:xanthosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(oxanosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0069733:oxanosine [Antibiotic]

Phrase: ":"

Phrase: "xanthosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0078606:xanthosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: "of 0.26"

Phrase: "at pH 7.0"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "20C."
Processing 00000000.tx.8: The ratio was not affected by the incubation pH between 2 and 10, but increased linearly with temperature from 0.22 (0C) to 0.32 (50C). 

Phrase: "The ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456603:Ratio [Quantitative Concept]
  1000   C1547037:Ratio [Intellectual Product]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affected by the incubation pH"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0020283:[pH] [Quantitative Concept]
   760   C0392760:Affected [Functional Concept]
   760   C0450407:ph+ [Finding]
   760   C0450408:ph++ [Finding]
   760   C0450409:ph+++ [Finding]
   760   C1314939:Affected [Functional Concept]
   726 E C0001721:Affect [Mental Process]

Phrase: "between 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "10,"

Phrase: "but"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "linearly with temperature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0005903:temperature [Organism Attribute]
   790   C0039476:*Temperature [Quantitative Concept]

Phrase: "from 0.22"

Phrase: "(0C"

Phrase: ")"

Phrase: "to 0.32"

Phrase: "(50C"

Phrase: ")."
Processing 00000000.tx.9: The addition of acetone also increased the ratio up to 0.85 (98% acetone). 

Phrase: "The addition of acetone also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1883712:Addition [Functional Concept]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the ratio up to 0.85"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0456603:Ratio [Quantitative Concept]
   753   C1547037:Ratio [Intellectual Product]

Phrase: "(98% acetone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001002:Acetone [Organic Chemical,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.10: Based on these results, a con-ceivable pathway for the formation of 2'-deoxyoxanosine from 2'-deoxyguanosine by HNO2 is proposed.  

Phrase: "Based on these results,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737 E C1880279:Base [Biomedical or Dental Material]
   737   C2825142:Result [Finding]

Phrase: "a con-ceivable pathway for the formation of 2'-deoxyoxanosine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1704259:Pathway [Molecular Function]
   739   C1705987:Pathway [Conceptual Entity]

Phrase: "from 2'-deoxyguanosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "by HNO2"

Phrase: "is"

Phrase: "proposed."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]
Processing 00000000.tx.11: INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS AND DISCUSSION REFERENCES  Oxanosine (Oxo), 5-amino-3--(D-ribofuranosyl)-3H-imidazo- [4,5-d][1,3]oxazin-7-one, was isolated as a novel antibiotic in 1981 from the culture broth of Streptomyces capreolus MG265-CF3 and characterized by X-ray crystallography (1,2). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "AND"

Phrase: "DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Oxanosine (Oxo),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0069733:oxanosine [Antibiotic]

Phrase: "5-amino-3--(D-ribofuranosyl"

Phrase: ")-"

Phrase: "3H-imidazo-"

Phrase: "[4,"

Phrase: "5-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "d]["

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "]oxazin-7-one,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205447:One [Quantitative Concept]

Phrase: "was"

Phrase: "isolated as a novel antibiotic"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0003232:Antibiotic [Antibiotic]
   760   C0205314:Novel [Temporal Concept]
   760   C0205409:Isolated [Functional Concept]
   760   C0679622:novel [Intellectual Product]
   760   C1548221:Isolated [Idea or Concept]
   726 E C0370215:Isolate [Substance]
   726 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "in 1981"

Phrase: "from the culture broth"

Phrase: "of Streptomyces capreolus MG265-CF3"

Phrase: "and"

Phrase: "characterized by X-ray crystallography"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   862   C0206755:Crystallography, X-Ray [Laboratory Procedure]
   806   C0034571:X-ray [Functional Concept]
   806   C0043299:X-ray, NOS [Diagnostic Procedure]
   806   C0043309:X-ray [Natural Phenomenon or Process]
   806   C1306645:X-ray [Diagnostic Procedure]
   806   C1962945:X-ray [Diagnostic Procedure]
   760   C0010424:Crystallography [Laboratory Procedure]
   760   C0086894:ray [Fish]
   760   C0851346:ray [Natural Phenomenon or Process]
   760   C1880022:Characterized [Activity]
   760   C2314876:ray [Fish]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.12: Oxo manifests a wide spectrum of biological effects including in vitro cytotoxicity against HeLa cells, antibacterial activity against Escherichia coli K-12 and Proteus mirabilis IFM OM-9, and induction of reversions to the normal phenotype of K-ras-transformed rat kidney cells (1,3). 

Phrase: "Oxo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0069733:oxanosine [Antibiotic]

Phrase: "manifests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205319:Manifest [Functional Concept]

Phrase: "a wide spectrum of biological effects"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0332464:Wide [Spatial Concept]
   753   C1883073:Spectrum [Quantitative Concept]
   753   C2827424:Spectrum [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "in vitro cytotoxicity against HeLa cells,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   731   C0022686:Cytotoxic cell [Cell]

Phrase: "antibacterial activity against Escherichia coli K-12"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0205177:Activity [Functional Concept]
   748   C0279516:Antibacterial [Antibiotic]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "Proteus mirabilis IFM OM-9,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C0033701:Proteus mirabilis [Bacterium]
   804   C0028971:OM [Geographic Area]
   804   C0033697:Proteus [Bacterium]
   804   C0330338:Mirabilis [Plant]
   804   C1504661:Proteus [Amphibian]
   804   C1705272:OM [Idea or Concept]

Phrase: "and"

Phrase: "induction of reversions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205263:Induction [Functional Concept]
   790   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "to the normal phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]

Phrase: "of K-ras-transformed rat kidney cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   895   C0022686:k cells [Cell]
   878 E C0022688:K cell [Cell]
   810   C0553257:kidney cell [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.13: 2'-Deoxyoxanosine (dOxo), a 2'-deoxyribonucleoside counterpart of Oxo, has been synthesized from Oxo and found to exhibit stronger antiviral and antineoplastic activities than Oxo (4). 

Phrase: "2'-Deoxyoxanosine (dOxo),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0622363:2'-deoxyoxanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "a 2'-deoxyribonucleoside counterpart of Oxo,"

Phrase: "has"

Phrase: "been"

Phrase: "synthesized from Oxo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0069733:oxanosine [Antibiotic]
   790   C1883254:Synthesized [Activity]

Phrase: "and"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "stronger antiviral"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003451:Antiviral [Pharmacologic Substance]

Phrase: "and"

Phrase: "antineoplastic activities than Oxo"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441655:Activities [Activity]
   737 E C0205177:Activity [Functional Concept]
   737 E C0439167:% activity [Quantitative Concept]
   737 E C1561536:*Activity [Idea or Concept]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.14: Oxo and its analogs have been chemically synthesized by several defined routes using 4-aminoimidazole derivatives (58) or inosine (9) as starting materials. 

Phrase: "Oxo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0069733:oxanosine [Antibiotic]

Phrase: "and"

Phrase: "its analogs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0243071:analogs [Chemical Viewed Structurally]
   893 E C0679213:analogies [Idea or Concept]

Phrase: "have"

Phrase: "been"

Phrase: "chemically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220806:Chemically [Chemical]

Phrase: "synthesized by several defined routes"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0449444:routes [Spatial Concept]
   760   C1704788:Defined [Conceptual Entity]
   760   C1883254:Synthesized [Activity]
   760   C3539106:Defined [Intellectual Product]
   726 E C0013153:ROUTE [Functional Concept]
   726 E C1879941:ROUTE [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "4-aminoimidazole derivatives"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0243072:derivatives [Chemical Viewed Structurally]
   793 E C1527240:Derivative [Functional Concept]
   734   C0387239:4-aminoimidazole [Organic Chemical,Pharmacologic Substance]

Phrase: "(58"

Phrase: ")"

Phrase: "or"

Phrase: "inosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021528:Inosine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "(9"

Phrase: ")"

Phrase: "as"

Phrase: "starting materials."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0520510:Materials [Substance]
Processing 00000000.tx.15: We have reported that the reaction of 2'-deoxyguanosine (dGuo) with nitrous acid (HNO2) results in the formation of dOxo together with 2'-deoxyxanthosine (dXao), a deaminated product of dGuo (10). 

Phrase: "We"

Phrase: "have"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "the reaction of 2'-deoxyguanosine (dGuo)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0443286:Reaction [Functional Concept]
   760   C1114821:Reaction [Clinical Attribute]

Phrase: "with nitrous acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028214:Nitrous Acid [Inorganic Chemical]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "(HNO2"

Phrase: ")"

Phrase: "results in the formation of dOxo"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1274040:Result [Functional Concept]
   753   C1522492:Formation [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C2825142:Result [Finding]

Phrase: "together with 2'-deoxyxanthosine (dXao),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0174507:2'-deoxyxanthosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "a deaminated product of dGuo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1514468:product [Entity]
   760   C1704444:Product [Quantitative Concept]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.16: The maximum yield of dOxo was 21.5%, which corresponded to ~1/3 of the deamination products. 

Phrase: "The maximum yield of dOxo"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0806909:Maximum [Quantitative Concept]
   760   C1552615:maximum [Quantitative Concept]
   760   C2826546:MAXIMUM [Quantitative Concept]

Phrase: "was"

Phrase: "21.5%,"

Phrase: "which"

Phrase: "corresponded"

Phrase: "to ~1/3 of the deamination products."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0011061:Deamination [Natural Phenomenon or Process]
   748   C1514468:Products [Entity]
   748   C1883351:To [Qualitative Concept]
   714 E C1704444:Product [Quantitative Concept]
Processing 00000000.tx.17: dOxo is also formed in a single-stranded oligodeoxynucleotide and double-stranded calf thymus DNA by HNO2 treatment with a comparable yield. 

Phrase: "dOxo"

Phrase: "is"

Phrase: "also"

Phrase: "formed in a single-stranded oligodeoxynucleotide"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   754   C1979975:Single strand [Qualitative Concept]
   753   C0037179:Single [Population Group]
   753   C0087136:single [Finding]
   753   C0205171:Single [Quantitative Concept]
   753   C0205431:Formed [Functional Concept]
   719 E C0348078:Form [Qualitative Concept]
   719 E C0376315:Form [Manufactured Object]
   719 E C1522492:Form [Functional Concept]

Phrase: "and"

Phrase: "double-stranded calf thymus DNA by HNO2 treatment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   800   C0966503:calf thymus DNA [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   793   C0311474:DNA, Double-Stranded [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "with a comparable yield."
Processing 00000000.tx.18: Furthermore, dOxo is generated from dGuo with nitric oxide (NO) at acidic and neutral pH. 

Phrase: "Furthermore,"

Phrase: "dOxo"

Phrase: "is"

Phrase: "generated from dGuo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]
   790   C3146294:Generated [Activity]

Phrase: "with nitric oxide (NO)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "at acidic"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001128:Acidic [Chemical]
   928 E C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "neutral pH."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1882074:Neutral pH [Qualitative Concept]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]
Processing 00000000.tx.19: We have also demonstrated that the N-glycosidic bond of dOxo is as stable as that of dGuo and is hydrolyzed 44-fold more slowly than that of dXao (11). 

Phrase: "We"

Phrase: "have"

Phrase: "also"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the N-glycosidic bond of dOxo"

Phrase: "is as stable"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205360:Stable [Qualitative Concept]
   790   C1547311:Stable [Intellectual Product]

Phrase: "as that"

Phrase: "of dGuo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "is"

Phrase: "hydrolyzed"

Phrase: "44-fold more slowly than that of dXao"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0332462:Fold [Spatial Concept]
   744   C0439834:Slowly [Qualitative Concept]
   744   C1880834:FOLD [Phenomenon or Process]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.20: 2'-Deoxyoxanosine 5'-triphosphate (dOTP) is more efficiently incorporated opposite cytosine in a DNA template than 2'-deoxyxanthosine 5'-triphosphate (dXTP) (12). 

Phrase: "2'-Deoxyoxanosine 5'-triphosphate (dOTP)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0146894:triphosphate [Inorganic Chemical]
   708   C0450346:2 5 [Quantitative Concept]

Phrase: "is"

Phrase: "more efficiently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205172:More [Functional Concept]

Phrase: "incorporated"

Phrase: "opposite cytosine in a DNA template"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0010843:Cytosine [Biologically Active Substance,Organic Chemical]

Phrase: "than 2'-deoxyxanthosine 5'-triphosphate (dXTP)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0146894:triphosphate [Inorganic Chemical]
   708   C0450346:2 5 [Quantitative Concept]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.21: Furthermore, dOTP is incorporated opposite thymine in the template, while dXTP is not incorporated under the same conditions. 

Phrase: "Furthermore,"

Phrase: "dOTP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0146894:triphosphate [Inorganic Chemical]

Phrase: "is"

Phrase: "incorporated"

Phrase: "opposite thymine in the template,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0040087:Thymine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "while"

Phrase: "dXTP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0146894:triphosphate [Inorganic Chemical]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "incorporated under the same conditions."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0445247:Same [Qualitative Concept]
   726   C0012634:condition [Disease or Syndrome]
   726   C0348080:Condition [Qualitative Concept]
   726   C1705253:Condition [Conceptual Entity]
Processing 00000000.tx.22: These results imply that the dOxo moiety generated from a dGuo moiety in the nucleotide pool or DNA may have important and unique roles in mutagenic and lethal events in cells. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "imply"

Phrase: "that"

Phrase: "the dOxo moiety"

Phrase: "generated from a dGuo moiety"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C3146294:Generated [Activity]

Phrase: "in the nucleotide pool"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0337051:Pool [Geographic Area]
   861   C1509144:pool [Clinical Attribute]
   861   C2349200:Pool [Functional Concept]

Phrase: "or"

Phrase: "DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "may"

Phrase: "have"

Phrase: "important"

Phrase: "and"

Phrase: "unique roles in mutagenic"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0035820:Roles [Social Behavior]
   737 E C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "lethal events in cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441471:Events [Event]
   770   C3541888:Events [Classification]
Processing 00000000.tx.23: dOxo has a six-membered ring in the base moiety in which the imino group at N1 of the pyrimidine ring of dGuo is substituted by an oxygen atom. 

Phrase: "dOxo"

Phrase: "has"

Phrase: "a six-membered ring in the base moiety"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0205452:Six [Quantitative Concept]
   744   C0521164:Ring [Spatial Concept]
   744   C1260969:Ring [Medical Device]
   744   C1705184:Ring [Medical Device]

Phrase: "in which"

Phrase: "the imino group at N1 of the pyrimidine ring of dGuo"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   738   C0441833:Group [Idea or Concept]
   738   C0687744:group [Population Group]
   738   C1257890:Group [Population Group]
   738   C1552516:Group [Health Care Related Organization]
   738   C1705428:Group [Conceptual Entity]
   738   C1705429:Group [Population Group]

Phrase: "is"

Phrase: "substituted by an oxygen atom."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0567415:Atom [Element, Ion, or Isotope]
   760   C1706222:Atom [Conceptual Entity]
Processing 00000000.tx.24: The formation of dOxo requires opening and closing of the pyrimidine ring of dGuo. 

Phrase: "The formation of dOxo"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "requires"

Phrase: "opening"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0175566:Opening [Spatial Concept]
  1000   C1882151:Opening [Spatial Concept]

Phrase: "and"

Phrase: "closing of the pyrimidine ring of dGuo."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0587267:closing [Functional Concept]
Processing 00000000.tx.25: Recent ab initio molecular orbital calculations predict that a ring-opened cation is formed synchronously with release of a nitrogen molecule from the diazonium ion of guanine (1315). 

Phrase: "Recent ab initio molecular orbital calculations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   766   C1441506:Calculation [Activity]

Phrase: "predict"

Phrase: "that a ring-opened cation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0007447:Cation [Chemical Viewed Structurally]

Phrase: "is"

Phrase: "formed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: "synchronously with release of a nitrogen molecule"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0028158:Nitrogen [Element, Ion, or Isotope]
   748   C0030685:Release [Health Care Activity]
   748   C0391871:Release [Functional Concept]
   748   C0439180:% release [Quantitative Concept]
   748   C0567416:Molecule [Substance]
   748   C0680255:release [Health Care Activity]
   748   C1283071:Release [Functional Concept]
   748   C1550581:nitrogen [Human-caused Phenomenon or Process]
   748   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "from the diazonium ion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022023:Ion [Element, Ion, or Isotope]
   861   C1700702:ION [Functional Concept]

Phrase: "of guanine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018321:Guanine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(1315"

Phrase: ")."
Processing 00000000.tx.26: However, direct evidence as to the reaction mechanism for the formation of dOxo from dGuo by HNO2 has not been shown so far. 

Phrase: "However,"

Phrase: "direct evidence as to the reaction mechanism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0332120:Evidence [Functional Concept]

Phrase: "for the formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0220781:formation [Biologic Function]
  1000   C0439634:formation [Spatial Concept]
  1000   C1522492:Formation [Functional Concept]

Phrase: "of dOxo"

Phrase: "from dGuo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "by HNO2"

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "so far."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037640:SO [Geographic Area]
   861   C0205108:far [Spatial Concept]
Processing 00000000.tx.27: Recently, we reported the detection and isolation of an intermediate in the reaction of 2'-deoxycytidine (dCyd) with HNO2 or NO (16). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "we"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "the detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "isolation of an intermediate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0204727:Isolation [Therapeutic or Preventive Procedure]
   770   C0205409:Isolation [Functional Concept]
   770   C0220862:isolation [Laboratory Procedure]

Phrase: "in the reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "of 2'-deoxycytidine (dCyd)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0011485:Deoxycytidine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "with HNO2"

Phrase: "or"

Phrase: "NO"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.28: The intermediate was identified from spectrometric data as a diazoate derivative of dCyd. 

Phrase: "The intermediate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205103:Intermediate [Spatial Concept]
  1000   C1550465:intermediate [Idea or Concept]
  1000   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "was"

Phrase: "identified from spectrometric data"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205396:Identified [Qualitative Concept]
   770   C1511726:Data [Idea or Concept]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]
   770   C3245479:data [Medical Device]

Phrase: "as a diazoate derivative"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1527240:Derivative [Functional Concept]

Phrase: "of dCyd."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011485:Deoxycytidine [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.29: Under physiological conditions (pH 7.4, 37C), the diazoate intermediate was fairly stable (t = 330 h) and was exclusively converted into 2'-deoxyuridine. 

Phrase: "Under physiological conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "(pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "37C"

Phrase: ")"

Phrase: ","

Phrase: "the diazoate"

Phrase: "intermediate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205103:Intermediate [Spatial Concept]
  1000   C1550465:intermediate [Idea or Concept]
  1000   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "was"

Phrase: "fairly stable"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205360:Stable [Qualitative Concept]
   861   C1547311:Stable [Intellectual Product]

Phrase: "(t = 330 h)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]
   734   C0388952:T 330 [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "was"

Phrase: "exclusively"

Phrase: "converted into 2'-deoxyuridine."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0011535:Deoxyuridine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.30: However, there is no information on the intermediates yielding dOxo and dXao in the reaction of dGuo with HNO2. 

Phrase: "However,"

Phrase: "there"

Phrase: "is"

Phrase: "no information on the intermediates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1546437:No Information [Qualitative Concept]
   806   C1549058:No Information [Idea or Concept]
   760   C1533716:Information [Idea or Concept]

Phrase: "yielding"

Phrase: "dOxo"

Phrase: "and"

Phrase: "dXao in the reaction of dGuo"

Phrase: "with HNO2."
Processing 00000000.tx.31: If the intermediates could be isolated, further insights into the reaction mechanism could be obtained. 

Phrase: "If"

Phrase: "the intermediates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0205103:Intermediate [Spatial Concept]
   966   C1550465:intermediate [Idea or Concept]
   966   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "could"

Phrase: "be"

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: ","

Phrase: "further insights into the reaction mechanism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0233820:insights [Mental Process]

Phrase: "could"

Phrase: "be"

Phrase: "obtained."
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]
Processing 00000000.tx.32: We report herein an analysis of the products formed by the reaction of methyl-substituted guanosines with HNO2. 

Phrase: "We"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "herein"

Phrase: "an analysis of the products"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "formed by the reaction of methyl-substituted guanosines"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   744   C0205431:Formed [Functional Concept]
   744   C0443286:Reaction [Functional Concept]
   744   C1114821:Reaction [Clinical Attribute]
   711   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   711 E C0348078:Form [Qualitative Concept]
   711 E C0376315:Form [Manufactured Object]
   711 E C1522492:Form [Functional Concept]

Phrase: "with HNO2."
Processing 00000000.tx.33: Furthermore, the diazoate intermediate of Guo was isolated and the influences of pH, temperature and solvent on the formation of Oxo and Xao from the intermediate were studied. 

Phrase: "Furthermore,"

Phrase: "the diazoate"

Phrase: "intermediate of Guo"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205103:Intermediate [Spatial Concept]
   790   C1550465:intermediate [Idea or Concept]
   790   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "was"

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "the influences of pH,"

Phrase: "temperature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005903:temperature [Organism Attribute]
  1000   C0039476:*Temperature [Quantitative Concept]

Phrase: "and"

Phrase: "solvent on the formation of Oxo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0037638:Solvent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "Xao from the intermediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0078606:xanthosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "studied."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]
Processing 00000000.tx.34: The reaction mechanism of dOxo formation by HNO2 is discussed based on these results.  

Phrase: "The reaction mechanism of dOxo formation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441712:Mechanism [Functional Concept]
   753   C1706376:Mechanism [Manufactured Object]

Phrase: "by HNO2"

Phrase: "is"

Phrase: "discussed"

Phrase: "based on these results."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737 E C1880279:Base [Biomedical or Dental Material]
   737   C2825142:Result [Finding]
Processing 00000000.tx.35: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS AND DISCUSSION REFERENCES  Materials Guanosine (Guo) was purchased from Kohjin (Tokyo, Japan). 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "AND"

Phrase: "DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Materials Guanosine (Guo)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "was"

Phrase: "purchased from Kohjin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0869011:purchased [Activity]

Phrase: "(Tokyo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040371:Tokyo [Geographic Area]

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: ")."
Processing 00000000.tx.36: N2,N2-Dimethylguanosine (N2,N2-diMe-Guo), N2-methylguanosine (N2-Me-Guo), 1-methlyguanosine (1-Me-Guo) and xanthosine (Xao) were obtained from Sigma (St Louis, MO). 

Phrase: "N2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441960:N2 [Finding]

Phrase: "N2-Dimethylguanosine (N2,N2-diMe-Guo),"

Phrase: "N2-methylguanosine (N2-Me-Guo),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0762000:methylguanosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "1-methlyguanosine"

Phrase: "(1-Me-Guo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "xanthosine (Xao)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0078606:xanthosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "obtained from Sigma"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1301820:Obtained [Functional Concept]
   790   C1719918:Sigma [Intellectual Product]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "(St Louis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272372:ST [Intellectual Product]

Phrase: "MO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.37: All other chemicals of reagent grade were purchased from Wako Pure Chemicals (Osaka, Japan) or Nacalai Tesque (Osaka, Japan), and used without further purification. 

Phrase: "All"

Phrase: "other chemicals of reagent grade"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0220806:Chemicals [Chemical]
   726 E C3272558:Chemical [Intellectual Product]

Phrase: "were"

Phrase: "purchased from Wako Pure Chemicals"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0220806:Chemicals [Chemical]
   760   C0869011:purchased [Activity]
   760   C2247561:PurE [Molecular Function]
   726 E C3272558:Chemical [Intellectual Product]

Phrase: "(Osaka,"

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: ")"

Phrase: "or"

Phrase: "Nacalai Tesque"

Phrase: "(Osaka,"

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "used without further purification."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0243114:purification [Functional Concept]
   770   C1273517:used [Finding]
   770   C1517331:Further [Spatial Concept]
   770   C1998793:Purification [Functional Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0205108:far [Spatial Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.38: Water was purified with a Millipore Milli-QII deionizer. 

Phrase: "Water"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
  1000   C0599638:WATER [Substance]
  1000   C1550678:Water [Inorganic Chemical]
   928 E C0443350:Watery [Qualitative Concept]

Phrase: "was"

Phrase: "purified with a Millipore Milli-QII deionizer."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1553034:Milli [Quantitative Concept]
   748   C1707661:Deionizer [Manufactured Object]
   748   C1998793:Purified [Functional Concept]
Processing 00000000.tx.39: HPLC conditions The HPLC system consisted of Shimadzu LC-6A pumps and a CTO-6A system controller. 

Phrase: "HPLC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008562:HPLC [Laboratory Procedure]

Phrase: "conditions"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
  1000   C0012634:condition [Disease or Syndrome]
  1000   C0348080:Condition [Qualitative Concept]
  1000   C1705253:Condition [Conceptual Entity]
   944 E C0040607:Training [Educational Activity]
   944 E C0220931:Training [Educational Activity]
   944 E C0336809:Train [Manufactured Object]
   944 E C1552514:Train [Manufactured Object]
   944 E C2673163:training [Qualitative Concept]
   916 E C0009647:Conditioned [Mental Process]

Phrase: "The HPLC system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "consisted of Shimadzu LC-6A pumps"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0182537:pumps [Medical Device]
   753   C1553638:6a [Medical Device]
   719   C0332529:CONSIST [Qualitative Concept]
   719 E C1706421:Pump [Manufactured Object]

Phrase: "and"

Phrase: "a CTO-6A system controller."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0180112:Controller [Medical Device]
Processing 00000000.tx.40: On-line UV spectra were obtained with a Shimadzu SPD-M6A UV-Vis photodiode array detector. 

Phrase: "On-line UV spectra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1883073:Spectrum [Quantitative Concept]
   779   C2827424:Spectrum [Conceptual Entity]

Phrase: "were"

Phrase: "obtained with a Shimadzu SPD-M6A UV-Vis photodiode array detector."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   738   C0023440:M6a [Neoplastic Process]
   738   C0041625:UV [Natural Phenomenon or Process]
   738   C0180392:Detector [Medical Device]
   738   C1301820:Obtained [Functional Concept]
   738   C1424999:M6A [Gene or Genome]
   738   C1510941:Array [Spatial Concept]
   738   C1571809:VIS [Therapeutic or Preventive Procedure]
   738   C1705235:Detector [Manufactured Object]
   738   C1961129:uV [Quantitative Concept]
   738   C3273505:SPD [Gene or Genome]
   704 E C1706701:Obtain [Activity]
Processing 00000000.tx.41: For reversed phase (RP-)HPLC, a Hypersil ODS-5 octadesylsilane column (4.6 x 150 mm, particle size 5 m; GL Sciences) was used. 

Phrase: "For reversed phase (RP-)HPLC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0008562:HPLC [Laboratory Procedure]

Phrase: "a Hypersil ODS-5 octadesylsilane column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1185738:Column [Body Part, Organ, or Organ Component]
   804   C1706132:Column [Idea or Concept]

Phrase: "(4.6 x 150 mm,"

Phrase: "particle size 5 m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441923:M+ [Intellectual Product]

Phrase: "; GL Sciences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Sciences [Occupation or Discipline]

Phrase: ")"

Phrase: "was"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.42: The eluant was 100 mM triethylammonium acetate (TEAA) buffer (pH 7.0) containing acetonitrile (CH3CN). 

Phrase: "The eluant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3469601:Eluent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "was"

Phrase: "100 mM triethylammonium acetate (TEAA) buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(pH 7.0"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "acetonitrile"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050456:acetonitrile [Organic Chemical]

Phrase: "(CH3CN"

Phrase: ")."
Processing 00000000.tx.43: For measurement of the hydrolysis rate constant of the intermediate only, 50 mM sodium phosphate buffer (pH7.0) containing CH3CN was used as the eluant. 

Phrase: "For measurement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242485:Measurement [Functional Concept]

Phrase: "of the hydrolysis rate constant"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C2986811:Rate Constant [Quantitative Concept]
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]
   827   C1547014:*Constant [Quantitative Concept]
   827   C1948059:Constant [Qualitative Concept]

Phrase: "of the intermediate only,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205103:Intermediate [Spatial Concept]
   861   C0205171:Only [Quantitative Concept]
   861   C1550465:intermediate [Idea or Concept]
   861   C1720467:Only [Intellectual Product]
   861   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "50 mM sodium phosphate buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C3256935:sodium phosphate buffer [Pharmacologic Substance]
   840   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(pH7.0"

Phrase: ")"

Phrase: "containing CH3CN"

Phrase: "was"

Phrase: "used as the eluant."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C1273517:used [Finding]
   770   C3469601:Eluent [Indicator, Reagent, or Diagnostic Aid]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.44: The CH3CN concentration was increased from 0 to 20% over 20 min as a linear gradient. 

Phrase: "The CH3CN concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "was"

Phrase: "increased from 0"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "to 20%"

Phrase: "over 20 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "as a linear gradient."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439182:% gradient [Quantitative Concept]
   861   C0812409:Gradient [Quantitative Concept]
Processing 00000000.tx.45: RP-HPLC analysis was performed at a flow rate of 1.0 ml/min and ambient temperature. 

Phrase: "RP-HPLC analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C2986798:Phase Analysis [Occupational Activity]
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "performed at a flow rate of 1.0 ml/min"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   775   C1301925:Min 0.1 [Temporal Concept]
   760   C0439445:mL/min [Quantitative Concept]
   760   C2826285:Flow Rate [Quantitative Concept]
   757   C1301862:Min 1 [Temporal Concept]
   739   C0439526:/mL [Quantitative Concept]
   739   C0702093:/min [Temporal Concept]
   739   C0806140:Flow [Natural Phenomenon or Process]
   739   C0871208:Rate [Activity]
   739   C0884358:Performed [Functional Concept]
   739   C1521828:Rate [Quantitative Concept]
   706 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "ambient temperature."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0428692:Ambient temperature [Natural Phenomenon or Process]
  1000   C0542496:Ambient temperature [Finding]
  1000   C2348236:Ambient Temperature [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1879688:Ambient [Qualitative Concept]
Processing 00000000.tx.46: Spectrometric measurements NMR spectra were measured on a Bruker ARX-500 NMR spectrometer (500 MHz) at 30C. 

Phrase: "Spectrometric measurements NMR spectra"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0024485:NMR [Diagnostic Procedure]
   812   C0028580:NMR [Natural Phenomenon or Process]
   779   C1883073:Spectrum [Quantitative Concept]
   779   C2827424:Spectrum [Conceptual Entity]

Phrase: "were"

Phrase: "measured on a Bruker ARX-500 NMR spectrometer"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   744   C0024485:NMR [Diagnostic Procedure]
   744   C0028580:NMR [Natural Phenomenon or Process]
   744   C0183395:Spectrometer [Medical Device]
   744   C0444706:Measured [Qualitative Concept]
   744   C1425272:ARX [Gene or Genome]
   744   C1710143:Spectrometer [Manufactured Object]
   744   C1826967:ARX [Gene or Genome]
   744   C3541278:ARX [Gene or Genome]
   744   C3541902:MEASURED [Diagnostic Procedure]
   711 E C0079809:Measure [Quantitative Concept]
   711 E C0242485:Measure [Functional Concept]

Phrase: "(500 MHz) at 30C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0556962:MHz [Quantitative Concept]
Processing 00000000.tx.47: The chemical shifts were referenced to sodium 3-(trimethylsilyl)[2,2,3,3-d4]propionate (TSP) in D2O or tetramethylsilane (TMS) in DMSO-d6 as an internal standard. 

Phrase: "The chemical shifts"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0220806:Chemical [Chemical]
   861   C0333051:shifts [Functional Concept]
   861   C3272558:Chemical [Intellectual Product]
   827 E C2347509:Shift [Phenomenon or Process]

Phrase: "were"

Phrase: "referenced to sodium 3-"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   770   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   770   C1706462:Referenced [Conceptual Entity]
   737 E C1514811:Reference [Idea or Concept]

Phrase: "(trimethylsilyl"

Phrase: ")"

Phrase: "[2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "3-d4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412526:D4 [Gene or Genome]

Phrase: "]propionate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033474:propionate [Organic Chemical]
  1000   C0392214:Propionate [Lipid]

Phrase: "(TSP) in D2O"

Phrase: "or"

Phrase: "tetramethylsilane (TMS) in DMSO-d6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0145408:silane, tetramethyl- [Organic Chemical]

Phrase: "as an internal standard."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205102:Internal [Spatial Concept]
   861   C1442989:Standard [Qualitative Concept]
   861   C1553872:Internal [Intellectual Product]
   861   C1619620:Internal [Intellectual Product]
   861   C2828392:Standard [Intellectual Product]
Processing 00000000.tx.48: The high resolution (HR) EI mass spectrum was recorded on a JEOL DX-300 at 30 eV. 

Phrase: "The high resolution (HR) EI mass spectrum"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C0037813:Mass Spectrum [Laboratory Procedure]
   804   C0577559:Mass [Finding]
   804   C1306372:*Mass [Quantitative Concept]
   804   C1883073:Spectrum [Quantitative Concept]
   804   C2827424:Spectrum [Conceptual Entity]
   804   C3152252:Mass [Quantitative Concept]

Phrase: "was"

Phrase: "recorded on a JEOL DX-300"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C3538936:DX [Idea or Concept]
   719   C0034869:Record [Intellectual Product]

Phrase: "at 30 eV."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014522:EV [Neoplastic Process]
   861   C0560135:eV [Quantitative Concept]
Processing 00000000.tx.49: Negative ion APCI (atmospheric pressure chemical ionization)-LC mass spectra were obtained with a Hitachi M-2000 MS system. 

Phrase: "Negative ion APCI"

Phrase: "(atmospheric pressure chemical ionization"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   861   C0004180:Atmospheric Pressure [Natural Phenomenon or Process]
   861   C0595910:Atmospheric pressure [Clinical Attribute]
   861   C0802868:Atmospheric pressure [Finding]
   812   C0033095:Pressure [Phenomenon or Process]
   812   C0220806:Chemical [Chemical]
   812   C0460139:Pressure [Finding]
   812   C0596801:Ionization [Phenomenon or Process]
   812   C1306345:Pressure [Functional Concept]
   812   C3272558:Chemical [Intellectual Product]

Phrase: ")-"

Phrase: "LC mass spectra"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   867   C0037813:Mass Spectrum [Laboratory Procedure]
   827   C0577559:Mass [Finding]
   827   C1306372:*Mass [Quantitative Concept]
   827   C3152252:Mass [Quantitative Concept]
   793   C1883073:Spectrum [Quantitative Concept]
   793   C2827424:Spectrum [Conceptual Entity]

Phrase: "were"

Phrase: "obtained with a Hitachi"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "M-"

Phrase: "2000 MS system."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.50: The sample was directly injected into the MS system by an HPLC pump without separation columns. 

Phrase: "The sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "was"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "injected into the MS system"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0449913:System [Functional Concept]
   760   C1553451:System [Manufactured Object]
   760   C1704459:System [Medical Device]
   760   C2349943:Ms. [Conceptual Entity]
   760   C3539704:MS [Gene or Genome]
   726   C1720154:Inject [Functional Concept]

Phrase: "by an HPLC pump"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0182537:Pump [Medical Device]
   861   C1706421:Pump [Manufactured Object]

Phrase: "without separation columns."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C1705246:Separation Column [Research Device]
   827   C1185738:Column [Body Part, Organ, or Organ Component]
   827   C1706132:Column [Idea or Concept]
Processing 00000000.tx.51: The LC/MS conditions were as follows: eluant, 100% CH3CN (isocratic); 

Phrase: "The LC/MS conditions"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   734   C0872318:LC/MS [Laboratory Procedure]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "were"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "eluant,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3469601:Eluent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "100% CH3CN"

Phrase: "(isocratic"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.52: flow rate, 1 ml/min; 

Phrase: "flow rate,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2826285:Flow Rate [Quantitative Concept]
   861   C0806140:Flow [Natural Phenomenon or Process]
   861   C0871208:Rate [Activity]
   861   C1521828:Rate [Quantitative Concept]

Phrase: "1 ml/min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439445:mL/min [Quantitative Concept]
   827   C0702093:/min [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.53: vaporization temperature, 300C; 

Phrase: "vaporization temperature,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]

Phrase: "300C"

Phrase: ";"
Processing 00000000.tx.54: desolvation temperature, 300370C; 

Phrase: "desolvation temperature,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]

Phrase: "300370C"

Phrase: ";"
Processing 00000000.tx.55: drift voltage, 195 V. 

Phrase: "drift voltage,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0598352:Voltage [Quantitative Concept]

Phrase: "195 V."
Processing 00000000.tx.56: UV spectra for hydrolysis of the intermediate were measured on a Shimadzu UV-260 UV-Vis spectrophotometer equipped with an SPR-5 temperature controller. 

Phrase: "UV spectra for hydrolysis of the intermediate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1883073:Spectrum [Quantitative Concept]
   714   C2827424:Spectrum [Conceptual Entity]

Phrase: "were"

Phrase: "measured on a Shimadzu UV-260 UV-Vis spectrophotometer"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   742   C0041625:UV [Natural Phenomenon or Process]
   742   C0183400:Spectrophotometer [Medical Device]
   742   C0444706:Measured [Qualitative Concept]
   742   C1571809:VIS [Therapeutic or Preventive Procedure]
   742   C1961129:uV [Quantitative Concept]
   742   C3541902:MEASURED [Diagnostic Procedure]
   708 E C0079809:Measure [Quantitative Concept]
   708 E C0242485:Measure [Functional Concept]

Phrase: "equipped with an SPR-5 temperature controller."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0005903:temperature [Organism Attribute]
   748   C0039476:*Temperature [Quantitative Concept]
   748   C0180112:Controller [Medical Device]
Processing 00000000.tx.57: Spectrometric data N2-Methyl-N2-nitrosoguanosine (N2-Me-N2-nitroso-Guo). 

Phrase: "Spectrometric data N2-Methyl-N2-nitrosoguanosine"

Phrase: "(N2-Me-N2-nitroso-Guo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.58: 1H NMR (500 MHz, DMSO-d6 at 30C) (p.p.m./TMS) 12.86 (br, 1H, NH), 8.35 (s, 1H, H-8), 5.55 (dd, 1H, H-1'), 5.48 (br,1H, OH), 5.21 (br, 1H, OH), 4.97 (br, 1H, OH), 4.55 (m,1H, H-2'), 4.16 (ddd, 1H, H-3'), 3.95 (ddd, 1H, H-4'), 3.61 (ABX, 2H, H-5',5''), 3.41 (s, 3H, CH3); 

Phrase: "1H NMR (500 MHz,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0556962:MHz [Quantitative Concept]

Phrase: "DMSO-d6 at 30C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1332648:D6 [Amino Acid, Peptide, or Protein,Receptor]
   770   C1332673:D6 [Gene or Genome]

Phrase: ")"

Phrase: "(p.p.m./TMS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0145408:silane, tetramethyl- [Organic Chemical]

Phrase: ")"

Phrase: "12.86"

Phrase: "(br,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704648:Br. [Conceptual Entity]

Phrase: "1H,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "NH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0268059:NH [Disease or Syndrome]

Phrase: ")"

Phrase: ","

Phrase: "8.35"

Phrase: "(s,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "1H,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "H-8"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "5.55"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439084:>5 [Quantitative Concept]
   861   C0450382:55 [Intellectual Product]
   861   C0728893:+5 [Quantitative Concept]

Phrase: "(dd,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538867:DD [Gene or Genome]

Phrase: "1H,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "H-1'"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:h 1 [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "5.48"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: "(br,1H,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1442450:1H [Temporal Concept]

Phrase: "OH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220853:OH- [Element, Ion, or Isotope]

Phrase: ")"

Phrase: ","

Phrase: "5.21"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: "(br,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704648:Br. [Conceptual Entity]

Phrase: "1H,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "OH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220853:OH- [Element, Ion, or Isotope]

Phrase: ")"

Phrase: ","

Phrase: "4.97"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439073:97 [Intellectual Product]
   861   C0439082:>97 [Quantitative Concept]

Phrase: "(br,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704648:Br. [Conceptual Entity]

Phrase: "1H,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "OH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220853:OH- [Element, Ion, or Isotope]

Phrase: ")"

Phrase: ","

Phrase: "4.55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450382:55 [Intellectual Product]

Phrase: "("

Phrase: "m,"

Phrase: "1H,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "H-2'"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:h 2 [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "4.16"

Phrase: "(ddd,"

Phrase: "1H,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "H-3'"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0041119:h 3 [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "3.95"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: "(ddd,"

Phrase: "1H,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "H-4'"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "3.61"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: "(ABX,"

Phrase: "2H,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292425:2H [Temporal Concept]

Phrase: "H-5',"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "5''"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "3.41"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: "(s,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "3H,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "CH3"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.59: UV max 240 nm, 293nm (pH 7); 

Phrase: "UV max 240 nm,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0312860:NM [Cell Function]

Phrase: "293nm"

Phrase: "(pH 7"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1882074:pH 7 [Qualitative Concept]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.60: APCI-LC/MS (negative) m/z 325 (M  H), 296 (M  NO). 

Phrase: "APCI-LC/MS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0872318:LC/MS [Laboratory Procedure]
   827   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   827   C2349943:Ms. [Conceptual Entity]
   827   C3539704:MS [Gene or Genome]

Phrase: "(negative"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205160:Negative [Qualitative Concept]
  1000   C1513916:Negative [Finding]
  1000   C2825415:Negative [Conceptual Entity]
  1000   C2825491:Negative [Qualitative Concept]

Phrase: ")"

Phrase: "m/"

Phrase: "z 325"

Phrase: "(M  H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "296"

Phrase: "(M  NO"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C0030015:oxide [Inorganic Chemical]
   827   C2986642:oxide [Chemical Viewed Functionally]

Phrase: ")."
Processing 00000000.tx.61: 1-Methylxanthosine (1-Me-Xao). 

Phrase: "1-Methylxanthosine (1-Me-Xao)."
Processing 00000000.tx.62: 1H NMR (500 MHz, DMSO-d6 at 30C) (p.p.m./TMS) 7.82 (s, 1H, H-8), 5.73 (dd, 1H, H-1'), 5.42 (br, 1H, 5'- or 2'-OH), 5.19 (br, 1H, 3'-OH), 4.30 (m, 1H, H-2'), 4.07 (ddd, 1H, H-3'), 4.00 (ddd, 1H, H-4'), 3.64 (ABX, 2H, H-5',5''), 3.17 (d, 3H, CH3). 

Phrase: "1H NMR (500 MHz,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0556962:MHz [Quantitative Concept]

Phrase: "DMSO-d6 at 30C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1332648:D6 [Amino Acid, Peptide, or Protein,Receptor]
   770   C1332673:D6 [Gene or Genome]

Phrase: ")"

Phrase: "(p.p.m./TMS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0145408:silane, tetramethyl- [Organic Chemical]

Phrase: ")"

Phrase: "7.82"

Phrase: "(s,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "1H,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "H-8"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "5.73"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: "(dd,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538867:DD [Gene or Genome]

Phrase: "1H,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "H-1'"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:h 1 [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "5.42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: "(br,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704648:Br. [Conceptual Entity]

Phrase: "1H,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "5'-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "or"

Phrase: "2'-OH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0220853:OH- [Element, Ion, or Isotope]

Phrase: ")"

Phrase: ","

Phrase: "5.19"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: "(br,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704648:Br. [Conceptual Entity]

Phrase: "1H,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "3'-OH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0220853:OH- [Element, Ion, or Isotope]

Phrase: ")"

Phrase: ","

Phrase: "4.30"

Phrase: "(m,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "1H,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "H-2'"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:h 2 [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "4.07"

Phrase: "(ddd,"

Phrase: "1H,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "H-3'"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0041119:h 3 [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "4.00"

Phrase: "(ddd,"

Phrase: "1H,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "H-4'"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "3.64"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: "(ABX,"

Phrase: "2H,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292425:2H [Temporal Concept]

Phrase: "H-5',"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "5''"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "3.17"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: "(d,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "3H,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "CH3"

Phrase: ")."
Processing 00000000.tx.63: [We measured the 1H NMR spectrum in the range 1 to 17 p.p.m. but could not observe the signal of the NH proton. 

Phrase: "["

Phrase: "We"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "the 1H NMR spectrum in the range 1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0024485:NMR [Diagnostic Procedure]
   744   C0028580:NMR [Natural Phenomenon or Process]
   744   C1883073:Spectrum [Quantitative Concept]
   744   C2827424:Spectrum [Conceptual Entity]

Phrase: "to 17 p.p.m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441923:M+ [Intellectual Product]

Phrase: "but"

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observe"

Phrase: "the signal of the NH proton."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.64: In H2O at neutral pH, 1-Me-Xao exists as the 6-keto-2-enol anion form (17). 

Phrase: "In H2O"

Phrase: "at neutral pH,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1882074:Neutral pH [Qualitative Concept]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "1-Me-Xao"

Phrase: "exists as the 6-keto-2-enol anion form"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0003075:Anion [Element, Ion, or Isotope]
   742   C0348078:Form [Qualitative Concept]
   742   C0376315:Form [Manufactured Object]
   742   C0596513:enol [Organic Chemical]
   742   C1522492:Form [Functional Concept]
   742   C2987476:Exist [Conceptual Entity]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.65: We suspect that 1-Me-Xao existed as the 6-keto-2-enol anion form in DMSO-d6 due to a trace of H2O present in DMSO or the sample, thus obscuring the NH signal. 

Phrase: "We"

Phrase: "suspect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750491:suspect [Idea or Concept]
  1000   C1571873:Suspect [Idea or Concept]

Phrase: "that 1-Me-Xao"

Phrase: "existed as the 6-keto-2-enol anion form"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0003075:Anion [Element, Ion, or Isotope]
   742   C0348078:Form [Qualitative Concept]
   742   C0376315:Form [Manufactured Object]
   742   C0596513:enol [Organic Chemical]
   742   C1522492:Form [Functional Concept]
   708   C2987476:Exist [Conceptual Entity]

Phrase: "in DMSO-d6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1332648:D6 [Amino Acid, Peptide, or Protein,Receptor]
   861   C1332673:D6 [Gene or Genome]

Phrase: "due to a trace"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0442822:Trace [Quantitative Concept]
  1000   C1524031:Trace [Qualitative Concept]
  1000   C1883002:Trace [Functional Concept]

Phrase: "of H2O present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]

Phrase: "in DMSO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012403:DMSO [Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "the sample,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "thus"

Phrase: "obscuring"

Phrase: "the NH signal."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.66: We observed only two OH proton signals derived from the ribose moiety. 

Phrase: "We"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "only two OH proton signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C1710082:Signal [Phenomenon or Process]

Phrase: "derived from the ribose moiety."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0035549:Ribose [Carbohydrate]
   760   C1441547:Derived [Qualitative Concept]
   760   C3245521:derived [Idea or Concept]
Processing 00000000.tx.67: One (5.19 p.p.m.) was identified as the 3'-OH proton by COSY measurement. 

Phrase: "One (5.19 p.p.m.)"

Phrase: "was"

Phrase: "identified as the 3'-OH proton"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0033727:Proton [Element, Ion, or Isotope]
   753   C0205396:Identified [Qualitative Concept]
   753   C0220853:OH- [Element, Ion, or Isotope]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]

Phrase: "by COSY measurement."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242485:Measurement [Functional Concept]
Processing 00000000.tx.68: However, for another (5.42 p.p.m., a fairly broadened signal), it could not be determined whether it arose from the 2'-OH or 5'-OH since no correlation was observed for this resonance in the COSY spectrum. 

Phrase: "However,"

Phrase: "for another"

Phrase: "(5.42 p.p.m.,"

Phrase: "a fairly broadened signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "determined"

Phrase: "whether"

Phrase: "it"

Phrase: "arose from the 2'-OH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0220853:OH- [Element, Ion, or Isotope]

Phrase: "or"

Phrase: "5'-OH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0220853:OH- [Element, Ion, or Isotope]

Phrase: "since"

Phrase: "no correlation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707520:Correlation [Qualitative Concept]

Phrase: "was"

Phrase: "observed for this resonance"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0231881:Resonance [Finding]
   770   C0459800:resonance [Natural Phenomenon or Process]
   770   C0684213:Resonance [Qualitative Concept]
   770   C1441672:Observed [Functional Concept]

Phrase: "in the COSY spectrum."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1883073:Spectrum [Quantitative Concept]
   861   C2827424:Spectrum [Conceptual Entity]
Processing 00000000.tx.69: It is likely that the third OH signal was completely obscured by further broadening.] 

Phrase: "It"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that"

Phrase: "the third OH signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "was"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "obscured by further broadening."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1517331:Further [Spatial Concept]
   737 E C0205108:far [Spatial Concept]

Phrase: "]"
Processing 00000000.tx.70: UV max 251 nm, 277 nm (pH 7); 

Phrase: "UV max 251 nm,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0312860:NM [Cell Function]

Phrase: "277 nm (pH 7"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1882074:pH 7 [Qualitative Concept]
   812   C0020283:[pH] [Quantitative Concept]
   812   C0312860:NM [Cell Function]
   812   C0450407:ph+ [Finding]
   812   C0450408:ph++ [Finding]
   812   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.71: APCI-LC/MS (negative) m/z 297 (M  H), 165 (Mbase fragment). 

Phrase: "APCI-LC/MS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0872318:LC/MS [Laboratory Procedure]
   827   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   827   C2349943:Ms. [Conceptual Entity]
   827   C3539704:MS [Gene or Genome]

Phrase: "(negative"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205160:Negative [Qualitative Concept]
  1000   C1513916:Negative [Finding]
  1000   C2825415:Negative [Conceptual Entity]
  1000   C2825491:Negative [Qualitative Concept]

Phrase: ")"

Phrase: "m/"

Phrase: "z 297"

Phrase: "(M  H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "165"

Phrase: "(Mbase fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332255:fragment [Functional Concept]
   861   C1708096:Fragment [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.72: N5-Methyloxanosine (N5-Me-Oxo). 

Phrase: "N5-Methyloxanosine (N5-Me-Oxo)."
Processing 00000000.tx.73: 1H NMR (500 MHz, DMSO-d6 at 30C) (p.p.m./TMS) 8.28 (br, 1H, NH), 8.01 (s, 1H, H-2), 5.68 (dd, J = 6.0 Hz, 1H, H-1'), 5.41 (d, J = 6.1 Hz, 1H, 2'-OH), 5.17 (d, J = 4.9 Hz, 1H, 3'-OH), 4.93 (dd, J = 4.1 Hz, J = 4.1 Hz, 1H, 5'-OH), 4.47 (m, 1H, H-2'), 4.11 (ddd, 1H, H-3'), 3.90 (ddd, 1H, H-4'), 3.60 (ABX, 2H, H-5',5''), 2.81 (d, J = 3.9 Hz, 3H, CH3). 

Phrase: "1H NMR (500 MHz,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0556962:MHz [Quantitative Concept]

Phrase: "DMSO-d6 at 30C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1332648:D6 [Amino Acid, Peptide, or Protein,Receptor]
   770   C1332673:D6 [Gene or Genome]

Phrase: ")"

Phrase: "(p.p.m./TMS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0145408:silane, tetramethyl- [Organic Chemical]

Phrase: ")"

Phrase: "8.28"

Phrase: "(br,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704648:Br. [Conceptual Entity]

Phrase: "1H,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "NH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0268059:NH [Disease or Syndrome]

Phrase: ")"

Phrase: ","

Phrase: "8.01"

Phrase: "(s,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "1H,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "H-2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:h 2 [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "5.68"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439084:>5 [Quantitative Concept]
   861   C0450387:68 [Intellectual Product]
   861   C0728893:+5 [Quantitative Concept]

Phrase: "(dd,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538867:DD [Gene or Genome]

Phrase: "J = 6.0 Hz,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439482:Hz [Quantitative Concept]

Phrase: "1H,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "H-1'"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:h 1 [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "5.41"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: "(d,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "J = 6.1 Hz,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439482:Hz [Quantitative Concept]

Phrase: "1H,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "2'-OH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0220853:OH- [Element, Ion, or Isotope]

Phrase: ")"

Phrase: ","

Phrase: "5.17"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: "(d,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "J = 4.9 Hz,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439482:Hz [Quantitative Concept]

Phrase: "1H,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "3'-OH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0220853:OH- [Element, Ion, or Isotope]

Phrase: ")"

Phrase: ","

Phrase: "4.93"

Phrase: "(dd,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538867:DD [Gene or Genome]

Phrase: "J = 4.1 Hz,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439482:Hz [Quantitative Concept]

Phrase: "J = 4.1 Hz,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439482:Hz [Quantitative Concept]

Phrase: "1H,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "5'-OH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0220853:OH- [Element, Ion, or Isotope]

Phrase: ")"

Phrase: ","

Phrase: "4.47"

Phrase: "(m,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "1H,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "H-2'"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:h 2 [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "4.11"

Phrase: "(ddd,"

Phrase: "1H,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "H-3'"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0041119:h 3 [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "3.90"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0439083:>90 [Quantitative Concept]
   861   C0439086:<3 [Quantitative Concept]
   861   C0439087:<90 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: "(ddd,"

Phrase: "1H,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "H-4'"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "3.60"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442765:3/60 [Finding]
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: "(ABX,"

Phrase: "2H,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292425:2H [Temporal Concept]

Phrase: "H-5',"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "5''"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "2.81"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "(d,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "J = 3.9 Hz,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439482:Hz [Quantitative Concept]

Phrase: "3H,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "CH3"

Phrase: ")."
Processing 00000000.tx.74: [A correlation between the NH proton signal (8.28p.p.m.) and the CH3 proton signal (2.81 p.p.m.) was observed in the COSY measurement.] 

Phrase: "["

Phrase: "A correlation between the NH proton signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1707520:Correlation [Qualitative Concept]

Phrase: "(8.28p.p.m.)"

Phrase: "and"

Phrase: "the CH3 proton signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "(2.81 p.p.m.)"

Phrase: "was"

Phrase: "observed in the COSY measurement."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0242485:Measurement [Functional Concept]
   760   C0599863:COSY [Diagnostic Procedure]
   760   C1441672:Observed [Functional Concept]

Phrase: "]"
Processing 00000000.tx.75: UV max 248 nm, 292nm(pH 7); 

Phrase: "UV max 248 nm,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0312860:NM [Cell Function]

Phrase: "292nm"

Phrase: "(pH 7"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1882074:pH 7 [Qualitative Concept]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.76: APCI-LC/MS (negative) m/z 297 (M  H), 165 (Mbase fragment); 

Phrase: "APCI-LC/MS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0872318:LC/MS [Laboratory Procedure]
   827   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   827   C2349943:Ms. [Conceptual Entity]
   827   C3539704:MS [Gene or Genome]

Phrase: "(negative"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205160:Negative [Qualitative Concept]
  1000   C1513916:Negative [Finding]
  1000   C2825415:Negative [Conceptual Entity]
  1000   C2825491:Negative [Qualitative Concept]

Phrase: ")"

Phrase: "m/"

Phrase: "z 297"

Phrase: "(M  H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "165"

Phrase: "(Mbase fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332255:fragment [Functional Concept]
   861   C1708096:Fragment [Qualitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.77: HR-EI (positive) m/z 166.049 72 (Mbase fragment + H)+ (calculated for C6H6N4O2, 166.049 08). 

Phrase: "HR-EI (positive"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0439178:% Positive [Quantitative Concept]
   812   C1446409:Positive [Qualitative Concept]
   812   C1514241:Positive [Finding]
   812   C2825490:Positive [Qualitative Concept]

Phrase: ")"

Phrase: "m/"

Phrase: "z 166.049 72"

Phrase: "(Mbase fragment + H)+ ("
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "calculated for C6H6N4O2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0444686:Calculated [Functional Concept]
   790   C1441506:Calculated [Activity]
   790   C1443182:Calculated [Laboratory Procedure]

Phrase: "166.049 08"

Phrase: ")."
Processing 00000000.tx.78: Quantitative procedures Guo or 1-Me-Guo (10 mM) was incubated with NaNO2 (100mM) in 1 ml sodium acetate buffer (3.0 M, pH 3.7) at 37C for 6 h. 

Phrase: "Quantitative procedures Guo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "or"

Phrase: "1-Me-Guo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "(10 mM)"

Phrase: "was"

Phrase: "incubated with NaNO2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "(100mM"

Phrase: ")"

Phrase: "in 1 ml sodium acetate buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(3.0 M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "pH 3.7"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C1882074:pH 7 [Qualitative Concept]
   901   C0601906:PH 3 [Pharmacologic Substance]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "at 37C"

Phrase: "for 6 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.79: For the GuoHNO2 system, the concentration of each reaction product was determined from the peak area of the RP-HPLC chromatogram monitored at 260 nm and the molar extinction coefficient. 

Phrase: "For the GuoHNO2 system,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "the concentration of each reaction product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0086045:Concentration [Mental Process]
   753   C1446561:Concentration [Quantitative Concept]

Phrase: "was"

Phrase: "determined from the peak area of the RP-HPLC chromatogram"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   738   C0008562:HPLC [Laboratory Procedure]
   738   C0017446:Area [Geographic Area]
   738   C0205146:Area [Spatial Concept]
   738   C0205390:Phase [Temporal Concept]
   738   C0444505:Peak [Quantitative Concept]
   704   C1555029:Reverse [Idea or Concept]

Phrase: "monitored at 260 nm"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0312860:NM [Cell Function]
   737   C0030695:monitor [Health Care Activity]
   737   C0150369:monitor [Health Care Activity]
   737   C0181904:Monitor [Medical Device]
   737   C0596972:Monitor [Medical Device]
   737   C1521743:Monitor [Professional or Occupational Group]
   737   C1704646:Monitor [Manufactured Object]

Phrase: "and"

Phrase: "the molar extinction coefficient."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0015347:extinction [Mental Process]
   827   C1707429:*Coefficient [Quantitative Concept]
Processing 00000000.tx.80: The molar extinction coefficients [260: Guo, 11 500; 

Phrase: "The molar extinction coefficients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0015347:extinction [Mental Process]
   793   C1707429:*Coefficient [Quantitative Concept]

Phrase: "[260"

Phrase: ":"

Phrase: "Guo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "11 500"

Phrase: ";"
Processing 00000000.tx.81: Oxo, 5100; 

Phrase: "Oxo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0069733:oxanosine [Antibiotic]

Phrase: "5100"

Phrase: ";"
Processing 00000000.tx.82: Xao, 7800] were taken from the literature (4,18,19). 

Phrase: "Xao,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0078606:xanthosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "7800"

Phrase: "]"

Phrase: "were"

Phrase: "taken from the literature"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0023866:Literature [Intellectual Product]
   770   C0034036:LITERATURE [Intellectual Product,Manufactured Object]
   770   C1883727:Taken [Conceptual Entity]
   737 E C1515187:Take [Health Care Activity]

Phrase: "(4,"

Phrase: "18,"

Phrase: "19"

Phrase: ")."
Processing 00000000.tx.83: The initial RP-HPLC peak area was used as a standard. 

Phrase: "The initial RP-HPLC peak area"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0017446:Area [Geographic Area]
   799   C0205146:Area [Spatial Concept]

Phrase: "was"

Phrase: "used as a standard."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C1273517:used [Finding]
   770   C1442989:Standard [Qualitative Concept]
   770   C2828392:Standard [Intellectual Product]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.84: Since the molar extinction coefficients of the methyl derivatives (1-Me-Guo, N5-Me-Oxo and 1-Me-Xao) were not available, the amounts of these products were determined using 1H NMR integration signals as follows. 

Phrase: "Since"

Phrase: "the molar extinction coefficients of the methyl derivatives"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0015347:extinction [Mental Process]
   711   C1707429:*Coefficient [Quantitative Concept]

Phrase: "(1-Me-Guo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "N5-Me-Oxo"

Phrase: "and"

Phrase: "1-Me-Xao"

Phrase: ")"

Phrase: "were"

Phrase: "not available,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548671:Not available [Idea or Concept]
   861   C0470187:Available [Functional Concept]

Phrase: "the amounts of these products"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:amounts [Quantitative Concept]

Phrase: "were"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "1H NMR integration signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1710082:Signal [Phenomenon or Process]

Phrase: "as"

Phrase: "follows."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]
Processing 00000000.tx.85: After reaction with HNO2, 1-Me-Guo solution was neutralized with concentrated NaOH. 

Phrase: "After reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "with HNO2,"

Phrase: "1-Me-Guo solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037633:Solution [Substance]
   812   C0525069:Solution [Biomedical or Dental Material]

Phrase: "was"

Phrase: "neutralized with concentrated NaOH."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.86: Then the sample was lyophilized and dissolved in 400l of D2O (98%). 

Phrase: "Then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "the sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "was"

Phrase: "lyophilized"

Phrase: "and"

Phrase: "dissolved in 400l of D2O"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1549535:Dissolve [Functional Concept]

Phrase: "(98%"

Phrase: ")."
Processing 00000000.tx.87: The 1H NMR spectrum of the sample was measured with a 45 pulse with a delay time of 10 s. 

Phrase: "The 1H NMR spectrum of the sample"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0024485:NMR [Diagnostic Procedure]
   748   C0028580:NMR [Natural Phenomenon or Process]
   748   C1883073:Spectrum [Quantitative Concept]
   748   C2827424:Spectrum [Conceptual Entity]

Phrase: "was"

Phrase: "measured with a 45 pulse"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0232117:PULSE [Clinical Attribute]
   760   C0391850:Pulse [Physiologic Function]
   760   C0444706:Measured [Qualitative Concept]
   760   C1947910:Pulse [Phenomenon or Process]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "with a delay time"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0522486:Delay time [Temporal Concept]
   861   C0040223:Time [Temporal Concept]
   861   C0205421:Delay [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "of 10 s."
Processing 00000000.tx.88: The yields of products were determined by the relative intensities of the integral values for the methyl proton resonances of 1-Me-Guo (3.48 p.p.m./TSP), N5-Me-Oxo (2.96 p.p.m./TSP) and 1-Me-Xao (3.35 p.p.m./TSP). 

Phrase: "The yields of products"

Phrase: "were"

Phrase: "determined by the relative intensities of the integral values"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   745   C0205345:Relative Value [Qualitative Concept]
           Relative
   742   C0042295:Values [Qualitative Concept]
   742   C0080103:Relative [Family Group]
   742   C0443238:Integral [Quantitative Concept]
   742   C0522510:intensities [Qualitative Concept]
   742   C1547039:*Relative [Quantitative Concept]
   708 E C1522609:Value [Quantitative Concept]

Phrase: "for the methyl proton resonances"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   793   C0231881:Resonance [Finding]
   793   C0459800:resonance [Natural Phenomenon or Process]
   793   C0684213:Resonance [Qualitative Concept]
   743 E C0577554:Resonant [Qualitative Concept]

Phrase: "of 1-Me-Guo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "(3.48 p.p.m./TSP"

Phrase: ")"

Phrase: ","

Phrase: "N5-Me-Oxo"

Phrase: "(2.96 p.p.m./TSP)"

Phrase: "and"

Phrase: "1-Me-Xao"

Phrase: "(3.35 p.p.m./TSP"

Phrase: ")."
Processing 00000000.tx.89: Kinetics pH dependence. 

Phrase: "Kinetics pH dependence."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0011546:Dependence [Mental Process]
   827   C0439857:Dependence [Mental or Behavioral Dysfunction]
   827   C2698668:DEPENDENCE [Regulation or Law]
   755 E C0851827:Dependent [Qualitative Concept]
   755 E C1701901:Dependent [Qualitative Concept]
   755 E C3244310:dependent [Functional Concept]
   727 E C1546937:Dependency [Idea or Concept]
Processing 00000000.tx.90: The RP-HPLC column eluant containing the diazoate (20 l) was directly dropped into 100 mM buffer (480l) and incubated at 37C. 

Phrase: "The RP-HPLC column eluant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C3469601:Eluent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the diazoate"

Phrase: "(20 l)"

Phrase: "was"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "dropped into 100 mM buffer"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C1705648:Dropped [Activity]
   726 E C1321095:Drop [Quantitative Concept]
   726 E C2347093:Drop [Quantitative Concept]
   726 E C2348338:Drop [Quantitative Concept]

Phrase: "(480l"

Phrase: ")"

Phrase: "and"

Phrase: "incubated at 37C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]
Processing 00000000.tx.91: The buffers used were sodium acetate buffer (pH 23.7, concentrated HCl was added for pH2 and 3), sodium phosphate buffer (pH 58) and sodium carbonate buffer (pH 9 and 10). 

Phrase: "The buffers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006353:Buffers [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "were"

Phrase: "sodium acetate buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   734   C0142785:Sodium Acetate [Organic Chemical,Pharmacologic Substance]

Phrase: "(pH 23.7,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450348:23 [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "concentrated HCl"

Phrase: "was"

Phrase: "added for pH2"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1415286:PH2 [Gene or Genome]
   790   C1524062:Added [Functional Concept]
   756 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "sodium phosphate buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3256935:sodium phosphate buffer [Pharmacologic Substance]
   901   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   734   C0074757:sodium phosphate [Inorganic Chemical,Pharmacologic Substance]

Phrase: "(pH 58"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "and"

Phrase: "sodium carbonate buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   734   C0074732:sodium carbonate [Organic Chemical,Pharmacologic Substance]

Phrase: "(pH 9"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.92: The incubation periods were 10 min for pH 2 and 3, 30 min for pH 46, 1 h for pH 7 and 8, 1.5 h for pH 9 and 2 h for pH 10. 

Phrase: "The incubation periods"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C1320226:incubation periods [Finding]
   827   C0439531:/period [Temporal Concept]
   827   C1948053:Period [Temporal Concept]
   777 E C0332182:Periodic [Temporal Concept]
   777 E C1706381:PERIODIC [Intellectual Product]
   755 E C0031084:Periodicities [Temporal Concept]

Phrase: "were"

Phrase: "10 min for pH 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0456692:/10 min [Temporal Concept]
   760   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "30 min for pH 46,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0456693:/30 min [Temporal Concept]
   806   C1442458:30 min [Temporal Concept]
   760   C0702093:/min [Temporal Concept]

Phrase: "1 h for pH 7"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0700308:1 H [Element, Ion, or Isotope]
   797   C0044222:H-7 [Organic Chemical,Pharmacologic Substance]
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441932:H+ [Classification]
   760   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "8,"

Phrase: "1.5 h for pH 9"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0067456:H-9 [Organic Chemical,Pharmacologic Substance]
   783   C0700308:1 H [Element, Ion, or Isotope]
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "2 h for pH 10."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0011744:2 H [Element, Ion, or Isotope]
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441932:H+ [Classification]
   760   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.93: The samples in acidic or alkaline buffer were neutralized by addition of 1 M NaOH or HCl and analyzed by RP-HPLC. 

Phrase: "The samples in acidic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0370003:Sample [Substance]
   737   C2347026:Sample [Conceptual Entity]

Phrase: "or"

Phrase: "alkaline buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "were"

Phrase: "neutralized by addition of 1 M NaOH"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441923:M+ [Intellectual Product]
   748   C1883712:Addition [Functional Concept]

Phrase: "or"

Phrase: "HCl"

Phrase: "and"

Phrase: "analyzed by RP-HPLC."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0008562:HPLC [Laboratory Procedure]
   760   C0205390:Phase [Temporal Concept]
   760   C0936012:Analyzed [Research Activity]
   726   C1555029:Reverse [Idea or Concept]
Processing 00000000.tx.94: Temperature dependence. 

Phrase: "Temperature dependence."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0011546:Dependence [Mental Process]
   861   C0439857:Dependence [Mental or Behavioral Dysfunction]
   861   C2698668:DEPENDENCE [Regulation or Law]
   789 E C0851827:Dependent [Qualitative Concept]
   789 E C1701901:Dependent [Qualitative Concept]
   789 E C3244310:dependent [Functional Concept]
   761 E C1546937:Dependency [Idea or Concept]
Processing 00000000.tx.95: The RP-HPLC column eluant containing the diazoate (20 l) was directly dropped into temperature controlled 100 mM sodium phosphate buffer (480l) at pH 7.0. 

Phrase: "The RP-HPLC column eluant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C3469601:Eluent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the diazoate"

Phrase: "(20 l)"

Phrase: "was"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "dropped into temperature"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0005903:temperature [Organism Attribute]
   790   C0039476:*Temperature [Quantitative Concept]
   790   C1705648:Dropped [Activity]
   756 E C1321095:Drop [Quantitative Concept]
   756 E C2347093:Drop [Quantitative Concept]
   756 E C2348338:Drop [Quantitative Concept]

Phrase: "controlled"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C2587213:Controlled [Functional Concept]
   966 E C0243148:control [Qualitative Concept]
   966 E C1550141:Control [Substance]
   966 E C1882979:Control [Conceptual Entity]
   966 E C3274648:Control [Qualitative Concept]

Phrase: "100 mM sodium phosphate buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C3256935:sodium phosphate buffer [Pharmacologic Substance]
   840   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(480l"

Phrase: ")"

Phrase: "at pH 7.0."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]
Processing 00000000.tx.96: The incubation periods were 4 h for 0C, 2h for 10C, 1 h for 20 and 30C and 30 min for 37 and 50C. 

Phrase: "The incubation periods"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C1320226:incubation periods [Finding]
   827   C0439531:/period [Temporal Concept]
   827   C1948053:Period [Temporal Concept]
   777 E C0332182:Periodic [Temporal Concept]
   777 E C1706381:PERIODIC [Intellectual Product]
   755 E C0031084:Periodicities [Temporal Concept]

Phrase: "were"

Phrase: "4 h for 0C,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "2h for 10C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1292425:2H [Temporal Concept]

Phrase: "1 h for 20"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0700308:1 H [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "30C"

Phrase: "and"

Phrase: "30 min for 37"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0456693:/30 min [Temporal Concept]
   833   C1442458:30 min [Temporal Concept]
   770   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "50C."
Processing 00000000.tx.97: The samples were analyzed by RP-HPLC. 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "analyzed by RP-HPLC."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0008562:HPLC [Laboratory Procedure]
   760   C0205390:Phase [Temporal Concept]
   760   C0936012:Analyzed [Research Activity]
   726   C1555029:Reverse [Idea or Concept]
Processing 00000000.tx.98: Solvent effect. 

Phrase: "Solvent effect."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.99: The RP-HPLC column eluant containing the diazoate (20 l) was directly dropped into the mixture of acetone and H2O (480 or 980 l) at 20C. 

Phrase: "The RP-HPLC column eluant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C3469601:Eluent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the diazoate"

Phrase: "(20 l)"

Phrase: "was"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "dropped into the mixture of acetone"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   753   C0001002:Acetone [Organic Chemical,Pharmacologic Substance]
   753   C0439962:Mixture [Substance]
   753   C1705648:Dropped [Activity]
   719 E C1321095:Drop [Quantitative Concept]
   719 E C2347093:Drop [Quantitative Concept]
   719 E C2348338:Drop [Quantitative Concept]

Phrase: "and"

Phrase: "H2O"

Phrase: "(480"

Phrase: "or"

Phrase: "980 l) at 20C."
Processing 00000000.tx.100: The incubation periods were 30 min for 0% (acetone % v/v), 1 h for 25%, 1.5h for 50%, 2 h for 75% and 48 h for 96 and 98%. 

Phrase: "The incubation periods"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C1320226:incubation periods [Finding]
   827   C0439531:/period [Temporal Concept]
   827   C1948053:Period [Temporal Concept]
   777 E C0332182:Periodic [Temporal Concept]
   777 E C1706381:PERIODIC [Intellectual Product]
   755 E C0031084:Periodicities [Temporal Concept]

Phrase: "were"

Phrase: "30 min for 0%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0456693:/30 min [Temporal Concept]
   833   C1442458:30 min [Temporal Concept]
   770   C0702093:/min [Temporal Concept]

Phrase: "(acetone % v/v), 1 h for 25%,"

Phrase: "1.5h for 50%,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1979835:1.5H [Temporal Concept]
   770   C1442467:5H [Temporal Concept]

Phrase: "2 h for 75%"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0011744:2 H [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "48 h for 96"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "98%."
Processing 00000000.tx.101: Acetone was removed from each sample by aspirator and the samples were analyzed by RP-HPLC.  

Phrase: "Acetone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001002:Acetone [Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "removed from each sample"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0370003:Sample [Substance]
   770   C0849355:Removed [Qualitative Concept]
   770   C2347026:Sample [Conceptual Entity]
   737 E C1883720:Remove [Activity]
   737 E C3244314:remove [Functional Concept]

Phrase: "by aspirator"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042226:Aspirator [Medical Device]
  1000   C3495388:aspirator [Medical Device]

Phrase: "and"

Phrase: "the samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "analyzed by RP-HPLC."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0008562:HPLC [Laboratory Procedure]
   760   C0205390:Phase [Temporal Concept]
   760   C0936012:Analyzed [Research Activity]
   726   C1555029:Reverse [Idea or Concept]
Processing 00000000.tx.102: RESULTS AND DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS AND DISCUSSION REFERENCES  Determination of the reaction site using methyl derivatives of Guo The reaction site leading to the conversion of dGuo into dOxo by HNO2 was explored using Guo (the ribonucleoside counterpart of dGuo) and its methyl derivatives to avoid cleavage of the labile N-glycosidic bond of deoxyribonucleosides. 

Phrase: "RESULTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "AND"

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "AND"

Phrase: "DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Determination of the reaction site"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1148554:determination [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "methyl derivatives of Guo"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0243072:derivatives [Chemical Viewed Structurally]
   737 E C1527240:Derivative [Functional Concept]

Phrase: "The reaction site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205145:Site [Spatial Concept]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "leading to the conversion of dGuo"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   753   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0332152:Leading [Temporal Concept]
   753   C0439836:Conversion [Functional Concept]
   753   C1522538:Leading [Functional Concept]
   719 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   719 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   719 E C2348269:Lead [Element, Ion, or Isotope]
   719 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "into dOxo"

Phrase: "by HNO2"

Phrase: "was"

Phrase: "explored"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Guo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "("

Phrase: "the ribonucleoside counterpart of dGuo"

Phrase: ")"

Phrase: "and"

Phrase: "its methyl derivatives to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0243072:derivatives [Chemical Viewed Structurally]
   793 E C1527240:Derivative [Functional Concept]

Phrase: "avoid"

Phrase: "cleavage of the labile N-glycosidic bond of deoxyribonucleosides."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0010813:cleavage [Cell Function]
   742   C0596311:Cleavage [Phenomenon or Process]
   742   C1330957:cleavage [Cell Function]
Processing 00000000.tx.103: Guo (10mM) was incubated with 100 mM NaNO2 in 3.0 M sodium acetate buffer (pH 3.7) at 37C for 6 h and analyzed by RP-HPLC (data not shown). 

Phrase: "Guo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "(10mM"

Phrase: ")"

Phrase: "was"

Phrase: "incubated with 100 mM NaNO2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "in 3.0 M sodium acetate buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(pH 3.7"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C1882074:pH 7 [Qualitative Concept]
   901   C0601906:PH 3 [Pharmacologic Substance]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "at 37C"

Phrase: "for 6 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "analyzed by RP-HPLC (data"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0008562:HPLC [Laboratory Procedure]
   753   C0205390:Phase [Temporal Concept]
   753   C0936012:Analyzed [Research Activity]
   753   C1511726:Data [Idea or Concept]
   753   C3245479:data [Medical Device]
   719   C1555029:Reverse [Idea or Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.104: The first peak (retention time tR = 9.1 min) was identified as Xao by agreement with the retention time and the on-line UV spectrum of the authentic sample. 

Phrase: "The first peak"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: "(retention time tR = 9.1 min)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0702093:/min [Temporal Concept]

Phrase: "was"

Phrase: "identified as Xao"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0078606:xanthosine [Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0205396:Identified [Qualitative Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]

Phrase: "by agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680240:Agreement [Social Behavior]

Phrase: "with the retention time"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0035280:Retention [Mental Process]
   861   C0040223:Time [Temporal Concept]
   861   C0333117:Retention [Functional Concept]
   861   C1753315:retention [Cell Function]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "and"

Phrase: "the on-line UV spectrum of the authentic sample."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1883073:Spectrum [Quantitative Concept]
   742   C2827424:Spectrum [Conceptual Entity]
Processing 00000000.tx.105: The second peak (tR = 10.6 min) was unreacted Guo. 

Phrase: "The second peak"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: "(tR = 10.6 min)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C0456692:/10 min [Temporal Concept]
   812   C0702093:/min [Temporal Concept]

Phrase: "was"

Phrase: "unreacted Guo."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
Processing 00000000.tx.106: The third peak (tR = 12.0 min) was identified as Oxo by coincidence with the UV spectrum in a previous paper (1). 

Phrase: "The third peak"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: "(tR = 12.0 min)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0702093:/min [Temporal Concept]

Phrase: "was"

Phrase: "identified as Oxo"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0069733:oxanosine [Antibiotic]
   790   C0205396:Identified [Qualitative Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]

Phrase: "by coincidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0205420:Coincident [Temporal Concept]

Phrase: "with the UV spectrum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1883073:Spectrum [Quantitative Concept]
   861   C2827424:Spectrum [Conceptual Entity]

Phrase: "in a previous paper"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0030351:Paper [Manufactured Object]
   861   C1547566:Paper [Idea or Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.107: The yields of reaction products were 17.9% Oxo and 79.3% Xao with 4.0% unreacted Guo. 

Phrase: "The yields of reaction products"

Phrase: "were"

Phrase: "17.9% Oxo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0069733:oxanosine [Antibiotic]

Phrase: "and"

Phrase: "79.3% Xao with 4.0% unreacted Guo."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0078606:xanthosine [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.108: Figure 1A shows the structures of these compounds with atomic numbering. 

Phrase: "Figure 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the structures of these compounds"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0678594:structures [Spatial Concept]

Phrase: "with atomic numbering."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0678551:atomic number [Quantitative Concept]
   861   C0449788:numbering [Quantitative Concept]
   827 E C0237753:*Number [Quantitative Concept]
Processing 00000000.tx.109: It should be noted that the atomic numbering of the base moiety of Oxo and its analog is different from that of purines. 

Phrase: "It"

Phrase: "should"

Phrase: "be"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "the atomic numbering of the base moiety of Oxo"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0678551:atomic number [Quantitative Concept]
   745   C2981742:Base Number [Conceptual Entity]
   742   C0449788:numbering [Quantitative Concept]
   708 E C0237753:*Number [Quantitative Concept]

Phrase: "and"

Phrase: "its analog"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0243071:Analog [Chemical Viewed Structurally]
   900 E C0679213:analogies [Idea or Concept]

Phrase: "is"

Phrase: "different from that of purines."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705242:Different [Qualitative Concept]
Processing 00000000.tx.110: Although the numbering of purines is customary, a systematic numbering following the IUPAC rules is applied to Oxa and its analog since they are not purines (2,20). 

Phrase: "Although"

Phrase: "the numbering of purines"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0449788:numbering [Quantitative Concept]
   737 E C0237753:*Number [Quantitative Concept]

Phrase: "is"

Phrase: "customary,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C3242380:customary [Intellectual Product]
  1000   C3538928:Customary [Qualitative Concept]
   928 E C0162343:Custom [Idea or Concept]
   928 E C1880202:Custom [Activity]

Phrase: "a systematic numbering"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449788:numbering [Quantitative Concept]
   827 E C0237753:*Number [Quantitative Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the IUPAC rules"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0870077:Rules [Intellectual Product]
   827 E C0805874:Rule [Idea or Concept]
   827 E C1446409:rule [Qualitative Concept]

Phrase: "is"

Phrase: "applied to Oxa"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0185125:Applied [Health Care Activity]
   790   C0376938:OXA [Amino Acid, Peptide, or Protein]
   756 E C1632850:Apply [Functional Concept]
   756 E C1879355:Apply [Functional Concept]

Phrase: "and"

Phrase: "its analog"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0243071:Analog [Chemical Viewed Structurally]
   900 E C0679213:analogies [Idea or Concept]

Phrase: "since"

Phrase: "they"

Phrase: "are"

Phrase: "not purines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034140:Purines [Organic Chemical]
   861   C0220903:purines [Organic Chemical]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "20"

Phrase: ")."
Processing 00000000.tx.111: For dGuo, it has been reported that the yields were 21.5% dOxo and 58.7% dXao and xanthine (a base moiety of dXao) with 7.6% unreacted dGuo under the same reaction conditions (10). 

Phrase: "For dGuo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "the yields"

Phrase: "were"

Phrase: "21.5% dOxo"

Phrase: "and"

Phrase: "58.7% dXao"

Phrase: "and"

Phrase: "xanthine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0043314:xanthine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0043318:xanthine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "("

Phrase: "a base moiety of dXao"

Phrase: ")"

Phrase: "with 7.6% unreacted dGuo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "under the same reaction conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.112: Accordingly, substitution of a hydroxyl group (Guo) for a hydrogen atom (dGuo) at the 2' sugar position had little influence on the formation of Oxo derivatives. 

Phrase: "Accordingly,"

Phrase: "substitution of a hydroxyl group"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1555721:Substitution [Idea or Concept]
   760   C1706204:Substitution [Activity]

Phrase: "(Guo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: ")"

Phrase: "for a hydrogen atom"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0567415:Atom [Element, Ion, or Isotope]
   861   C1706222:Atom [Conceptual Entity]

Phrase: "(dGuo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: "at the 2' sugar position"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0733755:Position [Spatial Concept]
   755 E C0240795:POSITIONAL [Finding]

Phrase: "had"

Phrase: "little influence on the formation of Oxo derivatives."
Processing 00000000.tx.113: View larger version (19K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(19K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.114: Reaction products of HNO2-treated (A) guanosine (Guo), with the atomic numbering, (B) N2,N2-dimethylguanosine (N2,N2-diMe-Guo), (C) N2-methylguanosine (N2-Me-Guo) and (D) 1-methylguanosine (1-Me-Guo). 

Phrase: "Reaction products of HNO2-treated"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0443286:Reaction [Functional Concept]
   760   C1114821:Reaction [Clinical Attribute]
   760   C1514468:Products [Entity]
   726 E C1704444:Product [Quantitative Concept]

Phrase: "(A) guanosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "(Guo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "with the atomic numbering,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0678551:atomic number [Quantitative Concept]
   861   C0449788:numbering [Quantitative Concept]
   827 E C0237753:*Number [Quantitative Concept]

Phrase: "(B) N2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441960:N2 [Finding]

Phrase: "N2-dimethylguanosine"

Phrase: "(N2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441960:N2 [Finding]

Phrase: "N2-diMe-Guo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "(C) N2-methylguanosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0762000:methylguanosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(N2-Me-Guo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: ")"

Phrase: "and ("

Phrase: "D)"

Phrase: "1-methylguanosine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0044469:1-methylguanosine [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0762000:methylguanosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(1-Me-Guo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.115: Note that the atomic numbering of the base moieties of oxanosine (Oxo) and its analog is different from that of purines (see text). 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "the atomic numbering of the base moieties of oxanosine"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0678551:atomic number [Quantitative Concept]
   745   C2981742:Base Number [Conceptual Entity]
   742   C0449788:numbering [Quantitative Concept]
   708 E C0237753:*Number [Quantitative Concept]

Phrase: "(Oxo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0069733:oxanosine [Antibiotic]

Phrase: ")"

Phrase: "and"

Phrase: "its analog"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0243071:Analog [Chemical Viewed Structurally]
   900 E C0679213:analogies [Idea or Concept]

Phrase: "is"

Phrase: "different from that of purines"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705242:Different [Qualitative Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1527021:Text [Intellectual Product]
  1000   C1554111:Text [Idea or Concept]
  1000   C1705606:Text [Intellectual Product]
  1000   C3541382:Text [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.116: The numbers in parentheses denote percentage yields of products at a reaction time of 6 h.  

Phrase: "The numbers in parentheses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "denote"

Phrase: "percentage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439165:Percentage [Quantitative Concept]
  1000   C1549488:Percentage [Idea or Concept]
  1000   C1561533:Percentage [Idea or Concept]

Phrase: "yields of products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1514468:Products [Entity]
   756 E C1704444:Product [Quantitative Concept]

Phrase: "at a reaction time"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0034746:Reaction Time [Temporal Concept]
   861   C0040223:Time [Temporal Concept]
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "of 6 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.117: Concerning the mechanism of dOxo formation, two conceivable pathways exist in the initial step of the reaction (Scheme 1). 

Phrase: "Concerning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2699424:Concern [Idea or Concept]

Phrase: "the mechanism of dOxo formation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: "two conceivable pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704259:Pathways [Molecular Function]
   827   C1705987:Pathways [Conceptual Entity]

Phrase: "exist in the initial step of the reaction"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   744   C0205265:Initial [Temporal Concept]
   744   C0443286:Reaction [Functional Concept]
   744   C1114821:Reaction [Clinical Attribute]
   744   C1261552:Step [Conceptual Entity]
   744   C1279901:Initial [Qualitative Concept]
   744   C1555582:Initial [Idea or Concept]
   744   C1704379:Step [Functional Concept]
   744   C1705117:Step [Quantitative Concept]
   744   C1705685:INITIAL [Functional Concept]
   744   C2825408:Step [Manufactured Object]
   744   C2987476:Exist [Conceptual Entity]

Phrase: "(Scheme 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1519193:Scheme [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.118: In Path I, the reaction is initiated by attack of NOx (probably N2O3) produced by protonation of nitrite on the N1-imino group of dGuo. 

Phrase: "In Path I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "the reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "is"

Phrase: "initiated by attack of NOx"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0277793:Attack, NOS [Temporal Concept]
   760   C1261512:attack [Social Behavior]
   760   C1304680:Attack [Finding]
   726   C1548602:Initiate [Idea or Concept]
   726   C1704686:Initiate [Functional Concept]

Phrase: "(probably N2O3"

Phrase: ")"

Phrase: "produced by protonation of nitrite"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0028137:Nitrite [Chemical Viewed Structurally]
   760   C0178812:Protonation [Phenomenon or Process]
   760   C1384115:Nitrite [Inorganic Chemical]

Phrase: "on the N1-imino group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]

Phrase: "of dGuo."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.119: In this case, dGuo bearing N1 substituents like nitroso, nitro or diazo groups are potential precursors en route to dOxo. 

Phrase: "In this case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "dGuo bearing N1 substituents like nitroso, nitro"

Phrase: "or"

Phrase: "diazo groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "are"

Phrase: "potential precursors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1709634:Precursor [Idea or Concept]

Phrase: "en route to dOxo."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0013153:ROUTE [Functional Concept]
   770   C0449444:Route [Spatial Concept]
   770   C1417861:eN [Gene or Genome]
   770   C1879941:ROUTE [Intellectual Product]
   770   C2987294:EN [Qualitative Concept]
Processing 00000000.tx.120: dOxo is formed by subsequent attack of a water molecule on N1 of the intermediates. 

Phrase: "dOxo"

Phrase: "is"

Phrase: "formed by subsequent attack of a water molecule"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   744   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   744   C0205431:Formed [Functional Concept]
   744   C0277793:Attack, NOS [Temporal Concept]
   744   C0332282:Subsequent [Temporal Concept]
   744   C0567416:Molecule [Substance]
   744   C0599638:WATER [Substance]
   744   C1261512:attack [Social Behavior]
   744   C1304680:Attack [Finding]
   744   C1550678:Water [Inorganic Chemical]
   711 E C0348078:Form [Qualitative Concept]
   711 E C0376315:Form [Manufactured Object]
   711 E C1522492:Form [Functional Concept]

Phrase: "on N1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441962:N1 [Finding]

Phrase: "of the intermediates."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0205103:Intermediate [Spatial Concept]
   966   C1550465:intermediate [Idea or Concept]
   966   C2827755:INTERMEDIATE [Laboratory or Test Result]
Processing 00000000.tx.121: To obtain 15N-labeled purine nucleosides, an N1-nitropurine compound has been employed as a precursor for N1 substitution by 15N compounds (21). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "15N-labeled purine nucleosides,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034136:Purine Nucleosides [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   812   C0028621:Nucleosides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "an N1-nitropurine compound"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205198:Compound [Qualitative Concept]
   827   C1706082:Compound [Chemical]

Phrase: "has"

Phrase: "been"

Phrase: "employed as a precursor"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0557351:Employed [Finding]
   770   C1709634:Precursor [Idea or Concept]
   737 E C0457083:Employ [Functional Concept]

Phrase: "for N1 substitution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1555721:Substitution [Idea or Concept]
   861   C1706204:Substitution [Activity]

Phrase: "by 15N compounds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205198:Compound [Qualitative Concept]
   827   C1706082:Compound [Chemical]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.122: Path II includes attack of N2O3 on the exocyclic amino group of dGuo. 

Phrase: "Path II"

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "attack of N2O3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0277793:Attack, NOS [Temporal Concept]
   790   C1261512:attack [Social Behavior]
   790   C1304680:Attack [Finding]

Phrase: "on the exocyclic amino group"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0596072:amino group [Inorganic Chemical]
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]

Phrase: "of dGuo."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.123: In this case, a nitroso group is introduced on a N2 atom. 

Phrase: "In this case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "a nitroso group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "is"

Phrase: "introduced on a N2 atom."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0441960:N2 [Finding]
   760   C0567415:Atom [Element, Ion, or Isotope]
   760   C1706222:Atom [Conceptual Entity]
   726   C1292748:introduce [Functional Concept]
Processing 00000000.tx.124: Subsequently several intermediates are formed, such as diazohydroxide, diazoate and diazonium derivatives, based on the diazo chemistry of aromatic primary amines (Scheme 2; 22,23). 

Phrase: "Subsequently several intermediates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0205103:Intermediate [Spatial Concept]
   793   C1550465:intermediate [Idea or Concept]
   793   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "are"

Phrase: "formed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: ","

Phrase: "such as diazohydroxide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0113608:diazohydroxide [Organic Chemical,Pharmacologic Substance]

Phrase: "diazoate"

Phrase: "and"

Phrase: "diazonium derivatives,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243072:derivatives [Chemical Viewed Structurally]
   827 E C1527240:Derivative [Functional Concept]

Phrase: "based on the diazo chemistry of aromatic primary amines"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   762   C0682958:Aromatic Amines [Organic Chemical]
   742   C0002508:Amines [Organic Chemical]
   742   C0007996:Chemistry [Occupation or Discipline]
   742   C0079107:chemistry [Classification]
   742   C0201682:Chemistry [Laboratory Procedure]
   742   C0205225:Primary [Qualitative Concept]
   742   C0439631:Primary [Therapeutic or Preventive Procedure]
   742   C0772162:Aromatic [Organic Chemical,Pharmacologic Substance]
   742   C1527178:Based [Functional Concept]
   742   C1705938:Based [Idea or Concept]
   708 E C0002055:base [Inorganic Chemical]
   708 E C0178499:Base [Chemical Viewed Functionally]
   708 E C1879694:Amine [Organic Chemical]
   708 E C1880279:Base [Biomedical or Dental Material]

Phrase: "(Scheme 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1519193:Scheme [Intellectual Product]

Phrase: "; 22,"

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.125: To determine which reaction pathway is responsible for dOxo formation, N2,N2-diMe-Guo, N2-Me-Guo and 1-Me-Guo were treated with HNO2 and the products were analyzed. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "which reaction pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "is"

Phrase: "responsible for dOxo formation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "N2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441960:N2 [Finding]

Phrase: "N2-diMe-Guo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "N2-Me-Guo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "and"

Phrase: "1-Me-Guo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "were"

Phrase: "treated with HNO2"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "and"

Phrase: "the products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514468:Products [Entity]
   966 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "analyzed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.126: If Path I is involved, substitution of N1 by an oxygen atom will not occur for 1-Me-Guo since the methyl group protects N1 against the attack of N2O3. 

Phrase: "If"

Phrase: "Path I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "is"

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: ","

Phrase: "substitution of N1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1555721:Substitution [Idea or Concept]
   790   C1706204:Substitution [Activity]

Phrase: "by an oxygen atom"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0567415:Atom [Element, Ion, or Isotope]
   861   C1706222:Atom [Conceptual Entity]

Phrase: "will"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "occur for 1-Me-Guo"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]

Phrase: "since"

Phrase: "the methyl group"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0596922:Methyl Group [Organic Chemical]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "protects"

Phrase: "N1 against the attack of N2O3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0441962:N1 [Finding]
Processing 00000000.tx.127: If Path II is involved, the reaction will not proceed for N2,N2-diMe-Guo since the methyl groups protect the exocyclic amino group on C2 against attack by N2O3. 

Phrase: "If"

Phrase: "Path II"

Phrase: "is"

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: ","

Phrase: "the reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "will"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "proceed for N2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0441960:N2 [Finding]

Phrase: "N2-diMe-Guo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "since"

Phrase: "the methyl groups"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C0596922:Methyl Group [Organic Chemical]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "protect"

Phrase: "the exocyclic amino group on C2"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0596072:amino group [Inorganic Chemical]
   753   C0441833:Group [Idea or Concept]
   753   C0687744:group [Population Group]
   753   C1257890:Group [Population Group]
   753   C1552516:Group [Health Care Related Organization]
   753   C1705428:Group [Conceptual Entity]
   753   C1705429:Group [Population Group]

Phrase: "against attack"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0277793:Attack, NOS [Temporal Concept]
  1000   C1261512:attack [Social Behavior]
  1000   C1304680:Attack [Finding]

Phrase: "by N2O3."
Processing 00000000.tx.128: The reaction of N2-Me-Guo carrying a secondary amine will stop at the step of the nitroso derivative. 

Phrase: "The reaction of N2-Me-Guo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0443286:Reaction [Functional Concept]
   753   C1114821:Reaction [Clinical Attribute]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "a secondary amine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0002508:Amine [Organic Chemical]
   861   C1879694:Amine [Organic Chemical]

Phrase: "will"

Phrase: "stop at the step of the nitroso derivative."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C1261552:Step [Conceptual Entity]
   744   C1527240:Derivative [Functional Concept]
   744   C1704379:Step [Functional Concept]
   744   C1705117:Step [Quantitative Concept]
   744   C1947925:Stop [Activity]
   744   C2746065:Stop [Temporal Concept]
   744   C2825408:Step [Manufactured Object]
Processing 00000000.tx.129: View larger version (19K): [in this window] [in a new window]  Scheme 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(19K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Scheme 1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1519193:Scheme [Intellectual Product]
Processing 00000000.tx.130: Two possible reaction pathways for the formation of 2'-deoxyoxanosine (dOxo) from 2'-deoxyguanosine (dGuo) by HNO2 treatment. 

Phrase: "Two possible reaction pathways for the formation of 2'-deoxyoxanosine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1704259:Pathways [Molecular Function]
   739   C1705987:Pathways [Conceptual Entity]

Phrase: "(dOxo"

Phrase: ")"

Phrase: "from 2'-deoxyguanosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(dGuo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: "by HNO2 treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.131: dR in the structures denotes a 2'-deoxyribose moiety.  

Phrase: "dR in the structures"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0031831:DR [Professional or Occupational Group]
   770   C1707664:DR [Biomedical or Dental Material]
   770   C2348314:Dr. [Conceptual Entity]
   770   C3540849:DR [Idea or Concept]

Phrase: "denotes"

Phrase: "a 2'-deoxyribose moiety."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0011530:2-Deoxyribose [Biologically Active Substance,Carbohydrate]
Processing 00000000.tx.132: View larger version (16K): [in this window] [in a new window]  Scheme 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(16K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Scheme 2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1519193:Scheme [Intellectual Product]
Processing 00000000.tx.133: Proposed reaction pathways for the nitrosative deamination of aromatic amines by HNO2.  

Phrase: "Proposed reaction pathways for the nitrosative deamination of aromatic amines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1704259:Pathways [Molecular Function]
   739   C1705987:Pathways [Conceptual Entity]

Phrase: "by HNO2."
Processing 00000000.tx.134: N2,N2-diMe-Guo (1.0 mM), N2-Me-Guo (10 mM) and 1-Me-Guo (10 mM) were incubated with NaNO2 (100 mM) in sodium acetate buffer (3.0 M, pH 3.7) for 6 h at 37C, and the reactions monitored by RP-HPLC. 

Phrase: "N2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441960:N2 [Finding]

Phrase: "N2-diMe-Guo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "(1.0 mM"

Phrase: ")"

Phrase: ","

Phrase: "N2-Me-Guo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "(10 mM)"

Phrase: "and"

Phrase: "1-Me-Guo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "(10 mM)"

Phrase: "were"

Phrase: "incubated with NaNO2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "(100 mM) in sodium acetate buffer"

Phrase: "(3.0 M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "pH 3.7"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C1882074:pH 7 [Qualitative Concept]
   901   C0601906:PH 3 [Pharmacologic Substance]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "for 6 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 37C,"

Phrase: "and"

Phrase: "the reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0443286:Reaction [Functional Concept]
   966   C1114821:Reaction [Clinical Attribute]

Phrase: "monitored by RP-HPLC."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0008562:HPLC [Laboratory Procedure]
   760   C0205390:Phase [Temporal Concept]
   726   C0030695:monitor [Health Care Activity]
   726   C0150369:monitor [Health Care Activity]
   726   C0181904:Monitor [Medical Device]
   726   C0596972:Monitor [Medical Device]
   726   C1521743:Monitor [Professional or Occupational Group]
   726   C1555029:Reverse [Idea or Concept]
   726   C1704646:Monitor [Manufactured Object]
Processing 00000000.tx.135: No product was observed in the reaction of N2,N2-diMe-Guo (Fig. 1B). 

Phrase: "No product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514468:product [Entity]
  1000   C1704444:Product [Quantitative Concept]

Phrase: "was"

Phrase: "observed in the reaction of N2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0441960:N2 [Finding]
   753   C0443286:Reaction [Functional Concept]
   753   C1114821:Reaction [Clinical Attribute]
   753   C1441672:Observed [Functional Concept]

Phrase: "N2-diMe-Guo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.136: One product was detected in the reaction of N2-Me-Guo and isolated by RP-HPLC. 

Phrase: "One product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1514468:product [Entity]
   861   C1704444:Product [Quantitative Concept]

Phrase: "was"

Phrase: "detected in the reaction of N2-Me-Guo"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   744   C0441960:N2 [Finding]
   744   C0442726:Detected [Finding]
   744   C0443286:Reaction [Functional Concept]
   744   C1114821:Reaction [Clinical Attribute]
   744   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "isolated by RP-HPLC."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0008562:HPLC [Laboratory Procedure]
   760   C0205390:Phase [Temporal Concept]
   760   C0205409:Isolated [Functional Concept]
   760   C1548221:Isolated [Idea or Concept]
   726 E C0370215:Isolate [Substance]
   726   C1555029:Reverse [Idea or Concept]
   726 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.137: From spectrometric data, the product was identified as a nitroso derivative, N2-methyl-N2-nitrosoguanosine (N2-Me-N2-nitroso-Guo) (Fig.1C). 

Phrase: "From spectrometric data,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "the product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514468:product [Entity]
  1000   C1704444:Product [Quantitative Concept]

Phrase: "was"

Phrase: "identified as a nitroso derivative,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205396:Identified [Qualitative Concept]
   760   C1527240:Derivative [Functional Concept]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]

Phrase: "N2-methyl-N2-nitrosoguanosine"

Phrase: "(N2-Me-N2-nitroso-Guo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: ")"

Phrase: "(Fig.1C"

Phrase: ")."
Processing 00000000.tx.138: N2-Me-Guo was completely converted to N2-Me-N2-nitroso-Guo after incubation for 6 h. 

Phrase: "N2-Me-Guo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "was"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "converted to N2-Me-N2-nitroso-Guo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   748   C0441960:N2 [Finding]

Phrase: "after incubation"

Phrase: "for 6 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.139: When 1-Me-Guo was incubated with HNO2, two major product peaks with tR = 10.2 and 13.7 min appeared in the RP-HPLC chromatogram (data not shown). 

Phrase: "When"

Phrase: "1-Me-Guo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "was"

Phrase: "incubated with HNO2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "two major product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1514468:product [Entity]
   827   C1704444:Product [Quantitative Concept]

Phrase: "peaks with tR = 10.2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0619562:TR 2 [Organic Chemical]
   760   C0444505:Peak [Quantitative Concept]

Phrase: "and"

Phrase: "13.7 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0702093:/min [Temporal Concept]

Phrase: "appeared in the RP-HPLC chromatogram"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0008562:HPLC [Laboratory Procedure]
   748   C0205390:Phase [Temporal Concept]
   714   C0700364:APPEAR [Qualitative Concept]
   714   C1555029:Reverse [Idea or Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.140: The UV spectra of the peaks were similar to those of Xao and Oxo, respectively. 

Phrase: "The UV spectra of the peaks"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1883073:Spectrum [Quantitative Concept]
   719   C2827424:Spectrum [Conceptual Entity]

Phrase: "were"

Phrase: "similar to those of Xao"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]

Phrase: "and"

Phrase: "Oxo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0069733:oxanosine [Antibiotic]

Phrase: "respectively."
Processing 00000000.tx.141: From the spectrometric data, these products were identified as 1-Me-Xao, a deamination product of 1-Me-Guo, and N5-methyloxanosine (N5-Me-Oxo), an Oxo analog bearing an exocyclic methyl amino group (Fig. 1D). 

Phrase: "From the spectrometric data,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "these products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514468:Products [Entity]
   966 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "identified as 1-Me-Xao,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205396:Identified [Qualitative Concept]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]

Phrase: "a deamination product of 1-Me-Guo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1514468:product [Entity]
   748   C1704444:Product [Quantitative Concept]

Phrase: "and"

Phrase: "N5-methyloxanosine"

Phrase: "(N5-Me-Oxo"

Phrase: ")"

Phrase: ","

Phrase: "an Oxo analog"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243071:Analog [Chemical Viewed Structurally]
   761 E C0679213:analogies [Idea or Concept]

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "an exocyclic methyl amino group"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   875   C0596922:Methyl Group [Organic Chemical]
   861   C0596072:amino group [Inorganic Chemical]
   812   C0441833:Group [Idea or Concept]
   812   C0687744:group [Population Group]
   812   C1257890:Group [Population Group]
   812   C1552516:Group [Health Care Related Organization]
   812   C1705428:Group [Conceptual Entity]
   812   C1705429:Group [Population Group]

Phrase: "(Fig. 1D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1416886:1D [Gene or Genome]
   861   C1442449:1D [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.142: The yields of the products (HNO2 treatment for 6 h) were 38.0% N5-Me-Oxo and 22.3% 1-Me-Xao with 39.7% unreacted 1-Me-Guo. 

Phrase: "The yields of the products"

Phrase: "(HNO2 treatment for 6 h)"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "were"

Phrase: "38.0% N5-Me-Oxo"

Phrase: "and"

Phrase: "22.3% 1-Me-Xao"

Phrase: "with 39.7% unreacted 1-Me-Guo."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
Processing 00000000.tx.143: Unlike the results for Guo and dGuo, treatment of 1-Me-Guo with HNO2 resulted in a higher yield of the Oxo derivative than the Xao derivative. 

Phrase: "Unlike the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "for Guo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "and"

Phrase: "dGuo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "treatment of 1-Me-Guo"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "with HNO2"

Phrase: "resulted in a higher yield of the Oxo derivative"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   742   C0069733:oxanosine [Antibiotic]
   742   C1527240:Derivative [Functional Concept]
   708   C0205250:High [Qualitative Concept]
   708   C1274040:Result [Functional Concept]
   708   C1299351:High [Qualitative Concept]
   708   C1546471:Result [Idea or Concept]
   708   C2700149:HIGH [Intellectual Product]
   708   C2825142:Result [Finding]

Phrase: "than the Xao derivative."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1527240:Derivative [Functional Concept]
Processing 00000000.tx.144: Consideration of rearrangements In the formation of N5-Me-Oxo from 1-Me-Guo (Fig. 1D), the N1-methyl group shifted from the endocyclic to exocyclic position. 

Phrase: "Consideration of rearrangements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0518609:consideration [Finding]

Phrase: "In the formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0220781:formation [Biologic Function]
  1000   C0439634:formation [Spatial Concept]
  1000   C1522492:Formation [Functional Concept]

Phrase: "of N5-Me-Oxo"

Phrase: "from 1-Me-Guo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "(Fig. 1D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1416886:1D [Gene or Genome]
   861   C1442449:1D [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "the N1-methyl group"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0596922:Methyl Group [Organic Chemical]
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]

Phrase: "shifted from the endocyclic"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0333051:shifted [Functional Concept]
   737 E C2347509:Shift [Phenomenon or Process]

Phrase: "to exocyclic position."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:Position [Spatial Concept]
   789 E C0240795:POSITIONAL [Finding]
Processing 00000000.tx.145: This type of methyl group shift, which is known as a Dimroth rearrangement, can take place in heterocyclic compounds when an exocyclic amino or imino group has a neighboring N-alkyl group in a ring (24,25). 

Phrase: "This type of methyl group shift,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332307:Type [Qualitative Concept]
   753   C1547052:*Type [Quantitative Concept]

Phrase: "which"

Phrase: "is"

Phrase: "known as a Dimroth rearrangement,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205309:Known [Qualitative Concept]
   760   C1511695:Rearrangement [Genetic Function]

Phrase: "can"

Phrase: "take"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515187:Take [Health Care Activity]

Phrase: "place in heterocyclic compounds"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0442504:Place [Spatial Concept]
   770   C1704765:Place [Functional Concept]
   770   C1882509:Place [Activity]
   770   C3496241:place [Disease or Syndrome]

Phrase: "when"

Phrase: "an exocyclic amino"

Phrase: "or"

Phrase: "imino group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "has"

Phrase: "a neighboring N-alkyl group in a ring"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0596066:alkyl group [Organic Chemical]
   767   C0441835:Group A [Classification]
   767   C0441848:Group N [Intellectual Product]
   744   C0441833:Group [Idea or Concept]
   744   C0687744:group [Population Group]
   744   C1257890:Group [Population Group]
   744   C1552516:Group [Health Care Related Organization]
   744   C1705428:Group [Conceptual Entity]
   744   C1705429:Group [Population Group]

Phrase: "(24,"

Phrase: "25"

Phrase: ")."
Processing 00000000.tx.146: Dimroth rearrangement proceeds under alkaline or acidic conditions for pyrimidines, purines and pteridine derivatives (2631). 

Phrase: "Dimroth rearrangement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511695:Rearrangement [Genetic Function]

Phrase: "proceeds under alkaline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1979842:Alkaline [Qualitative Concept]

Phrase: "or"

Phrase: "acidic conditions for pyrimidines,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]

Phrase: "purines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034140:Purines [Organic Chemical]
  1000   C0220903:purines [Organic Chemical]

Phrase: "and"

Phrase: "pteridine derivatives"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243072:derivatives [Chemical Viewed Structurally]
   827 E C1527240:Derivative [Functional Concept]

Phrase: "(2631"

Phrase: ")."
Processing 00000000.tx.147: If Dimroth rearrangement is involved in the present reaction system, generation of N5-Me-Oxo from 1-Me-Guo would require initial formation of N2-Me-Guo from 1-Me-Guo followed by substitution of the N1 atom by an oxygen atom. 

Phrase: "If"

Phrase: "Dimroth rearrangement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511695:Rearrangement [Genetic Function]

Phrase: "is"

Phrase: "involved in the present reaction system,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   783   C0449915:System involved [Spatial Concept]
   753   C0150312:Present [Quantitative Concept]
   753   C0443286:Reaction [Functional Concept]
   753   C0449450:Present [Idea or Concept]
   753   C0449913:System [Functional Concept]
   753   C1114821:Reaction [Clinical Attribute]
   753   C1314939:Involved [Functional Concept]
   753   C1553451:System [Manufactured Object]
   753   C1704459:System [Medical Device]
   748   C1710276:Systemic Reaction [Biologic Function]

Phrase: "generation of N5-Me-Oxo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0079411:Generation [Temporal Concept]
   770   C3146294:Generation [Activity]

Phrase: "from 1-Me-Guo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "would"

Phrase: "require"

Phrase: "initial formation of N2-Me-Guo"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C1157582:guanosine formation [Molecular Function]
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]

Phrase: "from 1-Me-Guo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "followed by substitution of the N1 atom"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   778   C0332283:Followed by [Temporal Concept]
           followed
   748   C0441962:N1 [Finding]
   748   C0567415:Atom [Element, Ion, or Isotope]
   748   C1555721:Substitution [Idea or Concept]
   748   C1706204:Substitution [Activity]
   748   C1706222:Atom [Conceptual Entity]
   714 E C1719822:Follow [Intellectual Product]

Phrase: "by an oxygen atom."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0567415:Atom [Element, Ion, or Isotope]
   861   C1706222:Atom [Conceptual Entity]
Processing 00000000.tx.148: To examine this possibility, 1-Me-Guo (10 mM) was incubated in 3.0 M sodium acetate buffer (pH 3.7) in the absence of NO2 for 48 h at 37C. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "this possibility,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "1-Me-Guo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "(10 mM)"

Phrase: "was"

Phrase: "incubated in 3.0 M sodium acetate buffer"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0142785:Sodium Acetate [Organic Chemical,Pharmacologic Substance]
   744   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   744   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   744   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0441923:M+ [Intellectual Product]
   744   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   744   C1439852:Incubated [Laboratory Procedure]

Phrase: "(pH 3.7"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C1882074:pH 7 [Qualitative Concept]
   901   C0601906:PH 3 [Pharmacologic Substance]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of NO2"

Phrase: "for 48 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 37C."
Processing 00000000.tx.149: No peak other than the starting 1-Me-Guo was observed in the RP-HPLC chromatogram. 

Phrase: "No peak other than the starting 1-Me-Guo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0444505:Peak [Quantitative Concept]

Phrase: "was"

Phrase: "observed in the RP-HPLC chromatogram."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0008562:HPLC [Laboratory Procedure]
   748   C0205390:Phase [Temporal Concept]
   748   C1441672:Observed [Functional Concept]
   714   C1555029:Reverse [Idea or Concept]
Processing 00000000.tx.150: Consequently, it is evident that intramolecular rearrangement from 1-Me-Guo to N2-Me-Guo is not involved in the present system. 

Phrase: "Consequently,"

Phrase: "it"

Phrase: "is"

Phrase: "evident"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0332120:Evidence [Functional Concept]

Phrase: "that intramolecular rearrangement from 1-Me-Guo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1511695:Rearrangement [Genetic Function]

Phrase: "to N2-Me-Guo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "involved in the present system."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C0449915:System involved [Spatial Concept]
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0449913:System [Functional Concept]
   760   C1314939:Involved [Functional Concept]
   760   C1553451:System [Manufactured Object]
   760   C1704459:System [Medical Device]
Processing 00000000.tx.151: Since the base moieties of the Oxo and Xao derivatives are structural isomers of each other, we also explored the possibility of interconversion between these derivatives. 

Phrase: "Since"

Phrase: "the base moieties of the Oxo"

Phrase: "and"

Phrase: "Xao derivatives"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243072:derivatives [Chemical Viewed Structurally]
   827 E C1527240:Derivative [Functional Concept]

Phrase: "are"

Phrase: "structural isomers of each other,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0022203:isomers [Natural Phenomenon or Process]

Phrase: "we also"

Phrase: "explored"

Phrase: "the possibility of interconversion"

Phrase: "between these derivatives."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0243072:derivatives [Chemical Viewed Structurally]
   966 E C1527240:Derivative [Functional Concept]
Processing 00000000.tx.152: An aqueous solution containing Xao or 1-Me-Xao was incubated in the presence or absence of 100 mM NaNO2 in 3.0 M sodium acetate buffer (pH3.7) at 37C for 48 h. 

Phrase: "An aqueous solution containing Xao"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0078606:xanthosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "or"

Phrase: "1-Me-Xao"

Phrase: "was"

Phrase: "incubated in the presence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "or"

Phrase: "absence of 100 mM NaNO2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:absence [Quantitative Concept]
   760   C1689985:Absence [Anatomical Abnormality]

Phrase: "in 3.0 M sodium acetate buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(pH3.7"

Phrase: ")"

Phrase: "at 37C"

Phrase: "for 48 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.153: However, Oxo or N5-Me-Oxo was not observed in the RP-HPLC chromatograms (data not shown). 

Phrase: "However,"

Phrase: "Oxo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0069733:oxanosine [Antibiotic]

Phrase: "or"

Phrase: "N5-Me-Oxo"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observed in the RP-HPLC chromatograms"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0008562:HPLC [Laboratory Procedure]
   748   C0205390:Phase [Temporal Concept]
   748   C1441672:Observed [Functional Concept]
   714   C1555029:Reverse [Idea or Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.154: In similar experiments, no conversion from Oxo and N5-Me-Oxo to Xao and 1-Me-Xao occurred, respectively. 

Phrase: "In similar experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "no conversion from Oxo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439836:Conversion [Functional Concept]

Phrase: "and"

Phrase: "N5-Me-Oxo to Xao"

Phrase: "and"

Phrase: "1-Me-Xao"

Phrase: "occurred"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1709305:Occurred [Activity]
   966 E C2745955:OCCUR [Temporal Concept]

Phrase: ","

Phrase: "respectively."
Processing 00000000.tx.155: Intramolecular rearrangement from 1-Me-Guo to N2-Me-Guo and conversion between Oxo and Xao derivatives were not involved in the present system. 

Phrase: "Intramolecular rearrangement from 1-Me-Guo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1511695:Rearrangement [Genetic Function]

Phrase: "to N2-Me-Guo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "and"

Phrase: "conversion between Oxo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439836:Conversion [Functional Concept]

Phrase: "and"

Phrase: "Xao derivatives"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243072:derivatives [Chemical Viewed Structurally]
   827 E C1527240:Derivative [Functional Concept]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "involved in the present system."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C0449915:System involved [Spatial Concept]
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0449913:System [Functional Concept]
   760   C1314939:Involved [Functional Concept]
   760   C1553451:System [Manufactured Object]
   760   C1704459:System [Medical Device]
Processing 00000000.tx.156: These results clearly show that the formation of dOxo is initiated by the attack of N2O3 on the exocyclic amino group of dGuo. 

Phrase: "These results clearly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the formation of dOxo"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "is"

Phrase: "initiated by the attack of N2O3"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0277793:Attack, NOS [Temporal Concept]
   753   C1261512:attack [Social Behavior]
   753   C1304680:Attack [Finding]
   719   C1548602:Initiate [Idea or Concept]
   719   C1704686:Initiate [Functional Concept]

Phrase: "on the exocyclic amino group"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0596072:amino group [Inorganic Chemical]
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]

Phrase: "of dGuo."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.157: It is also evident that the amino group of dOxo was derived from the N1-imino group of dGuo. 

Phrase: "It"

Phrase: "is"

Phrase: "also evident"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "the amino group of dOxo"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0596072:amino group [Inorganic Chemical]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "was"

Phrase: "derived from the N1-imino group of dGuo."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   744   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0441833:Group [Idea or Concept]
   744   C0441962:N1 [Finding]
   744   C0687744:group [Population Group]
   744   C1257890:Group [Population Group]
   744   C1441547:Derived [Qualitative Concept]
   744   C1552516:Group [Health Care Related Organization]
   744   C1705428:Group [Conceptual Entity]
   744   C1705429:Group [Population Group]
   744   C3245521:derived [Idea or Concept]
Processing 00000000.tx.158: Thus, cleavage of the C6N1 amido bond in the pyrimidine ring of dGuo occurs during the reaction. 

Phrase: "Thus,"

Phrase: "cleavage of the C6N1 amido bond"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0010813:cleavage [Cell Function]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]

Phrase: "in the pyrimidine ring"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0521164:Ring [Spatial Concept]
   861   C1260969:Ring [Medical Device]
   861   C1705184:Ring [Medical Device]

Phrase: "of dGuo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "occurs during the reaction."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0443286:Reaction [Functional Concept]
   770   C1114821:Reaction [Clinical Attribute]
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.159: Detection and separation of a reaction intermediate To obtain further information on the reaction mechanism of dOxo formation, we attempted to identify the reaction intermediates by RP-HPLC analysis. 

Phrase: "Detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "separation of a reaction intermediate To"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0036679:Separation [Pathologic Function]
   753   C0237868:Separation [Social Behavior]
   753   C1881713:SEPARATION [Phenomenon or Process]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "further information on the reaction mechanism of dOxo formation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1533716:Information [Idea or Concept]

Phrase: "we"

Phrase: "attempted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1516084:Attempt [Event]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "the reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "intermediates by RP-HPLC analysis."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   783   C2986798:Phase Analysis [Occupational Activity]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0008562:HPLC [Laboratory Procedure]
   753   C0205103:Intermediate [Spatial Concept]
   753   C0205390:Phase [Temporal Concept]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
   753   C1550465:intermediate [Idea or Concept]
   753   C2827755:INTERMEDIATE [Laboratory or Test Result]
   719   C1555029:Reverse [Idea or Concept]
Processing 00000000.tx.160: Guo (10 mM) and NaNO2 (100 mM) was incubated in sodium acetate buffer (3.0 M, pH 3.7) at 37C for a short period (5 min). 

Phrase: "Guo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "(10 mM)"

Phrase: "and"

Phrase: "NaNO2"

Phrase: "(100 mM)"

Phrase: "was"

Phrase: "incubated in sodium acetate buffer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0142785:Sodium Acetate [Organic Chemical,Pharmacologic Substance]
   760   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   760   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "(3.0 M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "pH 3.7"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C1882074:pH 7 [Qualitative Concept]
   901   C0601906:PH 3 [Pharmacologic Substance]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "at 37C"

Phrase: "for a short period"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0425946:short period [Finding]
   861   C0439531:/period [Temporal Concept]
   861   C1948053:Period [Temporal Concept]
   789 E C0332182:Periodic [Temporal Concept]
   789 E C1706381:PERIODIC [Intellectual Product]
   761 E C0031084:Periodicities [Temporal Concept]

Phrase: "(5 min)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.161: Immediately after neutralization, the reaction mixture was analyzed by RP-HPLC (Fig. 2A). 

Phrase: "Immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "after"

Phrase: "neutralization,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1578828:Neutralization [Laboratory Procedure]
  1000   C2987668:Neutralization [Functional Concept]

Phrase: "the reaction mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439962:Mixture [Substance]

Phrase: "was"

Phrase: "analyzed by RP-HPLC (Fig. 2A"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0008562:HPLC [Laboratory Procedure]
   748   C0205390:Phase [Temporal Concept]
   748   C0349966:Fig [Food]
   748   C0936012:Analyzed [Research Activity]
   748   C1337208:FIG [Food]
   714   C1555029:Reverse [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.162: In addition to the major products, several small peaks were detected. 

Phrase: "In addition to the major products,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "several small peaks"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C0442820:Small peak [Finding]
   827   C0444505:peaks [Quantitative Concept]

Phrase: "were"

Phrase: "detected."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.163: Among these peaks, only the peak with tR = 11.7 min, which showed a UV spectrum with max = 315 nm (Fig. 2A, inset), decreased at an incubation time of 30 min (data not shown). 

Phrase: "Among these peaks,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444505:peaks [Quantitative Concept]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the peak with tR = 11.7 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0444505:Peak [Quantitative Concept]

Phrase: "which"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a UV spectrum with max = 315 nm (Fig. 2A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1883073:Spectrum [Quantitative Concept]
   742   C2827424:Spectrum [Conceptual Entity]

Phrase: "inset"

Phrase: ")"

Phrase: ","

Phrase: "decreased at an incubation time of 30 min (data"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   764   C0456693:/30 min [Temporal Concept]
   764   C1442458:30 min [Temporal Concept]
   742   C0040223:Time [Temporal Concept]
   742   C0205216:Decreased [Quantitative Concept]
   742   C0392756:Decreased [Qualitative Concept]
   742   C0442797:decreased [Qualitative Concept]
   742   C0702093:/min [Temporal Concept]
   742   C1511726:Data [Idea or Concept]
   742   C3245479:data [Medical Device]
   742   C3541383:Time [Temporal Concept]
   708 E C0547047:Decrease [Quantitative Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.164: Therefore, a compound contained in this peak (referred to as 1) was assumed to be a reaction intermediate. 

Phrase: "Therefore,"

Phrase: "a compound"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205198:Compound [Qualitative Concept]
  1000   C1706082:Compound [Chemical]

Phrase: "contained in this peak"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332256:contained [Functional Concept]
   770   C0444505:Peak [Quantitative Concept]
   770   C2700400:Contained [Activity]

Phrase: "("

Phrase: "referred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205543:referred [Functional Concept]
  1000   C1691010:Referred [Functional Concept]

Phrase: "to as 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1883351:To [Qualitative Concept]

Phrase: ")"

Phrase: "was"

Phrase: "assumed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3242379:Assumed [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "intermediate."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205103:Intermediate [Spatial Concept]
  1000   C1550465:intermediate [Idea or Concept]
  1000   C2827755:INTERMEDIATE [Laboratory or Test Result]
Processing 00000000.tx.165: In order to obtain 1 in large scale, another reaction system was employed. 

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "1 in large scale,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0175659:Scale [Medical Device]
   770   C0349674:Scale [Intellectual Product]
   770   C0549177:Large [Quantitative Concept]
   770   C1947916:Scale [Activity]
   770   C2827734:1+ [Quantitative Concept]
   770   C2981698:1+ [Classification]
   770   C3536777:Scale [Manufactured Object]

Phrase: "another reaction system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "was"

Phrase: "employed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:Employed [Finding]
   966 E C0457083:Employ [Functional Concept]
Processing 00000000.tx.166: Guo (0.5 M) in 10 l of 5 M H2SO4 was added to 1.2 l of 4 M NaNO2 and incubated at 0C for 5 s. 

Phrase: "Guo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "(0.5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444499:0/5 [Quantitative Concept]

Phrase: "M) in 10 l of 5 M H2SO4"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   789   C0757631:M-L-M [Amino Acid, Peptide, or Protein,Lipid,Pharmacologic Substance]
   789   C3642200:10^5/L [Quantitative Concept]
   767   C1440942:M-5 [Immunologic Factor]
   744   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0441923:M+ [Intellectual Product]

Phrase: "was"

Phrase: "added to 1.2 l of 4 M NaNO2"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   745   C0945818:Add 1 [Quantitative Concept]
   745   C0947272:Add 2 [Quantitative Concept]
   742   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0441923:M+ [Intellectual Product]
   742   C1524062:Added [Functional Concept]
   708 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "incubated at 0C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 5 s."
Processing 00000000.tx.167: The solution was immediately neutralized with 10 M NaOH (10 l) and 100mM phosphate buffer (pH 7.0, 100 l) and analyzed by RP-HPLC. 

Phrase: "The solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037633:Solution [Substance]
  1000   C0525069:Solution [Biomedical or Dental Material]

Phrase: "was"

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "neutralized with 10 M NaOH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]

Phrase: "(10 l)"

Phrase: "and"

Phrase: "100mM phosphate buffer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "(pH 7.0,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "100 l)"

Phrase: "and"

Phrase: "analyzed by RP-HPLC."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0008562:HPLC [Laboratory Procedure]
   760   C0205390:Phase [Temporal Concept]
   760   C0936012:Analyzed [Research Activity]
   726   C1555029:Reverse [Idea or Concept]
Processing 00000000.tx.168: As shown in Figure 2B and its inset, a large peak appeared which had the same retention time and UV spectrum as 1, indicating that the peak contained 1. 

Phrase: "As"

Phrase: "shown in Figure 2B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0450354:2b [Intellectual Product]
   770   C1706096:2B [Research Activity]
   737   C1547282:Show [Intellectual Product]

Phrase: "and"

Phrase: "its inset,"

Phrase: "a large peak"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442810:Large peak [Qualitative Concept]
   861   C0444505:Peak [Quantitative Concept]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "which"

Phrase: "had"

Phrase: "the same retention time"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   827   C0035280:Retention [Mental Process]
   827   C0040223:Time [Temporal Concept]
   827   C0333117:Retention [Functional Concept]
   827   C1753315:retention [Cell Function]
   827   C3541383:Time [Temporal Concept]
   771 E C0442043:Temporal [Spatial Concept]
   771 E C2362314:Temporal [Temporal Concept]
   743 E C1632851:Times [Quantitative Concept]

Phrase: "and"

Phrase: "UV spectrum as 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1883073:Spectrum [Quantitative Concept]
   770   C2827424:Spectrum [Conceptual Entity]

Phrase: "indicating"

Phrase: "that"

Phrase: "the peak"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444505:Peak [Quantitative Concept]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.169: The RP-HPLC fraction of 1 obtained by the above method was used in the following experiments. 

Phrase: "The RP-HPLC fraction of 1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   814   C3642197:Fraction of 1 [Quantitative Concept]
   778   C1264633:Fraction of [Quantitative Concept]
           Fraction
   748   C1554103:Fraction [Idea or Concept]

Phrase: "obtained by the above method"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0025663:Method [Intellectual Product]
   760   C0449851:Method [Functional Concept]
   760   C0871511:METHOD [Intellectual Product]
   760   C1301820:Obtained [Functional Concept]
   726 E C1706701:Obtain [Activity]

Phrase: "was"

Phrase: "used in the following experiments."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   760   C0681814:Experiments [Research Activity]
   760   C1273517:used [Finding]
   726 E C0042153:use [Functional Concept]
   726   C0332283:follow [Temporal Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1706386:Experiment [Conceptual Entity]
   726   C1719822:Follow [Intellectual Product]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.170: The fraction also contained elution buffer (100mM TEAA buffer and ~10% CH3CN). 

Phrase: "The fraction also contained elution buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(100mM TEAA buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "and ~"

Phrase: "10% CH3CN"

Phrase: ")."
Processing 00000000.tx.171: View larger version (26K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(26K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.172: (A) RP-HPLC profile of the reaction mixture of guanosine (Guo) when 10 mM Guo and 100 mM NaNO2 were incubated in 3.0 M sodium acetate buffer (pH 3.7) for 5 min at 37C. 

Phrase: "(A) RP-HPLC profile of the reaction mixture of guanosine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C1979963:Profile [Laboratory Procedure]
   738   C2003903:Profile [Functional Concept]

Phrase: "(Guo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: ")"

Phrase: "when"

Phrase: "10 mM Guo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "and"

Phrase: "100 mM NaNO2"

Phrase: "were"

Phrase: "incubated in 3.0 M sodium acetate buffer"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0142785:Sodium Acetate [Organic Chemical,Pharmacologic Substance]
   744   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   744   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   744   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0441923:M+ [Intellectual Product]
   744   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   744   C1439852:Incubated [Laboratory Procedure]

Phrase: "(pH 3.7"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C1882074:pH 7 [Qualitative Concept]
   901   C0601906:PH 3 [Pharmacologic Substance]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "for 5 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at 37C."
Processing 00000000.tx.173: (B) RP-HPLC profile of the reaction mixture of Guo when 0.5 M Guo in 10 l of 5 M H2SO4 was added to 1.2 l of 4 M NaNO2 and incubated at 0C for 5 s. 

Phrase: "(B) RP-HPLC profile of the reaction mixture of Guo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C1979963:Profile [Laboratory Procedure]
   738   C2003903:Profile [Functional Concept]

Phrase: "when"

Phrase: "0.5 M Guo in 10 l of 5 M H2SO4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "was"

Phrase: "added to 1.2 l of 4 M NaNO2"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   745   C0945818:Add 1 [Quantitative Concept]
   745   C0947272:Add 2 [Quantitative Concept]
   742   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0441923:M+ [Intellectual Product]
   742   C1524062:Added [Functional Concept]
   708 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "incubated at 0C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 5 s."
Processing 00000000.tx.174: The inset shows the UV spectrum of 1 indicated by the arrow. 

Phrase: "The inset"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the UV spectrum of 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1883073:Spectrum [Quantitative Concept]
   760   C2827424:Spectrum [Conceptual Entity]

Phrase: "indicated by the arrow."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0336721:Arrow [Manufactured Object]
   770   C1444656:Indicated [Finding]
Processing 00000000.tx.175: The CH3CN concentration was increased in the linear gradient mode (0 min; 0%, 20 min; 20%).  

Phrase: "The CH3CN concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "was"

Phrase: "increased in the linear gradient mode"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   767   C1880999:GRADIENT INCREASE [Event]
   753   C0205132:Linear [Spatial Concept]
   753   C0205217:Increased [Quantitative Concept]
   753   C0439182:% gradient [Quantitative Concept]
   753   C0442805:Increased [Functional Concept]
   753   C0812409:Gradient [Quantitative Concept]
   753   C1513371:Mode [Functional Concept]
   753   C1705738:Mode [Quantitative Concept]
   753   C2347637:Mode [Quantitative Concept]
   753   C2348146:Mode [Quantitative Concept]

Phrase: "(0 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "; 0%,"

Phrase: "20 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "; 20%"

Phrase: ")."
Processing 00000000.tx.176: Identification of the intermediate To identify the intermediate, several measurements were performed. 

Phrase: "Identification of the intermediate To"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020792:Identification [Mental Process]
   760   C0205396:Identification [Qualitative Concept]

Phrase: "identify"

Phrase: "the intermediate, several measurements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0242485:measurements [Functional Concept]

Phrase: "were"

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.177: 1 was trapped completely by an anion exchange resin (Sephadex A-25, OH form) but passed directly through the same bed volume of a cation exchange resin (Bio-Rad AG50W-X8, H+ form). 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "was"

Phrase: "trapped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0184047:Trapped [Medical Device]

Phrase: "completely by an anion exchange resin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0003072:Anion exchange resin [Biomedical or Dental Material,Indicator, Reagent, or Diagnostic Aid]
   753   C0003075:Anion [Element, Ion, or Isotope]
   753   C0035191:Resin [Biomedical or Dental Material]
   753   C0205197:Completely [Qualitative Concept]
   753   C0678640:exchange [Social Behavior]

Phrase: "(Sephadex A-25,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0074343:sephadex [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "OH form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]

Phrase: ")"

Phrase: "but"

Phrase: "passed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828386:Passed [Finding]

Phrase: "directly through the same bed volume of a cation exchange resin"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   775   C0007445:Cation exchange resin [Biomedical or Dental Material,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   738   C0004916:Bed [Manufactured Object]
   738   C0007447:Cation [Chemical Viewed Structurally]
   738   C0035191:Resin [Biomedical or Dental Material]
   738   C0445247:Same [Qualitative Concept]
   738   C0449468:*Volume [Quantitative Concept]
   738   C0596170:BED [Mental or Behavioral Dysfunction]
   738   C0678640:exchange [Social Behavior]
   738   C1690016:% volume [Qualitative Concept]
   738   C1705102:Volume [Intellectual Product]
   738   C1947931:Directly [Qualitative Concept]
   738   C2700258:Volume [Laboratory Procedure]

Phrase: "(Bio-Rad AG50W-X8,"

Phrase: "H+ form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]

Phrase: ")."
Processing 00000000.tx.178: Among all of the expected intermediates in the reaction of Guo with HNO2, only the diazoate derivative is an anion (Scheme 2). 

Phrase: "Among all"

Phrase: "of the expected intermediates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205103:Intermediate [Spatial Concept]
   827   C1550465:intermediate [Idea or Concept]
   827   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "in the reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "of Guo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "with HNO2,"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the diazoate derivative"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1527240:Derivative [Functional Concept]

Phrase: "is"

Phrase: "an anion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003075:Anion [Element, Ion, or Isotope]

Phrase: "(Scheme 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1519193:Scheme [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.179: Negative ion APCI-LC/MS using 100% CH3CN as eluant showed a signal with m/z = 283 for 1. 

Phrase: "Negative ion APCI-LC/MS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0872318:LC/MS [Laboratory Procedure]
   804   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   804   C2349943:Ms. [Conceptual Entity]
   804   C3539704:MS [Gene or Genome]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "100% CH3CN as eluant"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a signal with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1710082:Signal [Phenomenon or Process]

Phrase: "m/"

Phrase: "z = 283 for 1."
Processing 00000000.tx.180: However, the signal at m/z = 311 expected for the intact diazoate anion could not be detected in the LC/MS measurements, probably due to its instability (vide infra). 

Phrase: "However,"

Phrase: "the signal at"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1710082:Signal [Phenomenon or Process]

Phrase: "m/"

Phrase: "z = 311"

Phrase: "expected for the intact diazoate anion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0003075:Anion [Element, Ion, or Isotope]
   753   C0205266:Intact [Qualitative Concept]
   753   C1517001:Expected [Idea or Concept]
   753   C1554187:Intact [Idea or Concept]

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "detected in the LC/MS measurements,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0872318:LC/MS [Laboratory Procedure]
   753   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0242485:measurements [Functional Concept]
   753   C0442726:Detected [Finding]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C2349943:Ms. [Conceptual Entity]
   753   C3539704:MS [Gene or Genome]

Phrase: "probably due to its instability"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0750492:Probably [Idea or Concept]
   760   C1444783:Instability [Finding]
   760   C3146286:Due [Idea or Concept]

Phrase: "(vide infra"

Phrase: ")."
Processing 00000000.tx.181: In general, aromatic diazoate compounds (RNNO) are known to give rise to a strong signal of the [M  28] fragment which is produced by loss of a molecular nitrogen through four-center skeletal rearrangement (32,33). 

Phrase: "In general, aromatic diazoate compounds"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C1510940:Aromatic Compounds [Organic Chemical]
   779   C0205198:Compound [Qualitative Concept]
   779   C1706082:Compound [Chemical]

Phrase: "(RNNO"

Phrase: ")"

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "give"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "rise to a strong signal of the [M  28"

Phrase: "] fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332255:fragment [Functional Concept]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "which"

Phrase: "is"

Phrase: "produced by loss of a molecular nitrogen"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0028158:Nitrogen [Element, Ion, or Isotope]
   748   C1517945:Loss [Quantitative Concept]
   748   C1521991:Molecular [Qualitative Concept]
   748   C1550581:nitrogen [Human-caused Phenomenon or Process]

Phrase: "through four-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205450:Four [Quantitative Concept]

Phrase: "center"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205099:Center [Spatial Concept]

Phrase: "skeletal rearrangement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511695:Rearrangement [Genetic Function]

Phrase: "(32,"

Phrase: "33"

Phrase: ")."
Processing 00000000.tx.182: Thus, the signal with m/z = 283 was attributed to the N2 product. 

Phrase: "Thus,"

Phrase: "the signal with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1710082:Signal [Phenomenon or Process]

Phrase: "m/"

Phrase: "z = 283"

Phrase: "was"

Phrase: "attributed to the N2 product."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0441960:N2 [Finding]
   760   C1514468:product [Entity]
   760   C1704444:Product [Quantitative Concept]
   726   C0449234:Attribute [Idea or Concept]
   726   C1704772:Attribute [Conceptual Entity]
   726   C1882133:Attribute [Qualitative Concept]
Processing 00000000.tx.183: The on-line UV spectrum of 1 (max = 315 nm) was similar to those of the diazoate derivatives of 2'-deoxycytidine (dCyd) (max = 305 nm) (16) and 9-alkyladenine (max = ~310 nm) (23). 

Phrase: "The on-line UV spectrum of 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1883073:Spectrum [Quantitative Concept]
   748   C2827424:Spectrum [Conceptual Entity]

Phrase: "(max = 315 nm)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]

Phrase: "was"

Phrase: "similar to those of the diazoate derivatives of 2'-deoxycytidine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C2348205:Similar [Qualitative Concept]

Phrase: "(dCyd"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011485:Deoxycytidine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: "(max = 305 nm) (16"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0312860:NM [Cell Function]

Phrase: ")"

Phrase: "and"

Phrase: "9-alkyladenine"

Phrase: "(max = ~310 nm) (23"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0312860:NM [Cell Function]
   812   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.184: Combining these data, we have tentatively assigned 1 as a diazoate derivative of Guo, 9-(-D-2'-ribofuranosyl)-6-oxopurine-2-diazoate (Fig. 3). 

Phrase: "Combining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0336789:Combine [Manufactured Object]

Phrase: "these data,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "we"

Phrase: "have"

Phrase: "tentatively"

Phrase: "assigned"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516050:Assigned [Functional Concept]
  1000   C1552601:assigned [Intellectual Product]

Phrase: "1 as a diazoate derivative of Guo,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   748   C1527240:Derivative [Functional Concept]
   748   C2827734:1+ [Quantitative Concept]
   748   C2981698:1+ [Classification]

Phrase: "9-"

Phrase: "(-D-2'-ribofuranosyl"

Phrase: ")-"

Phrase: "6-oxopurine-2-diazoate"

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.185: View larger version (10K): [in this window] [in a new window]  Figure 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(10K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 3."
Processing 00000000.tx.186: Structure of 1, a diazoate derivative of guanosine [9-(-D-2'-ribofuranosyl)-6-oxopurine-2-diazoate].  

Phrase: "Structure of 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0678594:Structure [Spatial Concept]

Phrase: "a diazoate derivative of guanosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1527240:Derivative [Functional Concept]

Phrase: "[9-"

Phrase: "(-D-2'-ribofuranosyl"

Phrase: ")-"

Phrase: "6-oxopurine-2-diazoate"

Phrase: "]."
Processing 00000000.tx.187: Hydrolysis of the diazoate intermediate The RP-HPLC fraction of the diazoate (100 l) was incubated in 50 mM phosphate buffer (pH 7.0, 500 l) at 37C for 20 min and analyzed by RP-HPLC. 

Phrase: "Hydrolysis of the diazoate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0020291:Hydrolysis [Natural Phenomenon or Process]

Phrase: "intermediate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205103:Intermediate [Spatial Concept]
  1000   C1550465:intermediate [Idea or Concept]
  1000   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "The RP-HPLC fraction of the diazoate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1264633:Fraction of [Quantitative Concept]
           Fraction
   744   C1554103:Fraction [Idea or Concept]

Phrase: "(100 l)"

Phrase: "was"

Phrase: "incubated in 50 mM phosphate buffer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   753   C0031701:phosphate [Organophosphorus Compound]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "(pH 7.0,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "500 l) at 37C"

Phrase: "for 20 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "analyzed by RP-HPLC."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0008562:HPLC [Laboratory Procedure]
   760   C0205390:Phase [Temporal Concept]
   760   C0936012:Analyzed [Research Activity]
   726   C1555029:Reverse [Idea or Concept]
Processing 00000000.tx.188: The peak of the diazoate disappeared and two peaks of Oxo and Xao appeared (data not shown). 

Phrase: "The peak of the diazoate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0444505:Peak [Quantitative Concept]

Phrase: "disappeared"

Phrase: "and"

Phrase: "two peaks of Oxo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0444505:peaks [Quantitative Concept]

Phrase: "and"

Phrase: "Xao"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0078606:xanthosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.189: The ratio of the yield of Oxo to Xao was 0.29. 

Phrase: "The ratio of the yield of Oxo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0456603:Ratio [Quantitative Concept]
   748   C1547037:Ratio [Intellectual Product]

Phrase: "to Xao"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0078606:xanthosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "0.29."
Processing 00000000.tx.190: This result clearly shows that the diazoate is the common precursor of Oxo and Xao in the GuoHNO2 system. 

Phrase: "This result clearly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1274040:Result [Functional Concept]
   861   C1546471:Result [Idea or Concept]
   861   C2825142:Result [Finding]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the diazoate"

Phrase: "is"

Phrase: "the common precursor of Oxo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "Xao in the GuoHNO2 system."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0078606:xanthosine [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.191: Incubation of the diazoate in 0.5 M H2SO4 at 37C for 20 min resulted in Guo as the main product with small amounts of Oxo and Xao. 

Phrase: "Incubation of the diazoate"

Phrase: "in 0.5 M H2SO4"

Phrase: "at 37C"

Phrase: "for 20 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "resulted in Guo"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   756   C1274040:Result [Functional Concept]
   756   C1546471:Result [Idea or Concept]
   756   C2825142:Result [Finding]

Phrase: "as the main product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1514468:product [Entity]
   861   C1704444:Product [Quantitative Concept]

Phrase: "with small amounts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1265611:amounts [Quantitative Concept]

Phrase: "of Oxo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0069733:oxanosine [Antibiotic]

Phrase: "and"

Phrase: "Xao."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0078606:xanthosine [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.192: In a previous study on the 9-alkyladenine diazoate derivative, similar conversion from the diazoate group to the starting amino group has been reported under strongly acidic conditions (23). 

Phrase: "In a previous study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "on the 9-alkyladenine diazoate derivative,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1527240:Derivative [Functional Concept]

Phrase: "similar conversion from the diazoate group"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439836:Conversion [Functional Concept]

Phrase: "to the starting amino group"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0596072:amino group [Inorganic Chemical]
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]

Phrase: "has"

Phrase: "been"

Phrase: "reported under strongly acidic conditions"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0001128:Acidic [Chemical]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C3496591:Reported [Clinical Attribute]
   726   C0012634:condition [Disease or Syndrome]
   726   C0348080:Condition [Qualitative Concept]
   726   C1705253:Condition [Conceptual Entity]
   726 E C3273238:Report [Intellectual Product]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.193: No change in the UV spectrum was observed when the diazoate derivative of Guo was incubated in 1 M NaOH at 37C for 2 h. 

Phrase: "No change in the UV spectrum"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0442739:No change [Finding]
   790   C1548568:No change [Intellectual Product]
   753   C0392747:Change [Functional Concept]
   753   C0443172:change [Quantitative Concept]
   753   C1705241:Change [Quantitative Concept]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "when"

Phrase: "the diazoate derivative of Guo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1527240:Derivative [Functional Concept]

Phrase: "was"

Phrase: "incubated in 1 M NaOH"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 37C"

Phrase: "for 2 h."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.194: Therefore, the diazoate is converted to Oxo and Xao at neutral pH, but to the starting Guo under acidic conditions. 

Phrase: "Therefore,"

Phrase: "the diazoate"

Phrase: "is"

Phrase: "converted to Oxo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0069733:oxanosine [Antibiotic]

Phrase: "and"

Phrase: "Xao at neutral pH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0078606:xanthosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "but to the starting Guo"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   760   C0233535:but [Mental or Behavioral Dysfunction]
   726   C0439659:Start [Temporal Concept]

Phrase: "under acidic conditions."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.195: The diazoate is stable under basic conditions. 

Phrase: "The diazoate"

Phrase: "is"

Phrase: "stable under basic conditions."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205360:Stable [Qualitative Concept]
   770   C1547311:Stable [Intellectual Product]
Processing 00000000.tx.196: The rate constant for hydrolysis of this intermediate was measured at neutral pH. 

Phrase: "The rate constant for hydrolysis of this intermediate"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C2986811:Rate Constant [Quantitative Concept]
   744   C0871208:Rate [Activity]
   744   C1521828:Rate [Quantitative Concept]
   744   C1547014:*Constant [Quantitative Concept]
   744   C1948059:Constant [Qualitative Concept]

Phrase: "was"

Phrase: "measured at neutral pH."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   833   C1882074:Neutral pH [Qualitative Concept]
           Neutral
   770   C0020283:[pH] [Quantitative Concept]
   770   C0444706:Measured [Qualitative Concept]
   770   C0450407:ph+ [Finding]
   770   C0450408:ph++ [Finding]
   770   C0450409:ph+++ [Finding]
   770   C2825492:Neutral [Phenomenon or Process]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.197: To avoid the influence of co-existing TEAA contained in the RP-HPLC eluant on the reaction rate, the diazoate was RP-HPLC purified using 50 mM phosphate buffer (pH 7.0) as eluant. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "avoid"

Phrase: "the influence of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C0021399:influential [Idea or Concept]

Phrase: "co-existing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2987476:Exist [Conceptual Entity]

Phrase: "TEAA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]

Phrase: "contained in the RP-HPLC eluant"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0008562:HPLC [Laboratory Procedure]
   748   C0205390:Phase [Temporal Concept]
   748   C0332256:contained [Functional Concept]
   748   C2700400:Contained [Activity]
   748   C3469601:Eluent [Indicator, Reagent, or Diagnostic Aid]
   714   C1555029:Reverse [Idea or Concept]

Phrase: "on the reaction rate,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0678608:reaction rate [Temporal Concept]
   861   C0443286:Reaction [Functional Concept]
   861   C0871208:Rate [Activity]
   861   C1114821:Reaction [Clinical Attribute]
   861   C1521828:Rate [Quantitative Concept]

Phrase: "the diazoate"

Phrase: "was"

Phrase: "RP-HPLC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0008562:HPLC [Laboratory Procedure]

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "50 mM phosphate buffer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "(pH 7.0"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "as"

Phrase: "eluant."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3469601:Eluent [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.198: The RP-HPLC fraction of the diazoate (200 l) was diluted with 50 mM phosphate buffer (400 l, pH 7.0) and then UV spectra were measured at intervals of 3 min at 20C. 

Phrase: "The RP-HPLC fraction of the diazoate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1264633:Fraction of [Quantitative Concept]
           Fraction
   744   C1554103:Fraction [Idea or Concept]

Phrase: "(200 l)"

Phrase: "was"

Phrase: "diluted with 50 mM phosphate buffer"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   753   C0031701:phosphate [Organophosphorus Compound]
   753   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   719   C1720119:Dilute [Functional Concept]
   719   C1948037:Dilute [Functional Concept]

Phrase: "(400 l,"

Phrase: "pH 7.0"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "and"

Phrase: "then UV spectra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1883073:Spectrum [Quantitative Concept]
   793   C2827424:Spectrum [Conceptual Entity]

Phrase: "were"

Phrase: "measured at intervals of 3 min"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   753   C0444706:Measured [Qualitative Concept]
   753   C0702093:/min [Temporal Concept]
   753   C1272706:intervals [Temporal Concept]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]
   719 E C1552654:Interval [Idea or Concept]
   719 E C1552713:Interval [Intellectual Product]

Phrase: "at 20C."
Processing 00000000.tx.199: The diazoate showed an absorption band at >310 nm, whereas Oxo and Xao showed no absorption. 

Phrase: "The diazoate"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "an absorption band at >310 nm,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0312860:NM [Cell Function]

Phrase: "whereas"

Phrase: "Oxo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0069733:oxanosine [Antibiotic]

Phrase: "and"

Phrase: "Xao"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0078606:xanthosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no absorption."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0000854:Absorption [Natural Phenomenon or Process]
  1000   C0220777:absorption [Functional Concept]
  1000   C2347023:Absorption [Phenomenon or Process]
  1000   C2347080:Absorption [Phenomenon or Process]
  1000   C2698776:ABSORPTION [Biomedical Occupation or Discipline]
  1000   C2825050:Absorption [Phenomenon or Process]
Processing 00000000.tx.200: Thus, as shown in the inset to Figure 4, the absorption at >310nm due to the diazoate rapidly decreased with incubation time. 

Phrase: "Thus,"

Phrase: "as"

Phrase: "shown in the inset to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1547282:Show [Intellectual Product]

Phrase: "Figure"

Phrase: "4,"

Phrase: "the absorption at >310nm due to the diazoate rapidly"

Phrase: "decreased with incubation time."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0040223:Time [Temporal Concept]
   770   C0205216:Decreased [Quantitative Concept]
   770   C0392756:Decreased [Qualitative Concept]
   770   C0442797:decreased [Qualitative Concept]
   770   C3541383:Time [Temporal Concept]
   737 E C0547047:Decrease [Quantitative Concept]
   715 E C0442043:Temporal [Spatial Concept]
   715 E C2362314:Temporal [Temporal Concept]
Processing 00000000.tx.201: The plot of absorbance at 340 nm against incubation time followed first order kinetics (Fig. 4). 

Phrase: "The plot of absorbance"

Phrase: "at 340 nm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "against incubation time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "followed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332283:followed [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "order"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1705175:Order [Intellectual Product]
  1000   C1705176:Order [Qualitative Concept]
  1000   C1705177:Order [Classification]
  1000   C1705178:Order [Activity]
  1000   C1882348:Order [Qualitative Concept]

Phrase: "kinetics"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022702:Kinetics [Natural Phenomenon or Process]
  1000   C0220865:kinetics [Functional Concept]
  1000   C2825046:Kinetics [Occupation or Discipline]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.202: The rate constant of the reaction was evaluated as 2.1 x 103 s1 (half life t1/2 = 5.6 min) from the slope. 

Phrase: "The rate constant of the reaction"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C2986811:Rate Constant [Quantitative Concept]
   783   C0678608:rate reaction [Temporal Concept]
   753   C0871208:Rate [Activity]
   753   C1521828:Rate [Quantitative Concept]
   753   C1547014:*Constant [Quantitative Concept]
   753   C1948059:Constant [Qualitative Concept]

Phrase: "was"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "as 2.1 x 103 s1 (half life t1/2 = 5.6 min)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   787   C0702093:/min [Temporal Concept]
   705   C0450346:2 5 [Quantitative Concept]

Phrase: "from the slope."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0807955:Slope [Quantitative Concept]
Processing 00000000.tx.203: View larger version (20K): [in this window] [in a new window]  Figure 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(20K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 4."
Processing 00000000.tx.204: Plot of the absorbance at 340 nm against incubation time. 

Phrase: "Plot of the absorbance"

Phrase: "at 340 nm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "against incubation time."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.205: The diazoate was incubated at 20C in 50 mM sodium phosphate buffer containing ~3% CH3CN. 

Phrase: "The diazoate"

Phrase: "was"

Phrase: "incubated at 20C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "in 50 mM sodium phosphate buffer containing ~3% CH3CN."
Processing 00000000.tx.206: The inset is the change in the UV spectrum of the reaction mixture measured at 3 min intervals.  

Phrase: "The inset"

Phrase: "is"

Phrase: "the change in the UV spectrum of the reaction mixture"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0025320:The change [Physiologic Function]
   739   C0392747:Change [Functional Concept]
   739   C0443172:change [Quantitative Concept]
   739   C1705241:Change [Quantitative Concept]

Phrase: "measured at 3 min intervals."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   760   C0444706:Measured [Qualitative Concept]
   760   C0702093:/min [Temporal Concept]
   760   C1272706:intervals [Temporal Concept]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]
   726 E C1552654:Interval [Idea or Concept]
   726 E C1552713:Interval [Intellectual Product]
Processing 00000000.tx.207: Ring-closed and ring-opened cations Generally, diazonium salts generate cations by dissociative loss of a molecular nitrogen (3436). 

Phrase: "Ring-closed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0587267:Closed [Functional Concept]

Phrase: "and"

Phrase: "ring-opened cations Generally,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0007447:Cations [Chemical Viewed Structurally]

Phrase: "diazonium salts"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   983   C1289946:Diazonium salt [Organic Chemical]
   861   C0036140:Salts [Chemical Viewed Structurally]
   827 E C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827 E C0206136:Salt [Food,Inorganic Chemical]
   777 E C1537053:salty [Qualitative Concept]
   755 E C0678584:saltiness [Qualitative Concept]

Phrase: "generate"

Phrase: "cations by dissociative loss of a molecular nitrogen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0007447:Cations [Chemical Viewed Structurally]

Phrase: "(3436"

Phrase: ")."
Processing 00000000.tx.208: Although aromatic diazonium compounds form ring-closed cations exclusively, some aliphatic ring compounds generate not only ring-closed but also ring-opened cations (3739). 

Phrase: "Although"

Phrase: "aromatic diazonium compounds"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C1510940:Aromatic Compounds [Organic Chemical]
   901   C0012019:Diazonium Compounds [Organic Chemical]
   793   C0205198:Compound [Qualitative Concept]
   793   C1706082:Compound [Chemical]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "ring-closed cations exclusively,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0007447:Cations [Chemical Viewed Structurally]

Phrase: "some aliphatic ring compounds"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   867   C1519100:Ring Compound [Chemical Viewed Structurally]
   827   C0521164:Ring [Spatial Concept]
   827   C1260969:Ring [Medical Device]
   827   C1705184:Ring [Medical Device]
   793   C0205198:Compound [Qualitative Concept]
   793   C1706082:Compound [Chemical]

Phrase: "generate"

Phrase: "not only ring-closed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0587267:Closed [Functional Concept]

Phrase: "but"

Phrase: "also ring-opened cations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0007447:Cations [Chemical Viewed Structurally]

Phrase: "(3739"

Phrase: ")."
Processing 00000000.tx.209: Two types of reaction mechanism have been proposed for the ring opening process on the basis of kinetic and stereochemical criteria. 

Phrase: "Two types of reaction mechanism"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0332307:Types [Qualitative Concept]
   726 E C1547052:*Type [Quantitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "proposed for the ring opening process"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0175566:Opening [Spatial Concept]
   753   C0521164:Ring [Spatial Concept]
   753   C1184743:Process [Body Part, Organ, or Organ Component]
   753   C1260969:Ring [Medical Device]
   753   C1441414:PROPOSED [Idea or Concept]
   753   C1522240:Process [Phenomenon or Process]
   753   C1553874:Proposed [Qualitative Concept]
   753   C1578820:Proposed [Idea or Concept]
   753   C1705184:Ring [Medical Device]
   753   C1882151:Opening [Spatial Concept]

Phrase: "on the basis of kinetic"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0022702:kinetic [Natural Phenomenon or Process]
   944 E C0026597:Motion [Natural Phenomenon or Process]
   944 E C0687704:Motions [Functional Concept]
   928 E C0022699:Kineses [Individual Behavior]

Phrase: "and"

Phrase: "stereochemical criteria."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0243161:criteria [Intellectual Product]
Processing 00000000.tx.210: One is the one-step reaction mechanism including synchronous ring opening with elimination of a nitrogen molecule. 

Phrase: "One"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "is"

Phrase: "the one-step reaction mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0441712:Mechanism [Functional Concept]
   812   C1706376:Mechanism [Manufactured Object]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "synchronous ring opening with elimination of a nitrogen molecule."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0175566:Opening [Spatial Concept]
   742   C1882151:Opening [Spatial Concept]
Processing 00000000.tx.211: Bicycloalkanediazonium ions undergo a synchronous ring opening reaction (37). 

Phrase: "Bicycloalkanediazonium ions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0022023:Ions [Element, Ion, or Isotope]
   827 E C1700702:ION [Functional Concept]

Phrase: "undergo"

Phrase: "a synchronous ring opening reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0443286:Reaction [Functional Concept]
   812   C1114821:Reaction [Clinical Attribute]

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.212: The other is the multi-step reaction mechanism, including formation of the ring-closed cation and sequential ring opening. 

Phrase: "The"

Phrase: "other"

Phrase: "is"

Phrase: "the multi-step reaction mechanism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0441712:Mechanism [Functional Concept]
   812   C1706376:Mechanism [Manufactured Object]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "formation of the ring-closed cation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "sequential ring opening."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0175566:Opening [Spatial Concept]
   827   C1882151:Opening [Spatial Concept]
Processing 00000000.tx.213: Decomposition of the phenyl-substituted cyclopropanediazonium ion occurs via a multi-step reaction (39). 

Phrase: "Decomposition of the phenyl-substituted cyclopropanediazonium ion"

Phrase: "occurs via a multi-step reaction"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0439064:Multi [Quantitative Concept]
   753   C0443286:Reaction [Functional Concept]
   753   C1114821:Reaction [Clinical Attribute]
   753   C1261552:Step [Conceptual Entity]
   753   C1704379:Step [Functional Concept]
   753   C1705117:Step [Quantitative Concept]
   753   C1709305:Occur [Activity]
   753   C2745955:OCCUR [Temporal Concept]
   753   C2825408:Step [Manufactured Object]

Phrase: "(39"

Phrase: ")."
Processing 00000000.tx.214: In recently published papers by Glaser and colleagues, the reaction mechanism for the formation of dOxo was explored using ab initio calculation (1315). 

Phrase: "In recently published papers"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0030351:Papers [Manufactured Object]
   793 E C1547566:Paper [Idea or Concept]

Phrase: "by Glaser"

Phrase: "and"

Phrase: "colleagues,"

Phrase: "the reaction mechanism for the formation of dOxo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0441712:Mechanism [Functional Concept]
   744   C1706376:Mechanism [Manufactured Object]

Phrase: "was"

Phrase: "explored"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "ab initio calculation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1441506:Calculation [Activity]

Phrase: "(1315"

Phrase: ")."
Processing 00000000.tx.215: According to their calculations, cleavage of the C6N1 bond occurs when the length of the C2N2+ bond of the guanine diazonium ion is >2.2 . All attempts to search the reaction channel connecting the diazonium ion to the ring-closed cation failed. 

Phrase: "According to their calculations,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1441506:Calculation [Activity]

Phrase: "cleavage of the C6N1 bond"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0010813:cleavage [Cell Function]
   760   C0596311:Cleavage [Phenomenon or Process]
   760   C1330957:cleavage [Cell Function]

Phrase: "occurs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "when"

Phrase: "the length of the C2N2+ bond"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0678597:bond length [Quantitative Concept]
   753   C1444754:Length [Quantitative Concept]
   753   C1706316:LENGTH [Research Activity]

Phrase: "of the guanine diazonium ion is >2.2 ."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0018321:Guanine [Nucleic Acid, Nucleoside, or Nucleotide]
   799   C0022023:Ion [Element, Ion, or Isotope]
   799   C1700702:ION [Functional Concept]

Phrase: "All"

Phrase: "attempts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516084:Attempt [Event]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "search"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552603:search [Intellectual Product]
  1000   C1706202:Search [Activity]

Phrase: "the reaction channel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439799:Channel [Spatial Concept]
   861   C1706095:Channel [Conceptual Entity]

Phrase: "connecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2986575:Connect [Activity]

Phrase: "the diazonium ion to the ring-closed cation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0022023:Ion [Element, Ion, or Isotope]
   744   C1700702:ION [Functional Concept]

Phrase: "failed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]
Processing 00000000.tx.216: The ring-opened cation was more stable (63.0 kcal/mol) than the ring-closed cation. 

Phrase: "The ring-opened cation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0007447:Cation [Chemical Viewed Structurally]

Phrase: "was"

Phrase: "more stable"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205360:Stable [Qualitative Concept]
   861   C1547311:Stable [Intellectual Product]

Phrase: "(63.0 kcal/mol"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1456781:mole [Neoplastic Process]
   812   C1824986:mol [Gene or Genome]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ")"

Phrase: "than the ring-closed cation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0007447:Cation [Chemical Viewed Structurally]
Processing 00000000.tx.217: These results suggest that release of a nitrogen molecule from the diazonium ion generates the ring-opened cation directly without formation of the ring-closed cation, supporting the one-step mechanism. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that release of a nitrogen molecule"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0030685:Release [Health Care Activity]
   753   C0391871:Release [Functional Concept]
   753   C0439180:% release [Quantitative Concept]
   753   C0680255:release [Health Care Activity]
   753   C1283071:Release [Functional Concept]
   753   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "from the diazonium ion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022023:Ion [Element, Ion, or Isotope]
   861   C1700702:ION [Functional Concept]

Phrase: "generates"

Phrase: "the ring-opened cation directly without formation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0007447:Cation [Chemical Viewed Structurally]

Phrase: "of the ring-closed cation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0007447:Cation [Chemical Viewed Structurally]

Phrase: "supporting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0183683:Support [Medical Device]
   966   C1521721:Support [Conceptual Entity]

Phrase: "the one-step mechanism."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441712:Mechanism [Functional Concept]
   827   C1706376:Mechanism [Manufactured Object]
   734   C0534010:one step [Biomedical or Dental Material,Organic Chemical]
Processing 00000000.tx.218: If the one-step reaction mechanism is involved in the present system, only the ring-opened cation would be generated (Scheme 3A). 

Phrase: "If"

Phrase: "the one-step reaction mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0441712:Mechanism [Functional Concept]
   812   C1706376:Mechanism [Manufactured Object]

Phrase: "is"

Phrase: "involved in the present system,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C0449915:System involved [Spatial Concept]
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0449913:System [Functional Concept]
   760   C1314939:Involved [Functional Concept]
   760   C1553451:System [Manufactured Object]
   760   C1704459:System [Medical Device]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the ring-opened cation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0007447:Cation [Chemical Viewed Structurally]

Phrase: "would"

Phrase: "be"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "(Scheme 3A"

Phrase: ")."
Processing 00000000.tx.219: Attack by H2O on the carbonyl and carbodiimide groups of the ring-opened cation generate Oxo and Xao, respectively, after ring closure. 

Phrase: "Attack by H2O"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0277793:Attack, NOS [Temporal Concept]
   790   C1261512:attack [Social Behavior]
   790   C1304680:Attack [Finding]

Phrase: "on the carbonyl"

Phrase: "and"

Phrase: "carbodiimide groups of the ring-opened cation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0441833:Group [Idea or Concept]
   748   C0687744:group [Population Group]
   748   C1257890:Group [Population Group]
   748   C1552516:Group [Health Care Related Organization]
   748   C1552839:groups [Idea or Concept]
   748   C1705428:Group [Conceptual Entity]
   748   C1705429:Group [Population Group]

Phrase: "generate"

Phrase: "Oxo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0069733:oxanosine [Antibiotic]

Phrase: "and"

Phrase: "Xao,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0078606:xanthosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "respectively,"

Phrase: "after"

Phrase: "ring closure."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0185003:Closure [Therapeutic or Preventive Procedure]
   861   C1521802:Closure [Research Activity]
   805 E C0447303:Occlusal [Body Location or Region]
   805 E C0591895:occlusal [Organic Chemical,Pharmacologic Substance]
   805 E C1947917:Occlusal [Functional Concept]
Processing 00000000.tx.220: In this case the ratio Oxo:Xao is determined only by the relative reactivity of the carbonyl and carbodiimide groups with H2O. 

Phrase: "In this case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "the ratio Oxo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0069733:oxanosine [Antibiotic]

Phrase: ":"

Phrase: "Xao"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0078606:xanthosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "determined"

Phrase: "only by the relative reactivity of the carbonyl"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0080103:Relative [Family Group]
   744   C0205171:Only [Quantitative Concept]
   744   C0205345:Relative [Qualitative Concept]
   744   C1547039:*Relative [Quantitative Concept]
   744   C1720467:Only [Intellectual Product]

Phrase: "and"

Phrase: "carbodiimide groups with H2O."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1552839:groups [Idea or Concept]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]
Processing 00000000.tx.221: If the multi-step mechanism is involved, the ring-closed cation exclusively generating Xao by reaction with H2O will be present in addition to the ring-opened cation (Scheme 3B). 

Phrase: "If"

Phrase: "the multi-step mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441712:Mechanism [Functional Concept]
   827   C1706376:Mechanism [Manufactured Object]

Phrase: "is"

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: ","

Phrase: "the ring-closed cation exclusively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0007447:Cation [Chemical Viewed Structurally]

Phrase: "generating"

Phrase: "Xao by reaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0078606:xanthosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "with H2O"

Phrase: "will"

Phrase: "be"

Phrase: "present in addition to the ring-opened cation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0150312:Present [Quantitative Concept]
   744   C0449450:Present [Idea or Concept]

Phrase: "(Scheme 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.222: To elucidate which reaction mechanism is operating in the present system, hydrolysis of the diazoate was carried out under various conditions and the influences of pH, temperature and solvent on the product ratio (Oxo:Xao) were determined. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "elucidate"

Phrase: "which reaction mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "is"

Phrase: "operating in the present system,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C1709324:Operating System [Intellectual Product]
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0449913:System [Functional Concept]
   760   C1553451:System [Manufactured Object]
   760   C1704459:System [Medical Device]
   726   C3242339:operate [Functional Concept]

Phrase: "hydrolysis of the diazoate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0020291:Hydrolysis [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out under various conditions"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0439787:Out [Spatial Concept]
   770   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   770   C0849355:Out [Qualitative Concept]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]

Phrase: "and"

Phrase: "the influences of pH,"

Phrase: "temperature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005903:temperature [Organism Attribute]
  1000   C0039476:*Temperature [Quantitative Concept]

Phrase: "and"

Phrase: "solvent on the product ratio"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0037638:Solvent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Oxo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0069733:oxanosine [Antibiotic]

Phrase: ":"

Phrase: "Xao"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0078606:xanthosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: "were"

Phrase: "determined."
Processing 00000000.tx.223: The products were quantified by RP-HPLC analysis. 

Phrase: "The products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514468:Products [Entity]
   966 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "quantified by RP-HPLC analysis."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   783   C2986798:Phase Analysis [Occupational Activity]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0008562:HPLC [Laboratory Procedure]
   753   C0205390:Phase [Temporal Concept]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
   719   C1555029:Reverse [Idea or Concept]
   719   C1709793:Quantify [Quantitative Concept]
Processing 00000000.tx.224: No products other than Oxo and Xao were detected in all reactions. 

Phrase: "No products other than Oxo"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1514468:Products [Entity]
   726 E C1704444:Product [Quantitative Concept]

Phrase: "and"

Phrase: "Xao"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0078606:xanthosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "detected in all reactions."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   737   C0443286:Reaction [Functional Concept]
   737   C1114821:Reaction [Clinical Attribute]
Processing 00000000.tx.225: The RP-HPLC fraction containing the diazoate was incubated at 20C in the pH range 210. 

Phrase: "The RP-HPLC fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1264633:Fraction [Quantitative Concept]
   812   C1554103:Fraction [Idea or Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the diazoate"

Phrase: "was"

Phrase: "incubated at 20C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "in the pH range 210."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]
   827   C1514721:Range [Quantitative Concept]
   827   C2348147:Range [Quantitative Concept]
   827   C3542016:Range [Intellectual Product]
Processing 00000000.tx.226: The Oxo:Xao ratio was independent of pH within the range tested, suggesting that no acidbase equilibrium was present for the intermediate cation(s). 

Phrase: "The Oxo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0069733:oxanosine [Antibiotic]

Phrase: ":"

Phrase: "Xao ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "was independent of pH"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0332291:Independent of [Functional Concept]
   770   C0020283:[pH] [Quantitative Concept]
   770   C0043194:WAS [Disease or Syndrome]
   770   C0085862:Independent [Idea or Concept]
   770   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0450407:ph+ [Finding]
   770   C0450408:ph++ [Finding]
   770   C0450409:ph+++ [Finding]
   770   C1299583:Independent [Finding]
   770   C1421478:WAS [Gene or Genome]

Phrase: "within the range"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1514721:Range [Quantitative Concept]
  1000   C2348147:Range [Quantitative Concept]
  1000   C3542016:Range [Intellectual Product]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "no acidbase equilibrium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014653:Equilibrium [Organism Function]
   861   C1547026:Equilibrium [Quantitative Concept]

Phrase: "was"

Phrase: "present for the intermediate cation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "("

Phrase: "s)."
Processing 00000000.tx.227: To clarify the temperature effect, the diazoate was incubated in 100 mM sodium phosphate buffer at pH 7.0 in the temperature range 050C. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "clarify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986669:Clarify [Activity]

Phrase: "the temperature effect,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0871499:temperature effect [Natural Phenomenon or Process]
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "the diazoate"

Phrase: "was"

Phrase: "incubated in 100 mM sodium phosphate buffer"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   814   C3256935:sodium phosphate buffer [Pharmacologic Substance]
   778   C0074757:sodium phosphate [Inorganic Chemical,Pharmacologic Substance]
   778   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   748   C0031701:phosphate [Organophosphorus Compound]
   748   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   748   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C1439852:Incubated [Laboratory Procedure]
   748   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "at pH 7.0"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "in the temperature range 050C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0457171:temperature range [Quantitative Concept]
Processing 00000000.tx.228: The Oxo:Xao ratio increased linearly with temperature from 0.22 (0C) to 0.32 (50C) (Fig. 5A). 

Phrase: "The Oxo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0069733:oxanosine [Antibiotic]

Phrase: ":"

Phrase: "Xao ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "linearly with temperature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0005903:temperature [Organism Attribute]
   790   C0039476:*Temperature [Quantitative Concept]

Phrase: "from 0.22"

Phrase: "(0C"

Phrase: ")"

Phrase: "to 0.32"

Phrase: "(50C"

Phrase: ")"

Phrase: "(Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.229: The previous ab initio calculations showed that the ring-opened cation was preferred over the ring-closed cation by 63.0 kcal/mol (13). 

Phrase: "The previous ab initio calculations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1441506:Calculation [Activity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the ring-opened cation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0007447:Cation [Chemical Viewed Structurally]

Phrase: "was"

Phrase: "preferred over the ring-closed cation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0007447:Cation [Chemical Viewed Structurally]
   753   C0521164:Ring [Spatial Concept]
   753   C0558295:Preferred [Idea or Concept]
   753   C0587267:Closed [Functional Concept]
   753   C1260969:Ring [Medical Device]
   753   C1548789:Preferred [Qualitative Concept]
   753   C1705184:Ring [Medical Device]
   753   C3543840:Preferred [Qualitative Concept]

Phrase: "by 63.0 kcal/mol"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1456781:mole [Neoplastic Process]
   812   C1824986:mol [Gene or Genome]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.230: If an equilibrium exists between these two cations (Scheme 3B) and the ring-opened cation is more stable than the ring-closed one, a rise in reaction temperature drives the equilibrium in the endothermic direction, hence increasing the fraction of the ring-closed cation. 

Phrase: "If"

Phrase: "an equilibrium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014653:Equilibrium [Organism Function]
  1000   C1547026:Equilibrium [Quantitative Concept]

Phrase: "exists between these two cations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0007447:Cations [Chemical Viewed Structurally]
   760   C0205448:Two [Quantitative Concept]
   760   C2987476:Exist [Conceptual Entity]

Phrase: "(Scheme 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")"

Phrase: "and"

Phrase: "the ring-opened cation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0007447:Cation [Chemical Viewed Structurally]

Phrase: "is"

Phrase: "more stable than the ring-closed one,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205360:Stable [Qualitative Concept]
   748   C1547311:Stable [Intellectual Product]

Phrase: "a rise in reaction temperature"

Phrase: "drives"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013126:Drive [Mental Process]

Phrase: "the equilibrium in the endothermic direction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0014653:Equilibrium [Organism Function]
   753   C1547026:Equilibrium [Quantitative Concept]

Phrase: "hence"

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the fraction of the ring-closed cation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1264633:Fraction of [Quantitative Concept]
           Fraction
   748   C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.231: In this case, a rise in incubation temperature will lead to a reduction in the Oxo:Xao ratio. 

Phrase: "In this case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "a rise in incubation temperature"

Phrase: "will"

Phrase: "lead to a reduction"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0301630:Reduction [Natural Phenomenon or Process]
   770   C0392756:Reduction [Qualitative Concept]
   770   C0441610:Reduction [Therapeutic or Preventive Procedure]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in the Oxo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0069733:oxanosine [Antibiotic]

Phrase: ":"

Phrase: "Xao ratio."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]
Processing 00000000.tx.232: Thus, the present results showing an opposite tendency do not support the multi-step reaction. 

Phrase: "Thus,"

Phrase: "the present results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "an opposite tendency"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the multi-step reaction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]
Processing 00000000.tx.233: The observed increase in the Oxo:Xao ratio with a temperature rise might be the result of the activation energy of hydrolysis of the carbonyl group being greater than that of the carbodiimide group on the ring-opened cation. 

Phrase: "The observed increase in the Oxo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: ":"

Phrase: "Xao ratio with a temperature rise"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0456603:Ratio [Quantitative Concept]
   753   C1547037:Ratio [Intellectual Product]

Phrase: "might"

Phrase: "be"

Phrase: "the result of the activation energy of hydrolysis of the carbonyl group"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   736   C1274040:Result [Functional Concept]
   736   C1546471:Result [Idea or Concept]
   736   C2825142:Result [Finding]

Phrase: "being"

Phrase: "greater than that of the carbodiimide group"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   778   C0439093:Greater Than [Quantitative Concept]
   748   C0443228:greater [Quantitative Concept]
   748   C1704243:Greater [Quantitative Concept]
   714 E C0549177:Great [Quantitative Concept]

Phrase: "on the ring-opened cation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0007447:Cation [Chemical Viewed Structurally]
Processing 00000000.tx.234: To examine the solvent effect, the Oxo:Xao ratio was measured by incubating the diazoate in solutions containing 098% (v/v) acetone at 20C. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "the solvent effect,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "the Oxo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0069733:oxanosine [Antibiotic]

Phrase: ":"

Phrase: "Xao ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "was"

Phrase: "measured by incubating"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0444706:Measured [Qualitative Concept]
   790   C1439852:incubating [Laboratory Procedure]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "the diazoate in solutions"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "098%"

Phrase: "(v/v) acetone at 20C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0001002:Acetone [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.235: The ratio increased with increasing acetone content from 0.26 (0% acetone) to 0.85 (98% acetone) (Fig. 5B). 

Phrase: "The ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456603:Ratio [Quantitative Concept]
  1000   C1547037:Ratio [Intellectual Product]

Phrase: "increased with increasing acetone content"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0001002:Acetone [Organic Chemical,Pharmacologic Substance]
   760   C0205217:Increased [Quantitative Concept]
   760   C0423896:Content [Mental Process]
   760   C0442805:Increased [Functional Concept]
   760   C0456205:Content [Conceptual Entity]

Phrase: "from 0.26"

Phrase: "(0% acetone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001002:Acetone [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "to 0.85"

Phrase: "(98% acetone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001002:Acetone [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "(Fig. 5B"

Phrase: ")."
Processing 00000000.tx.236: If an equilibrium exists between the two cations and the ring-closed cation is preferentially stabilized by reducing the dielectric constant of the solvent, addition of acetone should increase the fraction of the ring-closed cation. 

Phrase: "If"

Phrase: "an equilibrium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014653:Equilibrium [Organism Function]
  1000   C1547026:Equilibrium [Quantitative Concept]

Phrase: "exists between the two cations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0007447:Cations [Chemical Viewed Structurally]
   760   C0205448:Two [Quantitative Concept]
   760   C2987476:Exist [Conceptual Entity]

Phrase: "and"

Phrase: "the ring-closed cation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0007447:Cation [Chemical Viewed Structurally]

Phrase: "is"

Phrase: "preferentially"

Phrase: "stabilized by reducing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0184512:Stabilized [Qualitative Concept]
   790   C0392756:Reducing [Qualitative Concept]

Phrase: "the dielectric constant of the solvent,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0813980:dielectric constant [Quantitative Concept]
   753   C1547014:*Constant [Quantitative Concept]
   753   C1948059:Constant [Qualitative Concept]

Phrase: "addition of acetone"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1883712:Addition [Functional Concept]
   718 E C1524062:Additional [Functional Concept]

Phrase: "should"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the fraction of the ring-closed cation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1264633:Fraction of [Quantitative Concept]
           Fraction
   748   C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.237: In this case, the addition of acetone would reduce the Oxo:Xao ratio. 

Phrase: "In this case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "the addition of acetone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1883712:Addition [Functional Concept]

Phrase: "would"

Phrase: "reduce"

Phrase: "the Oxo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0069733:oxanosine [Antibiotic]

Phrase: ":"

Phrase: "Xao ratio."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]
Processing 00000000.tx.238: However, the observed effect of acetone was the opposite, not supporting the multi-step reaction. 

Phrase: "However,"

Phrase: "the observed effect of acetone"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "the opposite,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521805:Opposite [Spatial Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "supporting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0183683:Support [Medical Device]
   966   C1521721:Support [Conceptual Entity]

Phrase: "the multi-step reaction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]
Processing 00000000.tx.239: The increase in the Oxo:Xao ratio might result from the frequency of access of H2O to the cationic carbonyl group relative to the carbodiimide group of the ring-opened cation increasing with a rise in acetone content. 

Phrase: "The increase in the Oxo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: ":"

Phrase: "Xao ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "might"

Phrase: "result from the frequency of access of H2O"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   744   C0376249:frequency [Quantitative Concept]
   744   C0439603:Frequency [Temporal Concept]
   744   C0444454:Access [Spatial Concept]
   744   C0871396:Frequency [Quantitative Concept]
   744   C1274040:Result [Functional Concept]
   744   C1546471:Result [Idea or Concept]
   744   C1554204:access [Idea or Concept]
   744   C1561548:Frequency [Qualitative Concept]
   744   C1705502:Frequency [Quantitative Concept]
   744   C2825142:Result [Finding]

Phrase: "to the cationic carbonyl group"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0596259:carbonyl group [Inorganic Chemical]
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]

Phrase: "relative to the carbodiimide group of the ring-opened cation increasing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0080103:Relative [Family Group]
   738   C0205345:Relative [Qualitative Concept]
   738   C1547039:*Relative [Quantitative Concept]

Phrase: "with a rise"

Phrase: "in acetone content."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]
Processing 00000000.tx.240: View larger version (18K): [in this window] [in a new window]  Scheme 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(18K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Scheme 3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1519193:Scheme [Intellectual Product]
Processing 00000000.tx.241: Two conceivable reaction pathways for the formation of 2'-deoxyoxanosine (dOxo) and 2'-deoxyxanthosine (dXao) from the diazonium intermediate.  

Phrase: "Two conceivable reaction pathways for the formation of 2'-deoxyoxanosine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1704259:Pathways [Molecular Function]
   739   C1705987:Pathways [Conceptual Entity]

Phrase: "(dOxo"

Phrase: ")"

Phrase: "and"

Phrase: "2'-deoxyxanthosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0174507:2'-deoxyxanthosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(dXao"

Phrase: ")"

Phrase: "from the diazonium"

Phrase: "intermediate."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205103:Intermediate [Spatial Concept]
  1000   C1550465:intermediate [Idea or Concept]
  1000   C2827755:INTERMEDIATE [Laboratory or Test Result]
Processing 00000000.tx.242: View larger version (13K): [in this window] [in a new window]  Figure 5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(13K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 5."
Processing 00000000.tx.243: (A) The temperature dependence of the Oxo:Xao ratio at pH 7.0. 

Phrase: "(A)"

Phrase: "The temperature dependence of the Oxo"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0011546:Dependence [Mental Process]
   753   C0439857:Dependence [Mental or Behavioral Dysfunction]
   753   C2698668:DEPENDENCE [Regulation or Law]

Phrase: ":"

Phrase: "Xao ratio at pH 7.0."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0456603:Ratio [Quantitative Concept]
   753   C1547037:Ratio [Intellectual Product]
Processing 00000000.tx.244: (B) The dependence of the Oxo:Xao ratio on acetone content at 20C.  

Phrase: "(B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "The dependence of the Oxo"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0011546:Dependence [Mental Process]
   760   C0439857:Dependence [Mental or Behavioral Dysfunction]
   760   C2698668:DEPENDENCE [Regulation or Law]

Phrase: ":"

Phrase: "Xao ratio on acetone content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0456603:Ratio [Quantitative Concept]
   760   C1547037:Ratio [Intellectual Product]

Phrase: "at 20C."
Processing 00000000.tx.245: All the results concerning the effects of pH, temperature and solvent failed to support the existence of the ring-closed cation. 

Phrase: "All"

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "concerning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2699424:Concern [Idea or Concept]

Phrase: "the effects of pH,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "temperature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005903:temperature [Organism Attribute]
  1000   C0039476:*Temperature [Quantitative Concept]

Phrase: "and"

Phrase: "solvent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037638:Solvent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the existence of the ring-closed cation."
Processing 00000000.tx.246: It is very likely that the one-step mechanism dominates in the reaction of Guo with HNO2. 

Phrase: "It"

Phrase: "is"

Phrase: "very likely"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332148:Likely [Qualitative Concept]
   861   C0442824:Very [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "that"

Phrase: "the one-step mechanism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441712:Mechanism [Functional Concept]
   827   C1706376:Mechanism [Manufactured Object]
   734   C0534010:one step [Biomedical or Dental Material,Organic Chemical]

Phrase: "dominates in the reaction of Guo"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0018330:Guanosine [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   753   C0443286:Reaction [Functional Concept]
   753   C1114821:Reaction [Clinical Attribute]

Phrase: "with HNO2."
Processing 00000000.tx.247: Overall reaction mechanism A possible overall reaction pathway of dGuo with nitrous acid is summarized in Scheme 4 on the basis of the present results. 

Phrase: "Overall reaction mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441712:Mechanism [Functional Concept]
   827   C1706376:Mechanism [Manufactured Object]

Phrase: "A possible overall reaction pathway of dGuo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1704259:Pathway [Molecular Function]
   748   C1705987:Pathway [Conceptual Entity]

Phrase: "with nitrous acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028214:Nitrous Acid [Inorganic Chemical]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "is"

Phrase: "summarized in Scheme 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1519193:Scheme [Intellectual Product]

Phrase: "on the basis of the present results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]
Processing 00000000.tx.248: First, a reactive species NOx (probably N2O3) generated from protonated NO2 attacks the amino group on C2 of dGuo, resulting in the N2-nitroso intermediate. 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "a reactive species NOx"

Phrase: "(probably N2O3"

Phrase: ")"

Phrase: "generated from protonated NO2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0178812:Protonated [Phenomenon or Process]
   770   C3146294:Generated [Activity]

Phrase: "attacks"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0277793:Attack, NOS [Temporal Concept]
  1000   C1261512:attack [Social Behavior]
  1000   C1304680:Attack [Finding]

Phrase: "the amino group on C2 of dGuo,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0596072:amino group [Inorganic Chemical]
   748   C0441833:Group [Idea or Concept]
   748   C0687744:group [Population Group]
   748   C1257890:Group [Population Group]
   748   C1552516:Group [Health Care Related Organization]
   748   C1705428:Group [Conceptual Entity]
   748   C1705429:Group [Population Group]

Phrase: "resulting in the N2-nitroso intermediate."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C0332294:Resulting in [Functional Concept]
   753   C0205103:Intermediate [Spatial Concept]
   753   C0441960:N2 [Finding]
   753   C0678226:resulting [Functional Concept]
   753   C1550465:intermediate [Idea or Concept]
   753   C2827755:INTERMEDIATE [Laboratory or Test Result]
   719 E C1274040:Result [Functional Concept]
   719 E C1546471:Result [Idea or Concept]
   719 E C2825142:Result [Finding]
Processing 00000000.tx.249: The N2-nitroso intermediate is converted immediately to the diazoate intermediate, which appears to be the most stable intermediate throughout the reaction pathway. 

Phrase: "The N2-nitroso intermediate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205103:Intermediate [Spatial Concept]
   827   C1550465:intermediate [Idea or Concept]
   827   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "is"

Phrase: "converted"

Phrase: "immediately to the diazoate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205548:Immediately [Temporal Concept]

Phrase: "intermediate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205103:Intermediate [Spatial Concept]
  1000   C1550465:intermediate [Idea or Concept]
  1000   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "which"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "the most stable intermediate throughout the reaction pathway."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0205103:Intermediate [Spatial Concept]
   744   C1550465:intermediate [Idea or Concept]
   744   C2827755:INTERMEDIATE [Laboratory or Test Result]
Processing 00000000.tx.250: Then the diazoate intermediate is converted to the diazonium intermediate and the ring-opened cation is formed synchronously by the release of a nitrogen molecule from the diazonium. 

Phrase: "Then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "the diazoate"

Phrase: "intermediate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205103:Intermediate [Spatial Concept]
  1000   C1550465:intermediate [Idea or Concept]
  1000   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "is"

Phrase: "converted to the diazonium"

Phrase: "intermediate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205103:Intermediate [Spatial Concept]
  1000   C1550465:intermediate [Idea or Concept]
  1000   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "and"

Phrase: "the ring-opened cation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0007447:Cation [Chemical Viewed Structurally]

Phrase: "is"

Phrase: "formed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: "synchronously by the release of a nitrogen molecule"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   744   C0028158:Nitrogen [Element, Ion, or Isotope]
   744   C0030685:Release [Health Care Activity]
   744   C0391871:Release [Functional Concept]
   744   C0439180:% release [Quantitative Concept]
   744   C0567416:Molecule [Substance]
   744   C0680255:release [Health Care Activity]
   744   C1283071:Release [Functional Concept]
   744   C1550581:nitrogen [Human-caused Phenomenon or Process]
   744   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "from the diazonium."
Processing 00000000.tx.251: Attack by H2O on the carbodiimide of the ring-opened cation and subsequent ring closure and tautomerization generates dXao. 

Phrase: "Attack by H2O"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0277793:Attack, NOS [Temporal Concept]
   790   C1261512:attack [Social Behavior]
   790   C1304680:Attack [Finding]

Phrase: "on the carbodiimide"

Phrase: "of the ring-opened cation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0007447:Cation [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "subsequent ring closure"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0185003:Closure [Therapeutic or Preventive Procedure]
   827   C1521802:Closure [Research Activity]
   771 E C0447303:Occlusal [Body Location or Region]
   771 E C0591895:occlusal [Organic Chemical,Pharmacologic Substance]
   771 E C1947917:Occlusal [Functional Concept]

Phrase: "and"

Phrase: "tautomerization"

Phrase: "generates"

Phrase: "dXao."
Processing 00000000.tx.252: On the other hand, attack by H2O on the carbonyl group of the ring-opened cation and subsequent ring closure generates dOxo. 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "attack by H2O"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0277793:Attack, NOS [Temporal Concept]
   790   C1261512:attack [Social Behavior]
   790   C1304680:Attack [Finding]

Phrase: "on the carbonyl group"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0596259:carbonyl group [Inorganic Chemical]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "of the ring-opened cation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0007447:Cation [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "subsequent ring closure"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0185003:Closure [Therapeutic or Preventive Procedure]
   827   C1521802:Closure [Research Activity]
   771 E C0447303:Occlusal [Body Location or Region]
   771 E C0591895:occlusal [Organic Chemical,Pharmacologic Substance]
   771 E C1947917:Occlusal [Functional Concept]

Phrase: "generates"

Phrase: "dOxo."
Processing 00000000.tx.253: View larger version (11K): [in this window] [in a new window]  Scheme 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(11K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Scheme 4."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1519193:Scheme [Intellectual Product]
Processing 00000000.tx.254: The proposed overall mechanism for the reaction of 2'-deoxyguanosine (dGuo) with HNO2.   

Phrase: "The proposed overall mechanism for the reaction of 2'-deoxyguanosine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0441712:Mechanism [Functional Concept]
   739   C1706376:Mechanism [Manufactured Object]

Phrase: "(dGuo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011503:Deoxyguanosine [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: "with HNO2."
Processing 00000000.tx.255: ACKNOWLEDGEMENTS  We thank Dr M. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.256: Nishi (Setsunan University) for acquiring the HR-EI MS spectrum. 

Phrase: "Nishi"

Phrase: "(Setsunan University"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: ")"

Phrase: "for acquiring"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0439661:acquiring [Temporal Concept]
   966 E C1706701:Acquire [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the HR-EI MS spectrum."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1883073:Spectrum [Quantitative Concept]
   804   C2827424:Spectrum [Conceptual Entity]
Processing 00000000.tx.257: This work was supported partly by Grants-in-Aid for Scientific Research from the Ministry of Education, Science and Culture, Japan [to K.M. (11101001, 10151219 and 10878092), K.K. (09780545) and H.I.].  

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521721:Supported [Conceptual Entity]
   966 E C0183683:Support [Medical Device]

Phrase: "partly by Grants-in-Aid"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0018173:Grants [Quantitative Concept]
   760   C0018896:Aid [Social Behavior]
   760   C0449435:Aid [Manufactured Object]
   760   C3540469:AID [Gene or Genome]
   726 E C1548284:Grant [Idea or Concept]

Phrase: "for Scientific Research"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0683933:scientific research [Research Activity]
   861   C0035168:research [Research Activity]
   861   C0036397:Scientific [Occupation or Discipline]
   861   C0242481:Research [Research Activity]

Phrase: "from the Ministry"

Phrase: "of Education,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0013621:Education [Educational Activity]
  1000   C0013622:education [Classification]
  1000   C0013658:Education, NOS [Finding]
  1000   C0039401:Education [Educational Activity]
   928 E C1555905:Educational [Intellectual Product]

Phrase: "Science"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "and"

Phrase: "Culture,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: "["

Phrase: "to K.M."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "(11101001,"

Phrase: "10151219"

Phrase: "and"

Phrase: "10878092"

Phrase: ")"

Phrase: ","

Phrase: "K.K."

Phrase: "(09780545"

Phrase: ")"

Phrase: "and"

Phrase: "H.I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "]."
Processing 00000000.tx.258: FOOTNOTES  * To whom correspondence should be addressed. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.259: Tel: +81 774 38 3517; 

Phrase: "Tel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"

Phrase: "+81 774 38 3517"

Phrase: ";"
Processing 00000000.tx.260: Fax: +81 774 38 3524; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "+81 774 38 3524"

Phrase: ";"
Processing 00000000.tx.261: Email: kmak@iae.kyoto-u.ac.jp  REFERENCES TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS AND DISCUSSION REFERENCES  1 Shimada,N., Yagisawa,N., Naganawa,H., Takita,T., Hamada,M., Takeuchi,T. and Umezawa,H. 

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: ":"

Phrase: "kmak@iae.kyoto-u.ac.jp"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "AND"

Phrase: "DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1 Shimada,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Yagisawa,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Naganawa,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Takita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Hamada,"

Phrase: "M."

Phrase: ","

Phrase: "Takeuchi,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Umezawa,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.262: (1981) J. 

Phrase: "(1981"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.263: Antibiot. 

Phrase: "Antibiot."
Processing 00000000.tx.264: (Tokyo), 34, 12161218.[ISI][Medline] 2 Nakamura,H., Yagisawa,N., Shimada,N., Takita,T., Umezawa,H. and Iitaka,Y. 

Phrase: "(Tokyo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040371:Tokyo [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "34,"

Phrase: "12161218."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 2 Nakamura,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yagisawa,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Shimada,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Takita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Umezawa,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Iitaka,"

Phrase: "Y."
Processing 00000000.tx.265: (1981) J. 

Phrase: "(1981"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.266: Antibiot. 

Phrase: "Antibiot."
Processing 00000000.tx.267: (Tokyo), 34, 12191221.[ISI][Medline] 3 Itoh,O., Kuroiwa,K., Atsumi,S., Umezawa,K., Takeuchi,T. and Hori,M. 

Phrase: "(Tokyo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040371:Tokyo [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "34,"

Phrase: "12191221."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 3 Itoh,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Kuroiwa,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Atsumi,"

Phrase: "S."

Phrase: ","

Phrase: "Umezawa,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Takeuchi,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Hori,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.268: (1989) Cancer Res., 49, 9961000.[Abstract] 4 Kato,K., Yagisawa,N., Shimada,N., Hamada,M., Takita,T., Maeda,K. and Umezawa,H. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Cancer Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "49,"

Phrase: "9961000."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 4 Kato,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0721226:Kato [Inorganic Chemical,Pharmacologic Substance]
   861   C1551914:Kato [Language]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Yagisawa,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Shimada,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Hamada,"

Phrase: "M."

Phrase: ","

Phrase: "Takita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Maeda,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Umezawa,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.269: (1984) J. 

Phrase: "(1984"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.270: Antibiot. 

Phrase: "Antibiot."
Processing 00000000.tx.271: (Tokyo), 37, 941942.[ISI][Medline] 5 Yagisawa,N., Takita,T. and Umezawa,H. 

Phrase: "(Tokyo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040371:Tokyo [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "37,"

Phrase: "941942."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 5 Yagisawa,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Takita,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Umezawa,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.272: (1983) Tetrahedron Lett., 24, 931932.[ISI] 6 Bhattacharya,B.K., Robins,R.K. and Revankar,G.R. 

Phrase: "(1983"

Phrase: ")"

Phrase: "Tetrahedron Lett.,"

Phrase: "24,"

Phrase: "931932."

Phrase: "[ISI] 6 Bhattacharya,"

Phrase: "B.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Robins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0542318:Robins [Bird]

Phrase: "R.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Revankar,"

Phrase: "G.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.273: (1990) J. 

Phrase: "(1990"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.274: Heterocyclic Chem., 27, 787793.[ISI] 7 Matsumoto,H., Kaneko,C., Mori,T. and Mizuno,Y. 

Phrase: "Heterocyclic Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0201682:CHEM [Laboratory Procedure]

Phrase: "27,"

Phrase: "787793."

Phrase: "[ISI] 7 Matsumoto,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kaneko,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Mori,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Mizuno,"

Phrase: "Y."
Processing 00000000.tx.275: (1990) J. 

Phrase: "(1990"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.276: Heterocyclic Chem., 27, 13071311.[ISI] 8 Luk,K.-C., Moore,D.W. and Keith,D.D. 

Phrase: "Heterocyclic Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0201682:CHEM [Laboratory Procedure]

Phrase: "27,"

Phrase: "13071311."

Phrase: "[ISI] 8 Luk,"

Phrase: "K.-C., Moore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0443030:moore [Intellectual Product]

Phrase: "D.W."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Keith,"

Phrase: "D.D."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0112081:D-D [Hazardous or Poisonous Substance,Organic Chemical]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.277: (1994) Tetrahedron Lett., 35, 10071010.[ISI] 9 DeNapoli,L., DiFrabio,G., Messere,A., Montesarchio,D, Piccialli,G. and Varra,M. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Tetrahedron Lett.,"

Phrase: "35,"

Phrase: "10071010."

Phrase: "[ISI] 9 DeNapoli,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "DiFrabio,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Messere,"

Phrase: "A.,"

Phrase: "Montesarchio,"

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Piccialli,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Varra,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.278: (1998) Tetrahedron Lett., 39, 73977400.[ISI] 10 Suzuki,T., Yamaoka,R., Nishi,M., Ide,H. and Makino,K. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Tetrahedron Lett.,"

Phrase: "39,"

Phrase: "73977400."

Phrase: "[ISI] 10 Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0998924:suzuki [Fish]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Yamaoka,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Nishi,"

Phrase: "M."

Phrase: ","

Phrase: "Ide,H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Makino,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.279: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.280: Am. 

Phrase: "Am."
Processing 00000000.tx.281: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.282: Soc., 118, 25152516.[ISI] 11 Suzuki,T., Matsumura,Y., Ide,H., Kanaori,K., Tajima,K. and Makino,K. 

Phrase: "Soc.,"

Phrase: "118,"

Phrase: "25152516."

Phrase: "[ISI] 11 Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0998924:suzuki [Fish]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Matsumura,"

Phrase: "Y.,"

Phrase: "Ide,H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Kanaori,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Tajima,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Makino,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.283: (1997) Biochemistry, 36, 80138019.[ISI][Medline] 12 Suzuki,T., Yoshida,M., Yamada,M., Ide,H., Kobayashi,M., Kanaori,K., Tajima,K. and Makino,K. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Biochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "36,"

Phrase: "80138019."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 12 Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0998924:suzuki [Fish]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Yoshida,"

Phrase: "M."

Phrase: ","

Phrase: "Yamada,"

Phrase: "M."

Phrase: ","

Phrase: "Ide,H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Kobayashi,"

Phrase: "M."

Phrase: ","

Phrase: "Kanaori,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Tajima,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Makino,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.284: (1998) Biochemistry, 37, 1159211598.[ISI][Medline] 13 Glaser,R. and Son,M.-S. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Biochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "37,"

Phrase: "1159211598."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 13 Glaser,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Son,M.-S."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0439493:m/s [Quantitative Concept]
   901   C1513009:M.S. [Intellectual Product]
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.285: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.286: Am. 

Phrase: "Am."
Processing 00000000.tx.287: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.288: Soc., 118, 1094210943.[ISI] 14 Glaser,R. and Lewis,M. 

Phrase: "Soc.,"

Phrase: "118,"

Phrase: "1094210943."

Phrase: "[ISI] 14 Glaser,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Lewis,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.289: (1999) Organic Lett., 1, 273276.[ISI] 15 Glaser,R., Rayat,S., Lewis,M., Son,M.-S. and Meyer,S. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Organic Lett.,"

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "273276."

Phrase: "[ISI] 15 Glaser,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Rayat,"

Phrase: "S."

Phrase: ","

Phrase: "Lewis,"

Phrase: "M."

Phrase: ","

Phrase: "Son,M.-S."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0439493:m/s [Quantitative Concept]
   901   C1513009:M.S. [Intellectual Product]
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Meyer,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.290: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.291: Am. 

Phrase: "Am."
Processing 00000000.tx.292: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.293: Soc., 121, 61086119.[ISI] 16 Suzuki,T., Nakamura,T., Yamada,M., Ide,H., Kanaori,K., Tajima,K., Morii,T. and Makino,K. 

Phrase: "Soc.,"

Phrase: "121,"

Phrase: "61086119."

Phrase: "[ISI] 16 Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0998924:suzuki [Fish]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Nakamura,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Yamada,"

Phrase: "M."

Phrase: ","

Phrase: "Ide,H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Kanaori,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Tajima,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Morii,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Makino,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.294: (1999) Biochemistry, 38, 71517158.[ISI][Medline] 17 Roy,K.B. and Miles,T. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Biochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "38,"

Phrase: "71517158."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] 17 Roy,"

Phrase: "K.B."

Phrase: "and"

Phrase: "Miles,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0331865:Miles [Quantitative Concept]
   966 E C2347127:mile [Quantitative Concept]
   966 E C2348616:mile [Quantitative Concept]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.295: (1983) Nucl. 

Phrase: "(1983"

Phrase: ")"

Phrase: "Nucl."
Processing 00000000.tx.296: Nucl., 2, 231242.[ISI] 18 Sambrook,J., Fritsch,E.F. and Maniatis,T. 

Phrase: "Nucl.,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "231242."

Phrase: "[ISI] 18 Sambrook,"

Phrase: "J.,"

Phrase: "Fritsch,"

Phrase: "E.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Maniatis,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.297: (1989) Molecular Cloning: A Laboratory Manual. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Molecular Cloning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009017:Cloning, Molecular [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0009015:Cloning [Research Activity]

Phrase: ":"

Phrase: "A Laboratory"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022877:Laboratory [Manufactured Object,Organization]
  1000   C3244292:laboratory [Functional Concept]

Phrase: "Manual."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0024763:Manual [Intellectual Product,Manufactured Object]
  1000   C0175674:Manual [Functional Concept]
Processing 00000000.tx.298: Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. 

Phrase: "Cold Spring Harbor Laboratory Press,"

Phrase: "Cold Spring Harbor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0475311:Harbor [Manufactured Object]

Phrase: "NY."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]
Processing 00000000.tx.299: 19 McClure,T.D., Scharm,K.H., Nakano,K. and Yasaka,T. 

Phrase: "19 McClure,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "D."

Phrase: ","

Phrase: "Scharm,"

Phrase: "K.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Nakano,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Yasaka,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.300: (1989) Nucl. 

Phrase: "(1989"

Phrase: ")"

Phrase: "Nucl."
Processing 00000000.tx.301: Nucl., 8, 13991415.[ISI] 20 Rigaudy,J. and Klesney,S.P. 

Phrase: "Nucl.,"

Phrase: "8,"

Phrase: "13991415."

Phrase: "[ISI] 20 Rigaudy,"

Phrase: "J."

Phrase: "and"

Phrase: "Klesney,"

Phrase: "S.P."
Processing 00000000.tx.302: (1979) Nomenclature of Organic Chemistry: Sections A, B, C, D, E, F and H. 

Phrase: "(1979"

Phrase: ")"

Phrase: "Nomenclature of Organic Chemistry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0600281:Nomenclature [Intellectual Product]
   770   C1524067:Nomenclature [Intellectual Product]

Phrase: ":"

Phrase: "Sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "A,"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "C,"

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "E,"

Phrase: "F"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.303: Pergamon Press, Oxford, UK. 

Phrase: "Pergamon Press,"

Phrase: "Oxford,"

Phrase: "UK."
Processing 00000000.tx.304: 21 Ariza,X., Bou,V. and Vilarrasa,J. 

Phrase: "21 Ariza,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2697500:Ariza [Pharmacologic Substance]

Phrase: "X.,"

Phrase: "Bou,"

Phrase: "V."

Phrase: "and"

Phrase: "Vilarrasa,"

Phrase: "J."
Processing 00000000.tx.305: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.306: Am. 

Phrase: "Am."
Processing 00000000.tx.307: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.308: Soc., 117, 36653673.[ISI] 22 Zollinger,H. 

Phrase: "Soc.,"

Phrase: "117,"

Phrase: "36653673."

Phrase: "[ISI] 22 Zollinger,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.309: (1994) Diazo Chemistry IAromatic and Heteroaromatic Compounds. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Diazo Chemistry IAromatic"

Phrase: "and"

Phrase: "Heteroaromatic Compounds."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205198:Compound [Qualitative Concept]
   827   C1706082:Compound [Chemical]
Processing 00000000.tx.310: VCH, Weinheim, Germany. 

Phrase: "VCH,"

Phrase: "Weinheim,"

Phrase: "Germany."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]
Processing 00000000.tx.311: 23 Bunton,C.A. and Wolfe,B.B. 

Phrase: "23 Bunton,"

Phrase: "C."

Phrase: "A."

Phrase: "and"

Phrase: "Wolfe,"

Phrase: "B.B."
Processing 00000000.tx.312: (1974) J. 

Phrase: "(1974"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.313: Am. 

Phrase: "Am."
Processing 00000000.tx.314: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.315: Soc., 96, 77477752.[ISI] 24 Dimroth,O. 

Phrase: "Soc.,"

Phrase: "96,"

Phrase: "77477752."

Phrase: "[ISI] 24 Dimroth,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.316: (1909) Annalen, 364, 183226. 

Phrase: "(1909"

Phrase: ")"

Phrase: "Annalen,"

Phrase: "364,"

Phrase: "183226."
Processing 00000000.tx.317: 25 Dimroth,O. 

Phrase: "25 Dimroth,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.318: (1910) Annalen, 373, 336370. 

Phrase: "(1910"

Phrase: ")"

Phrase: "Annalen,"

Phrase: "373,"

Phrase: "336370."
Processing 00000000.tx.319: 26 Brown,D.J. 

Phrase: "26 Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "D.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.320: (1961) Nature, 189, 828829.[ISI] 27 Brookes,P. and Lawley,P.D. 

Phrase: "(1961"

Phrase: ")"

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "189,"

Phrase: "828829."

Phrase: "[ISI] 27 Brookes,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Lawley,"

Phrase: "P.D."
Processing 00000000.tx.321: (1960) J. 

Phrase: "(1960"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.322: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.323: Soc., 539545. 

Phrase: "Soc.,"

Phrase: "539545."
Processing 00000000.tx.324: 28 Jones,J.W. and Robins,R.K. 

Phrase: "28 Jones,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0443013:Jones [Intellectual Product]

Phrase: "J.W."

Phrase: "and"

Phrase: "Robins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0542318:Robins [Bird]

Phrase: "R.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.325: (1963) J. 

Phrase: "(1963"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.326: Am. 

Phrase: "Am."
Processing 00000000.tx.327: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.328: Soc., 85, 193201.[ISI] 29 Brookes,P., Dipple,A. and Lawley,P.D. 

Phrase: "Soc.,"

Phrase: "85,"

Phrase: "193201."

Phrase: "[ISI] 29 Brookes,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Dipple,"

Phrase: "A."

Phrase: "and"

Phrase: "Lawley,"

Phrase: "P.D."
Processing 00000000.tx.329: (1968) J. 

Phrase: "(1968"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.330: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.331: Soc. 

Phrase: "Soc."
Processing 00000000.tx.332: (C), 20262028. 

Phrase: "(C), 20262028."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.333: 30 Brown,D.J. and Jacobsen,N.W. 

Phrase: "30 Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "D.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Jacobsen,"

Phrase: "N.W."
Processing 00000000.tx.334: (1960) J. 

Phrase: "(1960"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.335: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.336: Soc., 19781985. 

Phrase: "Soc.,"

Phrase: "19781985."
Processing 00000000.tx.337: 31 Brown,D.M. 

Phrase: "31 Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "D."

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.338: (1974) In Tso,P.O.P. 

Phrase: "(1974"

Phrase: ")"

Phrase: "In Tso,"

Phrase: "P.O.P."
Processing 00000000.tx.339: (ed.), Basic Principles in Nucleic Acid Chemistry. 

Phrase: "(ed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538926:ED [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "Basic Principles in Nucleic Acid Chemistry."
Processing 00000000.tx.340: Academic Press, New York, NY, Vol. 

Phrase: "Academic Press,"

Phrase: "New York,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: "NY,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: "Vol."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0449468:VOL [Quantitative Concept]
  1000   C0560268:vol% [Quantitative Concept]
  1000   C1690016:% vol [Qualitative Concept]
Processing 00000000.tx.341: 2, pp. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "pp."
Processing 00000000.tx.342: 191. 

Phrase: "191."
Processing 00000000.tx.343: 32 Broxton,T.J., Colton,R. and Traeger,J.C. 

Phrase: "32 Broxton,"

Phrase: "T.J.,"

Phrase: "Colton,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Traeger,"

Phrase: "J.C."
Processing 00000000.tx.344: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.345: Mass Spectrom., 30, 319323.[ISI] 33 Broxton,T.J. and Rowe,J.E. 

Phrase: "Mass Spectrom.,"

Phrase: "30,"

Phrase: "319323."

Phrase: "[ISI] 33 Broxton,"

Phrase: "T.J."

Phrase: "and"

Phrase: "Rowe,"

Phrase: "J.E."
Processing 00000000.tx.346: (1977) Org. 

Phrase: "(1977"

Phrase: ")"

Phrase: "Org."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522486:ORG [Professional or Occupational Group]
Processing 00000000.tx.347: Mass Spectrom., 12, 185190.[ISI] 34 Gasper,S.M., Devadoss,C. and Schuster,G.B. 

Phrase: "Mass Spectrom.,"

Phrase: "12,"

Phrase: "185190."

Phrase: "[ISI] 34 Gasper,"

Phrase: "S.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Devadoss,"

Phrase: "C."

Phrase: "and"

Phrase: "Schuster,"

Phrase: "G.B."
Processing 00000000.tx.348: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.349: Am. 

Phrase: "Am."
Processing 00000000.tx.350: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.351: Soc., 117, 52065211.[ISI] 35 Ambroz,H.B. and Kemp,T. 

Phrase: "Soc.,"

Phrase: "117,"

Phrase: "52065211."

Phrase: "[ISI] 35 Ambroz,"

Phrase: "H.B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0919534:H-B [Gene or Genome]

Phrase: "and"

Phrase: "Kemp,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.352: (1979) J. 

Phrase: "(1979"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.353: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.354: Soc. 

Phrase: "Soc."
Processing 00000000.tx.355: Rev., 8, 353365. 

Phrase: "Rev.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]

Phrase: "8,"

Phrase: "353365."
Processing 00000000.tx.356: 36 Zollinger,H. 

Phrase: "36 Zollinger,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.357: (1978) Angew. 

Phrase: "(1978"

Phrase: ")"

Phrase: "Angew."
Processing 00000000.tx.358: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.359: Int. 

Phrase: "Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063789:INT [Organic Chemical]
  1000   C3272375:INT [Intellectual Product]
Processing 00000000.tx.360: Ed. 

Phrase: "Ed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538926:ED [Idea or Concept]
Processing 00000000.tx.361: Engl., 17, 141150.[ISI] 37 Kirmse,W. and Scheidt,F. 

Phrase: "Engl.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414400:ENGL [Gene or Genome]

Phrase: "17,"

Phrase: "141150."

Phrase: "[ISI] 37 Kirmse,"

Phrase: "W."

Phrase: "and"

Phrase: "Scheidt,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.362: (1970) Chem. 

Phrase: "(1970"

Phrase: ")"

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.363: Ber., 103, 37113721.[ISI] 38 Kirmse,W. and Schtte,H. 

Phrase: "Ber.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1075351:ber [Plant]
  1000   C1158530:BER [Genetic Function]

Phrase: "103,"

Phrase: "37113721."

Phrase: "[ISI] 38 Kirmse,"

Phrase: "W."

Phrase: "and"

Phrase: "Schtte,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.364: (1968) Chem. 

Phrase: "(1968"

Phrase: ")"

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.365: Ber., 101, 16741688.[ISI] 39 Kirmse,W. 

Phrase: "Ber.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1075351:ber [Plant]
  1000   C1158530:BER [Genetic Function]

Phrase: "101,"

Phrase: "16741688."

Phrase: "[ISI] 39 Kirmse,"

Phrase: "W."
Processing 00000000.tx.366: (1976) Angew. 

Phrase: "(1976"

Phrase: ")"

Phrase: "Angew."
Processing 00000000.tx.367: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.368: Int. 

Phrase: "Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063789:INT [Organic Chemical]
  1000   C3272375:INT [Intellectual Product]
Processing 00000000.tx.369: Ed. 

Phrase: "Ed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538926:ED [Idea or Concept]
Processing 00000000.tx.370: Engl., 15, 251261.[ISI]

Phrase: "Engl.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414400:ENGL [Gene or Genome]

Phrase: "15,"

Phrase: "251261."

Phrase: "[ISI"

Phrase: "]"

